{
  "schemaVersion": "deck-intelligence.v1",
  "id": "019de075-3cec-7700-94db-076a5ce30d84",
  "slug": "8c2d629a90974743be7d15f16a23e50f",
  "title": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides",
  "subtitle": "Aeglea BioTherapeutics · 2023-07",
  "author": "Aeglea BioTherapeutics",
  "date": "2023-07-01 00:00:00",
  "pageCount": 56,
  "kind": "pitchdeck",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "document": {
    "id": "019de075-3cec-7700-94db-076a5ce30d84",
    "slug": "8c2d629a90974743be7d15f16a23e50f",
    "title": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides",
    "rawTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides",
    "authorId": "aeglea-biotherapeutics",
    "authorName": "Aeglea BioTherapeutics",
    "authorDisplay": "Aeglea BioTherapeutics",
    "kind": {
      "slug": "pitchdeck",
      "label": "Pitch deck"
    },
    "sourceType": {
      "slug": "investor_relations",
      "label": "Investor relations"
    },
    "fileName": "2023-07__aeglea-biotherapeutics__investor-pres__8c2d629a.pdf",
    "sourceUrl": "https://www.slidebook.io/company/aeglea-biotherapeutics/presentation/8c2d629a90974743be7d15f16a23e50f/",
    "sourceDate": "2023-09-30 00:00:00",
    "presentationDate": "2023-07-01 00:00:00",
    "ingestedAt": "2026-04-30 22:14:33.042649+00",
    "status": "ready",
    "pageCount": 56,
    "orientation": "landscape",
    "aspectRatio": 1.7777778,
    "targetCompany": null,
    "targetTicker": null,
    "metadata": {
      "corpus": "slidebook",
      "industry": "biotechnology",
      "local_root": "/Users/miguelsuredasuau/Desktop/lalalalla/_scrape/slidebook/decks/2023-07__aeglea-biotherapeutics__investor-pres__8c2d629a",
      "image_width": 1920,
      "image_format": "jpg",
      "deck_type_raw": "Investor Presentation Deck",
      "deck_type_slug": null,
      "source_url_pattern": "https://www.slidebook.io/company/{company_slug}/presentation/{deck_id}/"
    }
  },
  "coverage": {
    "pageCount": 56,
    "pagesIndexed": 56,
    "pagesWithImages": 56,
    "pagesWithMetadata": 56,
    "imageCoveragePct": 100,
    "metadataCoveragePct": 100,
    "componentCount": 270,
    "chartCount": 43,
    "metricSlides": 0,
    "toolMatches": 23,
    "documentToolMatches": 0,
    "frameworkMatches": 33,
    "arcMatches": 1,
    "beatMatches": 6,
    "loopMatches": 3,
    "patternMatches": 0,
    "storymakersMatch": false,
    "scoreAvailable": false,
    "reviewAvailable": false,
    "activistThesisAvailable": false,
    "pitchdeckMetadataAvailable": false,
    "pitchdeckProfileAvailable": false
  },
  "blocks": [],
  "matches": {
    "arcs": [
      {
        "arc": {
          "name": "Problem-Agitate-Solution",
          "slug": "problem-agitate-solution",
          "status": "active",
          "bestFor": "Sales pitches, urgency-driven, competitive displacement",
          "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
          "version": 1,
          "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
          "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
          "description": null,
          "familyLabel": null,
          "categoryName": "Strategy & Business",
          "categorySlug": "strategy-business"
        },
        "matchId": "a1bcf76f-a4ea-452c-9399-8bc5a62efe28",
        "evidence": "The document follows a clear problem-agitate-solution arc, highlighting the limitations of current treatments, the need for new approaches, and the company's solution",
        "isPrimary": true,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-07-16 22:34:50.255006+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": "doc-narrative-v1"
        }
      }
    ],
    "beats": [
      {
        "to": 4,
        "arc": {
          "name": "Problem-Agitate-Solution",
          "slug": "problem-agitate-solution",
          "status": "active",
          "bestFor": "Sales pitches, urgency-driven, competitive displacement",
          "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
          "version": 1,
          "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
          "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
          "description": null,
          "familyLabel": null,
          "categoryName": "Strategy & Business",
          "categorySlug": "strategy-business"
        },
        "from": 1,
        "name": "Setup",
        "beatId": "e1ceccc7-d9f1-43f8-940e-04c5912c3a13",
        "matchId": "a1bcf76f-a4ea-452c-9399-8bc5a62efe28",
        "beatType": {
          "name": "Setup",
          "slug": "setup",
          "status": "active",
          "canonId": "019dd9b8-020e-7505-af9b-d9b9a4679bcc",
          "version": 1,
          "description": "Where the deck grounds the reader before doing anything else. Almost every arc opens here."
        },
        "evidence": "The document sets up the company and its mission",
        "position": 0,
        "isPrimaryArc": true,
        "parentBeatType": null,
        "alignedBlockIds": null,
        "matchConfidence": 0.9
      },
      {
        "to": 8,
        "arc": {
          "name": "Problem-Agitate-Solution",
          "slug": "problem-agitate-solution",
          "status": "active",
          "bestFor": "Sales pitches, urgency-driven, competitive displacement",
          "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
          "version": 1,
          "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
          "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
          "description": null,
          "familyLabel": null,
          "categoryName": "Strategy & Business",
          "categorySlug": "strategy-business"
        },
        "from": 5,
        "name": "Problem (Identify pain)",
        "beatId": "50cfb41c-c55f-4d71-bad7-662cc5ddaf6c",
        "matchId": "a1bcf76f-a4ea-452c-9399-8bc5a62efe28",
        "beatType": {
          "name": "Problem (Identify pain)",
          "slug": "problem-agitate-solution-problem-identify-pain",
          "status": "active",
          "canonId": "019dd9b8-0e78-74bb-b8f6-54348367a131",
          "version": 1,
          "description": null
        },
        "evidence": "The document identifies the problem and the need for new approaches",
        "position": 1,
        "isPrimaryArc": true,
        "parentBeatType": {
          "name": "Complication",
          "slug": "complication",
          "status": "active",
          "canonId": "019dd9b8-0275-7709-b2d6-4f77c3fc7579",
          "version": 1,
          "description": "The point in the narrative where the audience should feel discomfort. Required for argumentative arcs."
        },
        "alignedBlockIds": null,
        "matchConfidence": 0.9
      },
      {
        "to": 12,
        "arc": {
          "name": "Problem-Agitate-Solution",
          "slug": "problem-agitate-solution",
          "status": "active",
          "bestFor": "Sales pitches, urgency-driven, competitive displacement",
          "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
          "version": 1,
          "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
          "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
          "description": null,
          "familyLabel": null,
          "categoryName": "Strategy & Business",
          "categorySlug": "strategy-business"
        },
        "from": 9,
        "name": "Agitate (Make it worse)",
        "beatId": "2c7f8b77-f27b-419f-a0e9-300e30f17da7",
        "matchId": "a1bcf76f-a4ea-452c-9399-8bc5a62efe28",
        "beatType": {
          "name": "Agitate (Make it worse)",
          "slug": "problem-agitate-solution-agitate-make-it-worse",
          "status": "active",
          "canonId": "019dd9b8-0f5a-71dd-bae7-8fadb0d09456",
          "version": 1,
          "description": null
        },
        "evidence": "The document agitates the problem, highlighting the limitations of current treatments",
        "position": 2,
        "isPrimaryArc": true,
        "parentBeatType": {
          "name": "Development",
          "slug": "development",
          "status": "active",
          "canonId": "019dd9b8-0332-7008-b3aa-11b0840a57b1",
          "version": 1,
          "description": "The middle stretch in arcs that have one. Often where length problems creep in."
        },
        "alignedBlockIds": null,
        "matchConfidence": 0.9
      },
      {
        "to": 30,
        "arc": {
          "name": "Problem-Agitate-Solution",
          "slug": "problem-agitate-solution",
          "status": "active",
          "bestFor": "Sales pitches, urgency-driven, competitive displacement",
          "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
          "version": 1,
          "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
          "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
          "description": null,
          "familyLabel": null,
          "categoryName": "Strategy & Business",
          "categorySlug": "strategy-business"
        },
        "from": 13,
        "name": "Solution (Provide relief)",
        "beatId": "5fcb9464-3068-4031-9434-ce301bbe9fd3",
        "matchId": "a1bcf76f-a4ea-452c-9399-8bc5a62efe28",
        "beatType": {
          "name": "Solution (Provide relief)",
          "slug": "problem-agitate-solution-solution-provide-relief",
          "status": "active",
          "canonId": "019dd9b8-0fee-73e9-9ae5-799c7f3895cd",
          "version": 1,
          "description": null
        },
        "evidence": "The document presents the company's solution, including its pipeline and strategy",
        "position": 3,
        "isPrimaryArc": true,
        "parentBeatType": {
          "name": "Resolution",
          "slug": "resolution",
          "status": "active",
          "canonId": "019dd9b8-045d-703b-8dd7-e92aba3ba91b",
          "version": 1,
          "description": "How the deck ends. Required in 19/20 arcs. The exception (Sparkline) ends with new bliss which is functionally a resolution."
        },
        "alignedBlockIds": null,
        "matchConfidence": 0.9
      },
      {
        "to": 44,
        "arc": {
          "name": "Problem-Agitate-Solution",
          "slug": "problem-agitate-solution",
          "status": "active",
          "bestFor": "Sales pitches, urgency-driven, competitive displacement",
          "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
          "version": 1,
          "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
          "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
          "description": null,
          "familyLabel": null,
          "categoryName": "Strategy & Business",
          "categorySlug": "strategy-business"
        },
        "from": 31,
        "name": "Evidence",
        "beatId": "5c590fe3-bdd5-4bd1-85d4-420b5f2a4608",
        "matchId": "a1bcf76f-a4ea-452c-9399-8bc5a62efe28",
        "beatType": {
          "name": "Evidence",
          "slug": "evidence",
          "status": "active",
          "canonId": "019dd9b8-03f9-772a-b84a-4f07b415b77a",
          "version": 1,
          "description": "A dedicated proof beat exists in only ~4 arcs (Gambit, Sequoia, AIDA, Monroes). Other arcs embed evidence inline within development."
        },
        "evidence": "The document provides evidence to support the company's solution",
        "position": 4,
        "isPrimaryArc": true,
        "parentBeatType": null,
        "alignedBlockIds": null,
        "matchConfidence": 0.9
      },
      {
        "to": 56,
        "arc": {
          "name": "Problem-Agitate-Solution",
          "slug": "problem-agitate-solution",
          "status": "active",
          "bestFor": "Sales pitches, urgency-driven, competitive displacement",
          "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
          "version": 1,
          "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
          "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
          "description": null,
          "familyLabel": null,
          "categoryName": "Strategy & Business",
          "categorySlug": "strategy-business"
        },
        "from": 45,
        "name": "Action",
        "beatId": "712c62dc-223b-4b2c-ba9f-cd5c102db383",
        "matchId": "a1bcf76f-a4ea-452c-9399-8bc5a62efe28",
        "beatType": {
          "name": "Action",
          "slug": "monroes-sequence-action",
          "status": "active",
          "canonId": "019dd9b8-181e-760d-befc-010c2424fa89",
          "version": 1,
          "description": null
        },
        "evidence": "The document calls for action, outlining the company's plans and milestones",
        "position": 5,
        "isPrimaryArc": true,
        "parentBeatType": {
          "name": "Resolution",
          "slug": "resolution",
          "status": "active",
          "canonId": "019dd9b8-045d-703b-8dd7-e92aba3ba91b",
          "version": 1,
          "description": "How the deck ends. Required in 19/20 arcs. The exception (Sparkline) ends with new bliss which is functionally a resolution."
        },
        "alignedBlockIds": null,
        "matchConfidence": 0.9
      }
    ],
    "loops": [
      {
        "to": 12,
        "from": 5,
        "loop": {
          "name": "11_golden_circle",
          "slug": "11-golden-circle",
          "status": "active",
          "bestFor": "Visionary leadership, brand positioning, mission statements",
          "canonId": "019dd956-6a50-7202-882d-505fcb9922ed",
          "version": 1,
          "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
          "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
          "description": "Invert the typical pitch by starting with why you exist, rather than what you do",
          "familyLabel": null,
          "categoryName": "Vision",
          "categorySlug": "vision"
        },
        "matchId": "2c2ea794-d311-4166-8444-be0ff8d81ce6",
        "evidence": "The document uses the golden circle to explain the company's mission and vision",
        "position": 0,
        "objective": "Why is this important?",
        "confidence": 0.8,
        "extraction": {
          "at": "2026-07-16 22:34:50.584918+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": "doc-narrative-v1"
        }
      },
      {
        "to": 12,
        "from": 9,
        "loop": {
          "name": "27_cost_of_inaction",
          "slug": "27-cost-of-inaction",
          "status": "active",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "canonId": "019dd956-70d1-7395-a15b-857ba858b394",
          "version": 1,
          "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "description": "Quantify what happens if the audience does nothing",
          "familyLabel": null,
          "categoryName": "Urgency",
          "categorySlug": "urgency"
        },
        "matchId": "f38e4bf0-5d35-4227-a5cd-f584d52537ff",
        "evidence": "The document highlights the limitations of current treatments and the need for new approaches",
        "position": 1,
        "objective": "What are the consequences of not acting?",
        "confidence": 0.7,
        "extraction": {
          "at": "2026-07-16 22:34:50.628606+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": "doc-narrative-v1"
        }
      },
      {
        "to": 30,
        "from": 13,
        "loop": {
          "name": "47_quick_win_big_bet",
          "slug": "47-quick-win-big-bet",
          "status": "active",
          "bestFor": "Transformation planning, 100-day plans, resource allocation",
          "canonId": "019dd956-790d-708d-983e-ef9bbc68f741",
          "version": 1,
          "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
          "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap",
          "description": "Separate initiatives into immediate wins and longer-term strategic bets",
          "familyLabel": null,
          "categoryName": "Consulting Framework",
          "categorySlug": "consulting-framework"
        },
        "matchId": "1d2b0809-4269-4aea-a725-b67c9452d570",
        "evidence": "The document presents the company's solution, including its pipeline and strategy",
        "position": 2,
        "objective": "What is the company's solution?",
        "confidence": 0.8,
        "extraction": {
          "at": "2026-07-16 22:34:50.673683+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": "doc-narrative-v1"
        }
      }
    ],
    "tools": [
      {
        "tool": {
          "name": "Slide recipe: Cover",
          "slug": "cover-slide",
          "status": "active",
          "bestFor": null,
          "canonId": "019df269-2a08-767d-9128-e7431e6fe8a3",
          "version": 1,
          "bodyDocId": "019df269-29e5-7738-b5fa-6892e5dc8e65",
          "description": "The first ten seconds. Build it deliberately.",
          "familyLabel": "slide-recipe",
          "categoryName": "Slide",
          "categorySlug": "slide"
        },
        "agent": "designer",
        "layer": "slide",
        "agents": [
          "designer"
        ],
        "matchId": "2cdb45f5-1b26-43ae-b700-b9d56c26c24b",
        "evidence": "CORPORATE OVERVIEW",
        "pageRefs": null,
        "priority": null,
        "whenToUse": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-07-17 00:26:45.650887+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 1,
        "whyItWorks": null,
        "antipattern": null,
        "cardinality": null,
        "narrativePurpose": null
      },
      {
        "tool": {
          "name": "2x2 matrix",
          "slug": "matrix-2x2",
          "status": "active",
          "bestFor": null,
          "canonId": "019dd9e1-50ab-72d1-8afb-3ab0a38e32a8",
          "version": 1,
          "bodyDocId": null,
          "description": "BCG matrix, importance/urgency, any axes-and-quadrants frame.",
          "familyLabel": null,
          "categoryName": null,
          "categorySlug": null
        },
        "agent": null,
        "layer": "slide",
        "agents": null,
        "matchId": "c286e321-5d61-4a4e-93f5-a528e43faae1",
        "evidence": "Comparison matrix of Entyvio IV, Entyvio SC, and SPY001 across 8 clinical/convenience attributes.",
        "pageRefs": null,
        "priority": null,
        "whenToUse": null,
        "confidence": 0.7,
        "extraction": {
          "at": "2026-07-17 00:26:46.791036+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 17,
        "whyItWorks": null,
        "antipattern": null,
        "cardinality": "common",
        "narrativePurpose": null
      },
      {
        "tool": {
          "name": "List presentation",
          "slug": "list-presentation",
          "status": "active",
          "bestFor": null,
          "canonId": "019dd9e1-4ef7-777d-ba68-9074c2b3bcf1",
          "version": 1,
          "bodyDocId": null,
          "description": "Bulleted, numbered, or checklist enumerations.",
          "familyLabel": null,
          "categoryName": null,
          "categorySlug": null
        },
        "agent": null,
        "layer": "slide",
        "agents": null,
        "matchId": "57971335-dbd9-472b-a17b-3ca6288d4cab",
        "evidence": "list/bullet: High concentration SC: Ability to formulate at >150 mg/mL with low viscosity, Citrate-free formulation may improve patient comfort",
        "pageRefs": null,
        "priority": null,
        "whenToUse": null,
        "confidence": 0.8,
        "extraction": {
          "at": "2026-07-17 00:26:46.861455+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 18,
        "whyItWorks": null,
        "antipattern": null,
        "cardinality": "common",
        "narrativePurpose": null
      },
      {
        "tool": {
          "name": "Chart Selection Guide",
          "slug": "chart-selection-guide",
          "status": "active",
          "bestFor": null,
          "canonId": "019dd956-b1a0-700b-ba17-0e16c4d5bcae",
          "version": 1,
          "bodyDocId": null,
          "description": "Choosing the right chart type for your data and message",
          "familyLabel": null,
          "categoryName": "Slide",
          "categorySlug": "slide"
        },
        "agent": "Designer",
        "layer": "slide",
        "agents": [
          "Designer"
        ],
        "matchId": "2e8697b4-3e25-4cb6-b8b9-51479d4e166a",
        "evidence": "chart/line: Blocking MADCAM-1 Adhesion dose-response curve",
        "pageRefs": null,
        "priority": null,
        "whenToUse": null,
        "confidence": 0.7,
        "extraction": {
          "at": "2026-07-17 00:26:46.930903+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 19,
        "whyItWorks": null,
        "antipattern": null,
        "cardinality": null,
        "narrativePurpose": null
      },
      {
        "tool": {
          "name": "Data Story Arc",
          "slug": "data-story-arc",
          "status": "active",
          "bestFor": null,
          "canonId": "019dd956-9c30-728e-b974-d3fb123dcf5a",
          "version": 1,
          "bodyDocId": null,
          "description": "Context → Conflict → Insight → Implication structure for data narratives",
          "familyLabel": null,
          "categoryName": "Loop",
          "categorySlug": "loop"
        },
        "agent": "Storyteller",
        "layer": "slide",
        "agents": [
          "Storyteller"
        ],
        "matchId": "a26e1205-6922-46d0-89de-716f7abfa4d6",
        "evidence": "chart/line: Binding curve showing Cell Binding (MFI) vs Antibody Concentration (nM) for SPY001 and Vedolizumab across 3 donors.",
        "pageRefs": null,
        "priority": "Core",
        "whenToUse": null,
        "confidence": 0.6,
        "extraction": {
          "at": "2026-07-17 00:26:47.000208+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 20,
        "whyItWorks": null,
        "antipattern": null,
        "cardinality": null,
        "narrativePurpose": null
      },
      {
        "tool": {
          "name": "Chart Selection Guide",
          "slug": "chart-selection-guide",
          "status": "active",
          "bestFor": null,
          "canonId": "019dd956-b1a0-700b-ba17-0e16c4d5bcae",
          "version": 1,
          "bodyDocId": null,
          "description": "Choosing the right chart type for your data and message",
          "familyLabel": null,
          "categoryName": "Slide",
          "categorySlug": "slide"
        },
        "agent": "Designer",
        "layer": "slide",
        "agents": [
          "Designer"
        ],
        "matchId": "efb522bb-5653-401e-9e9c-3e9a39b0ce00",
        "evidence": "chart/line: Pharmacokinetics in NHP, IV Bolus",
        "pageRefs": null,
        "priority": null,
        "whenToUse": null,
        "confidence": 0.7,
        "extraction": {
          "at": "2026-07-17 00:26:47.069103+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 21,
        "whyItWorks": null,
        "antipattern": null,
        "cardinality": null,
        "narrativePurpose": null
      },
      {
        "tool": {
          "name": "Comparison frame",
          "slug": "comparison-frame",
          "status": "active",
          "bestFor": null,
          "canonId": "019dd9e1-484b-7399-a4fc-d14644b99f93",
          "version": 1,
          "bodyDocId": null,
          "description": "Two or more states/subjects placed side by side to expose a gap.",
          "familyLabel": null,
          "categoryName": null,
          "categorySlug": null
        },
        "agent": null,
        "layer": "slide",
        "agents": null,
        "matchId": "92742dd5-05ce-4be9-b87c-68805d5600d2",
        "evidence": "chart/bar-horizontal: Seasonal or every other month injections",
        "pageRefs": null,
        "priority": null,
        "whenToUse": null,
        "confidence": 0.6,
        "extraction": {
          "at": "2026-07-17 00:26:47.172286+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 23,
        "whyItWorks": null,
        "antipattern": null,
        "cardinality": "common",
        "narrativePurpose": null
      },
      {
        "tool": {
          "name": "Problem-Agitate-Solve (PAS)",
          "slug": "problem-agitate-solve-pas",
          "status": "active",
          "bestFor": null,
          "canonId": "019dd956-869f-7564-8d42-de54ed29ab90",
          "version": 1,
          "bodyDocId": null,
          "description": "Identify problem, agitate the pain, present the solution",
          "familyLabel": null,
          "categoryName": "Block",
          "categorySlug": "block"
        },
        "agent": "Storyteller",
        "layer": "slide",
        "agents": [
          "Storyteller"
        ],
        "matchId": "3365a66c-9b8d-4c40-95d4-ed51193f75f1",
        "evidence": "list/bullet: Slow onset of vedolizumab efficacy may be explained by insufficient dosing.",
        "pageRefs": null,
        "priority": null,
        "whenToUse": null,
        "confidence": 0.6,
        "extraction": {
          "at": "2026-07-17 00:26:47.241501+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 24,
        "whyItWorks": null,
        "antipattern": null,
        "cardinality": null,
        "narrativePurpose": null
      },
      {
        "tool": {
          "name": "Thesis archetype",
          "slug": "thesis-archetype",
          "status": "active",
          "bestFor": null,
          "canonId": "019dd9e1-4b0b-7428-9b26-f171d1e753fb",
          "version": 1,
          "bodyDocId": null,
          "description": "A canonical investment / activist thesis shape (breakup, fraud, governance).",
          "familyLabel": null,
          "categoryName": null,
          "categorySlug": null
        },
        "agent": null,
        "layer": "slide",
        "agents": null,
        "matchId": "daae947d-1004-4fcf-96ed-ca8adc2f7c2f",
        "evidence": "list/bullet: Promising early data: SPY001 observed to match vedolizumab's potency and selectivity and has ~2x half-life in NHPs",
        "pageRefs": null,
        "priority": null,
        "whenToUse": null,
        "confidence": 0.7,
        "extraction": {
          "at": "2026-07-17 00:26:47.344792+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 26,
        "whyItWorks": null,
        "antipattern": null,
        "cardinality": "optional",
        "narrativePurpose": null
      },
      {
        "tool": {
          "name": "Slide recipe: the peer-gap chart",
          "slug": "peer-gap-chart-recipe",
          "status": "active",
          "bestFor": null,
          "canonId": "019df269-2b04-75bc-ad85-e0179264bdd7",
          "version": 1,
          "bodyDocId": "019df269-2ae1-771d-9cd1-193a2e25f21c",
          "description": "The single most-copied slide in activism. This is the exact layout, used",
          "familyLabel": "slide-recipe",
          "categoryName": "Slide",
          "categorySlug": "slide"
        },
        "agent": "designer",
        "layer": "slide",
        "agents": [
          "designer"
        ],
        "matchId": "8fdaaf4e-219c-406e-8580-d42854a76124",
        "evidence": "chart/bar-grouped: Market cap comps at key events: Projected",
        "pageRefs": null,
        "priority": null,
        "whenToUse": null,
        "confidence": 0.6,
        "extraction": {
          "at": "2026-07-17 00:26:47.414348+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 27,
        "whyItWorks": null,
        "antipattern": null,
        "cardinality": null,
        "narrativePurpose": null
      },
      {
        "tool": {
          "name": "Audience Definition",
          "slug": "audience-definition",
          "status": "active",
          "bestFor": null,
          "canonId": "019dd956-7f2a-775d-aeee-ff099bcb7756",
          "version": 1,
          "bodyDocId": null,
          "description": "Six key questions: Who are they? What do they know? What do they believe? What do they care about? What do they fear? What decisions can they make?",
          "familyLabel": null,
          "categoryName": "Block",
          "categorySlug": "block"
        },
        "agent": "Storyteller",
        "layer": "slide",
        "agents": [
          "Storyteller"
        ],
        "matchId": "187c366a-ad52-4186-a14f-0778141e5bc3",
        "evidence": "The slide mentions expert calls with N=14 gastroenterologists, indicating a specific audience.",
        "pageRefs": null,
        "priority": "Core",
        "whenToUse": null,
        "confidence": 0.7,
        "extraction": {
          "at": "2026-07-17 00:26:47.064203+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 29,
        "whyItWorks": null,
        "antipattern": null,
        "cardinality": null,
        "narrativePurpose": null
      },
      {
        "tool": {
          "name": "Analytical method",
          "slug": "analytical-method",
          "status": "active",
          "bestFor": null,
          "canonId": "b42c4911-7946-49b5-951c-5f3d23f4e2bd",
          "version": 1,
          "bodyDocId": null,
          "description": "Diagnostic / structuring methods (5-whys, fishbone, issue tree, hypothesis-driven).",
          "familyLabel": null,
          "categoryName": null,
          "categorySlug": null
        },
        "agent": null,
        "layer": "slide",
        "agents": null,
        "matchId": "f1e3ea7f-43f6-4d27-a630-9c761c4f43c1",
        "evidence": "The slide presents data from multiple studies, indicating an analytical approach.",
        "pageRefs": null,
        "priority": null,
        "whenToUse": null,
        "confidence": 0.7,
        "extraction": {
          "at": "2026-07-17 00:26:47.170925+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 31,
        "whyItWorks": null,
        "antipattern": null,
        "cardinality": "common",
        "narrativePurpose": null
      },
      {
        "tool": {
          "name": "2x2 matrix",
          "slug": "matrix-2x2",
          "status": "active",
          "bestFor": null,
          "canonId": "019dd9e1-50ab-72d1-8afb-3ab0a38e32a8",
          "version": 1,
          "bodyDocId": null,
          "description": "BCG matrix, importance/urgency, any axes-and-quadrants frame.",
          "familyLabel": null,
          "categoryName": null,
          "categorySlug": null
        },
        "agent": null,
        "layer": "slide",
        "agents": null,
        "matchId": "c98c797a-85d6-40e6-b8a1-5ecb259fc542",
        "evidence": "Although not explicitly a 2x2 matrix, the comparison table could be interpreted as a form of matrix analysis.",
        "pageRefs": null,
        "priority": null,
        "whenToUse": null,
        "confidence": 0.5,
        "extraction": {
          "at": "2026-07-17 00:26:47.240961+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 32,
        "whyItWorks": null,
        "antipattern": null,
        "cardinality": "common",
        "narrativePurpose": null
      },
      {
        "tool": {
          "name": "Action Titles",
          "slug": "action-titles",
          "status": "active",
          "bestFor": "Any decision-grade deliverable — strategy recommendation, board update, investment memo, M&A review, post-mortem — where the reader is being asked to agree, decide, or act and will skim the title bar at speed.",
          "canonId": "019dd956-ac70-700b-a608-ba58e78f5dcc",
          "version": 1,
          "bodyDocId": "816dad3c-9983-41c1-a86e-978ebd582841",
          "description": "The McKinsey-bred discipline of writing every slide title as a complete declarative sentence with a verb and an insight, not a topic label. Each title is a sub-claim that ladders up to the deck's governing thought; read in sequence, the titles reconstruct the executive summary.",
          "familyLabel": null,
          "categoryName": "Slide",
          "categorySlug": "slide"
        },
        "agent": "Architect",
        "layer": "slide",
        "agents": [
          "Architect"
        ],
        "matchId": "c33715b2-6fb4-40ba-b9d6-7a572565f3f6",
        "evidence": "The slide contains action titles such as 'Spyre is a pioneer in developing best-in-class mAbs'.",
        "pageRefs": null,
        "priority": "Core",
        "whenToUse": "Any decision-grade deliverable — strategy recommendation, board update, investment memo, M&A review, post-mortem — where the reader is being asked to agree, decide, or act and will skim the title bar at speed.",
        "confidence": 0.7,
        "extraction": {
          "at": "2026-07-17 00:26:47.518947+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 39,
        "whyItWorks": "Solves two failure modes at once. (1) The buried claim: action titles place the conclusion on the page before any analysis is read, so a busy reader doesn't reverse-engineer it from the chart. (2) The spineless deck: because each title is a claim, slides have to ladder up to the governing thought; logical gaps become visible as topic-shaped titles in a sequence that no longer reads as a story.",
        "antipattern": "Topic labels disguised as titles — Volume by quarter, Key findings, Pricing strategy, Margins have been impacted. No verb, or a passive verb with no agent, or a fact (Revenue grew 12%) without the so-what. Also: titles that overreach the chart's evidence, multi-claim X-grew-but-Y-fell welded titles, and mechanical repetition of the same X-drove-Y template across the deck.",
        "cardinality": null,
        "narrativePurpose": "Forces the deck to carry its argument in the title bar so a senior reader can extract the recommendation without opening a single slide; converts a binder of topics into a navigable pyramid where every slide is a node defending the apex."
      },
      {
        "tool": {
          "name": "Audience Definition",
          "slug": "audience-definition",
          "status": "active",
          "bestFor": null,
          "canonId": "019dd956-7f2a-775d-aeee-ff099bcb7756",
          "version": 1,
          "bodyDocId": null,
          "description": "Six key questions: Who are they? What do they know? What do they believe? What do they care about? What do they fear? What decisions can they make?",
          "familyLabel": null,
          "categoryName": "Block",
          "categorySlug": "block"
        },
        "agent": "Storyteller",
        "layer": "slide",
        "agents": [
          "Storyteller"
        ],
        "matchId": "84476625-8ef6-4b4d-88dd-eb7791b6e217",
        "evidence": "The slide seems to be targeted towards investors or stakeholders in the pharmaceutical industry, indicating a specific audience definition.",
        "pageRefs": null,
        "priority": "Core",
        "whenToUse": null,
        "confidence": 0.7,
        "extraction": {
          "at": "2026-07-17 03:38:14.138225+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 44,
        "whyItWorks": null,
        "antipattern": null,
        "cardinality": null,
        "narrativePurpose": null
      },
      {
        "tool": {
          "name": "Big Idea Formula",
          "slug": "big-idea-formula",
          "status": "active",
          "bestFor": "Any narrative-driven persuasive deck whose job is to move the audience: keynotes, fundraising pitches, capital-allocation board asks, all-hands behaviour-change talks, conference talks meant to shift mental models. Use it before structuring; pair with Pyramid when the deck must also withstand line-by-line scrutiny.",
          "canonId": "019dd956-7dd1-74d7-9866-ffdef19ecfbf",
          "version": 1,
          "bodyDocId": "c30d7484-69e0-4e21-82cf-20fa0966869e",
          "description": "Nancy Duarte's articulation of how to frame a presentation's central message: the speaker's unique point of view plus what's at stake for the audience, expressed as one complete declarative sentence. The narrative-driven counterpart to Minto's analytical governing thought.",
          "familyLabel": null,
          "categoryName": "Block",
          "categorySlug": "block"
        },
        "agent": "Storyteller",
        "layer": "slide",
        "agents": [
          "Storyteller"
        ],
        "matchId": "16bfd72d-eff5-45ce-b226-f419fe10c2c6",
        "evidence": "The slide presents a clear and concise big idea: 'the future of IBD includes combination therapies and precision approaches to break the therapeutic ceiling'.",
        "pageRefs": null,
        "priority": "Core",
        "whenToUse": "Any narrative-driven persuasive deck whose job is to move the audience: keynotes, fundraising pitches, capital-allocation board asks, all-hands behaviour-change talks, conference talks meant to shift mental models. Use it before structuring; pair with Pyramid when the deck must also withstand line-by-line scrutiny.",
        "confidence": 0.7,
        "extraction": {
          "at": "2026-07-17 03:38:14.176576+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 44,
        "whyItWorks": "Solves the topic-not-thesis trap and the stake-less recommendation trap simultaneously. A single declarative sentence with a verb forces the speaker's stance into the room; routing the consequence through the word 'you' translates internal urgency into the audience's currency. The result is short enough to be repeated after the meeting — and that repetition is the persuasion mechanism.",
        "antipattern": "A topic dressed as a thesis ('Sustainability Roadmap 2026'), a stake attached to the speaker rather than the audience, two ideas spliced with 'and', abstract verbs (leverage / unlock / empower) that survive deletion, or writing the Big Idea after the deck is already built so the slides don't actually defend it.",
        "cardinality": null,
        "narrativePurpose": "Forces the deck to commit to a single declarative thesis before slide one — a sentence that names the speaker's stance and routes a consequence through the audience's currency. Acts as the filter every slide, anecdote, and chart must ladder up to."
      },
      {
        "tool": {
          "name": "SCQA Framework",
          "slug": "scqa-framework",
          "status": "active",
          "bestFor": null,
          "canonId": "019dd956-7bcb-763f-bdf6-1dfedf3bd36c",
          "version": 1,
          "bodyDocId": "019df22a-a0b0-719e-937e-2ac31e53d32c",
          "description": "Situation, Complication, Question, Answer - structured problem framing",
          "familyLabel": null,
          "categoryName": "Block",
          "categorySlug": "block"
        },
        "agent": "Architect",
        "layer": "slide",
        "agents": [
          "Architect"
        ],
        "matchId": "c9f21eef-0aa7-4992-a83f-fe583d362db6",
        "evidence": "The slide follows a general SCQA ( Situation, Complication, Question, Answer) framework.",
        "pageRefs": null,
        "priority": "Core",
        "whenToUse": null,
        "confidence": 0.5,
        "extraction": {
          "at": "2026-07-17 03:38:14.216092+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 44,
        "whyItWorks": null,
        "antipattern": null,
        "cardinality": null,
        "narrativePurpose": null
      },
      {
        "tool": {
          "name": "Chart Selection Guide",
          "slug": "chart-selection-guide",
          "status": "active",
          "bestFor": null,
          "canonId": "019dd956-b1a0-700b-ba17-0e16c4d5bcae",
          "version": 1,
          "bodyDocId": null,
          "description": "Choosing the right chart type for your data and message",
          "familyLabel": null,
          "categoryName": "Slide",
          "categorySlug": "slide"
        },
        "agent": "Designer",
        "layer": "slide",
        "agents": [
          "Designer"
        ],
        "matchId": "d68d4fbe-faa9-4e8b-ae5e-1c71ff4c1188",
        "evidence": "The slide uses bar charts to display clinical remission data.",
        "pageRefs": null,
        "priority": null,
        "whenToUse": null,
        "confidence": 0.5,
        "extraction": {
          "at": "2026-07-17 03:38:14.332576+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 45,
        "whyItWorks": null,
        "antipattern": null,
        "cardinality": null,
        "narrativePurpose": null
      },
      {
        "tool": {
          "name": "Evidence Matrix",
          "slug": "evidence-matrix",
          "status": "active",
          "bestFor": null,
          "canonId": "019dd956-7ecc-74c2-b46c-0b9c1f4c73d7",
          "version": 1,
          "bodyDocId": null,
          "description": "Planning visual assets: Claim → Evidence Needed → Data Source → Visual Type",
          "familyLabel": null,
          "categoryName": "Block",
          "categorySlug": "block"
        },
        "agent": "Designer",
        "layer": "slide",
        "agents": [
          "Designer"
        ],
        "matchId": "6a669d76-d616-4a23-adee-9f8eb29e3b12",
        "evidence": "The slide presents clinical data in a table format to support the proof of concept (POC) for a genetic CDx.",
        "pageRefs": null,
        "priority": null,
        "whenToUse": null,
        "confidence": 0.7,
        "extraction": {
          "at": "2026-07-17 03:38:14.293454+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 45,
        "whyItWorks": null,
        "antipattern": null,
        "cardinality": null,
        "narrativePurpose": null
      },
      {
        "tool": {
          "name": "Table data",
          "slug": "table-data",
          "status": "active",
          "bestFor": null,
          "canonId": "019dd9e1-4fab-7168-a82f-b847350a006d",
          "version": 1,
          "bodyDocId": null,
          "description": "Tabular layouts of structured data.",
          "familyLabel": null,
          "categoryName": null,
          "categorySlug": null
        },
        "agent": null,
        "layer": "slide",
        "agents": null,
        "matchId": "ce71bf24-99fa-440e-b9c6-b3c2697eb0aa",
        "evidence": "The slide presents a table with peer company data.",
        "pageRefs": null,
        "priority": null,
        "whenToUse": null,
        "confidence": 0.7,
        "extraction": {
          "at": "2026-07-17 03:38:14.480807+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 49,
        "whyItWorks": null,
        "antipattern": null,
        "cardinality": "common",
        "narrativePurpose": null
      },
      {
        "tool": {
          "name": "Slide recipe: the peer-gap chart",
          "slug": "peer-gap-chart-recipe",
          "status": "active",
          "bestFor": null,
          "canonId": "019df269-2b04-75bc-ad85-e0179264bdd7",
          "version": 1,
          "bodyDocId": "019df269-2ae1-771d-9cd1-193a2e25f21c",
          "description": "The single most-copied slide in activism. This is the exact layout, used",
          "familyLabel": "slide-recipe",
          "categoryName": "Slide",
          "categorySlug": "slide"
        },
        "agent": "designer",
        "layer": "slide",
        "agents": [
          "designer"
        ],
        "matchId": "35dabfbe-d288-4f34-bc27-8b112c237339",
        "evidence": "Comparable acquisitions illustrate optionality that exists for potential exits.",
        "pageRefs": null,
        "priority": null,
        "whenToUse": null,
        "confidence": 0.7,
        "extraction": {
          "at": "2026-07-17 03:58:10.349255+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 50,
        "whyItWorks": null,
        "antipattern": null,
        "cardinality": null,
        "narrativePurpose": null
      },
      {
        "tool": {
          "name": "2x2 matrix",
          "slug": "matrix-2x2",
          "status": "active",
          "bestFor": null,
          "canonId": "019dd9e1-50ab-72d1-8afb-3ab0a38e32a8",
          "version": 1,
          "bodyDocId": null,
          "description": "BCG matrix, importance/urgency, any axes-and-quadrants frame.",
          "familyLabel": null,
          "categoryName": null,
          "categorySlug": null
        },
        "agent": null,
        "layer": "slide",
        "agents": null,
        "matchId": "e26f0613-b299-40a5-bfc3-5cdce52d9a98",
        "evidence": "The slide presents a pentagonal framework of antibody properties.",
        "pageRefs": null,
        "priority": null,
        "whenToUse": null,
        "confidence": 0.5,
        "extraction": {
          "at": "2026-07-17 03:38:14.592918+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 54,
        "whyItWorks": null,
        "antipattern": null,
        "cardinality": "common",
        "narrativePurpose": null
      },
      {
        "tool": {
          "name": "Waterfall chart",
          "slug": "waterfall-chart",
          "status": "active",
          "bestFor": null,
          "canonId": "e2799da3-725f-44a9-a093-570f1f388e64",
          "version": 1,
          "bodyDocId": null,
          "description": null,
          "familyLabel": null,
          "categoryName": null,
          "categorySlug": null
        },
        "agent": null,
        "layer": "slide",
        "agents": null,
        "matchId": "a4767ef7-79e0-4965-a4e9-ce1f6563efcb",
        "evidence": "chart/waterfall: not present, but chart/scatter and chart/bar-vertical are present",
        "pageRefs": null,
        "priority": null,
        "whenToUse": null,
        "confidence": 0.8,
        "extraction": {
          "at": "2026-07-17 03:38:15.304113+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 56,
        "whyItWorks": null,
        "antipattern": null,
        "cardinality": null,
        "narrativePurpose": null
      }
    ],
    "frameworks": [
      {
        "matchId": "504c094a-3407-4e0a-813d-922a03861770",
        "evidence": "Pipeline development timeline visualization",
        "framework": null,
        "confidence": 0.8,
        "extraction": {
          "at": "2026-05-02 11:46:10.253+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 5,
        "frameworkName": "gantt-chart"
      },
      {
        "matchId": "bc506c21-6819-4419-b132-7afa4a88234c",
        "evidence": "Contrasts current SOC with future target to define the market gap.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 11:46:10.922+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 8,
        "frameworkName": "comparison-frame"
      },
      {
        "matchId": "4547a060-1649-4565-a423-b9fa12681f52",
        "evidence": "The slide explicitly structures the strategy into three numbered pillars.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 11:46:10.583+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 9,
        "frameworkName": "strategic-pillars"
      },
      {
        "matchId": "f478f9bc-8b5e-4a1c-9cd6-ac243fee6d13",
        "evidence": "Comparison of clinical data points against biological properties",
        "framework": null,
        "confidence": 0.8,
        "extraction": {
          "at": "2026-05-02 11:46:11.431+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 10,
        "frameworkName": "evidence-matrix"
      },
      {
        "matchId": "ced833a9-6852-4be1-8028-ba32bf24294d",
        "evidence": "Shows single agents leading to a combined, more effective outcome.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 11:46:10.901+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 11,
        "frameworkName": "before-after-framing"
      },
      {
        "matchId": "e0e7dfad-e88e-40d7-85f9-fbb3e4068f88",
        "evidence": "Uses clinical precedent data to validate the efficacy of the proposed genetic selection method.",
        "framework": null,
        "confidence": 0.8,
        "extraction": {
          "at": "2026-05-02 11:46:11.188+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 12,
        "frameworkName": "authority-citation"
      },
      {
        "matchId": "131aa868-fdb4-43f1-b6d1-f5e66ec68b57",
        "evidence": "Visual representation of project timelines and stages",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 11:46:11.421+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 13,
        "frameworkName": "gantt-chart"
      },
      {
        "matchId": "e35b22bc-dade-4ecf-8be5-874ce6ee8a40",
        "evidence": "Visual representation of project timelines and stages",
        "framework": null,
        "confidence": 1,
        "extraction": {
          "at": "2026-05-02 11:46:10.917+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 14,
        "frameworkName": "gantt-chart"
      },
      {
        "matchId": "7bef0963-153d-4e2c-ae7c-ea8654f92ab0",
        "evidence": "Compares efficacy and safety of multiple drugs in a single chart.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 11:46:11.432+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 16,
        "frameworkName": "comparison_frame"
      },
      {
        "matchId": "d526653a-acca-4d5d-8c46-541a2d06d417",
        "evidence": "Feature-by-feature comparison table against competitors",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 11:46:11.797+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 17,
        "frameworkName": "comparison_frame"
      },
      {
        "matchId": "549a5507-1539-4fc9-bdea-63abcc53d606",
        "evidence": "Direct visual comparison of two products across key metrics (dosing frequency, comfort).",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 11:46:12.588+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 23,
        "frameworkName": "comparison-frame"
      },
      {
        "matchId": "0783aa15-4946-4614-96c8-6e4e421a85e2",
        "evidence": "Upcoming catalysts section uses a linear timeline representation",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 11:46:13.155+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 26,
        "frameworkName": "timeline"
      },
      {
        "matchId": "fcf1c03d-fc0b-4e3d-b38d-e934d3fd3681",
        "evidence": "The slide uses a horizontal timeline to map clinical milestones to projected value inflection points.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 11:46:14.256+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 27,
        "frameworkName": "timeline"
      },
      {
        "matchId": "723704dd-0bcc-43f3-95c1-114e4dc3a0e5",
        "evidence": "The slide explicitly compares the company's asset against two key competitors across standardized clinical metrics.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 11:46:13.217+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 28,
        "frameworkName": "comparison_frame"
      },
      {
        "matchId": "1294e997-0420-4e4e-ab7d-1d518bb9852c",
        "evidence": "Use of KOL quotes to validate market preference",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 11:46:17.315+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 29,
        "frameworkName": "authority-citation"
      },
      {
        "matchId": "f4fa3973-3fff-4570-960d-eb5247fb56d4",
        "evidence": "Pipeline development stages over time",
        "framework": null,
        "confidence": 0.8,
        "extraction": {
          "at": "2026-05-02 11:46:13.156+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 30,
        "frameworkName": "gantt-chart"
      },
      {
        "matchId": "c114ba61-99a1-4201-9031-cda16099effa",
        "evidence": "Comparing efficacy of different drug classes against a benchmark",
        "framework": null,
        "confidence": 0.8,
        "extraction": {
          "at": "2026-05-02 11:46:14.146+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 31,
        "frameworkName": "comparison_frame"
      },
      {
        "matchId": "68f27c1d-66d3-46b0-9ec9-c0cb0ed5584e",
        "evidence": "The slide uses a feature-by-feature comparison table to establish competitive superiority.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 11:46:14.084+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 32,
        "frameworkName": "comparison-frame"
      },
      {
        "matchId": "dcd82ff2-1f5e-40da-bcea-0b28fd9216d7",
        "evidence": "Comparing clinical trial data between two competitors to justify a strategic product development decision.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 11:46:13.844+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 34,
        "frameworkName": "comparison_frame"
      },
      {
        "matchId": "87441833-b3d8-4459-8d98-0829660edd7f",
        "evidence": "Visual progression of indications over time/scale",
        "framework": null,
        "confidence": 0.8,
        "extraction": {
          "at": "2026-05-02 11:46:16.677+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 37,
        "frameworkName": "roadmap"
      },
      {
        "matchId": "b710d2c3-7dae-4310-8fe2-feb5577120e3",
        "evidence": "Visual representation of drug development stages across multiple programs",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 11:46:14.851+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 38,
        "frameworkName": "pipeline-chart"
      },
      {
        "matchId": "d764f74c-ac6b-4998-a4bb-d2df44303517",
        "evidence": "Comparing single agents against a combination therapy to demonstrate additive value.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 11:46:15.11+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 40,
        "frameworkName": "comparison_frame"
      },
      {
        "matchId": "c8aa86ea-5c51-4aeb-9d55-262947018935",
        "evidence": "Table comparing competitor JNJ-4804 against Spyre's internal programs.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 11:46:15.71+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 41,
        "frameworkName": "comparison_frame"
      },
      {
        "matchId": "b338290d-bfc3-46b0-bf2e-335ffa29eead",
        "evidence": "The slide depicts a sequential progression of clinical trial phases over time.",
        "framework": null,
        "confidence": 1,
        "extraction": {
          "at": "2026-05-02 11:46:16.035+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 42,
        "frameworkName": "timeline"
      },
      {
        "matchId": "21662e4d-2d2a-45f8-bb13-306a9e98dae2",
        "evidence": "JNJ VEGA study precedent",
        "framework": null,
        "confidence": 0.8,
        "extraction": {
          "at": "2026-05-02 11:46:15.609+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 43,
        "frameworkName": "authority-citation"
      },
      {
        "matchId": "cf470829-c85e-4007-8bed-682dfc81df39",
        "evidence": "Venn diagram used to show target overlap",
        "framework": null,
        "confidence": 1,
        "extraction": {
          "at": "2026-05-02 11:46:15.829+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 44,
        "frameworkName": "venn"
      },
      {
        "matchId": "9ae806ff-4a3b-4a8f-accc-50ed9d6f90a8",
        "evidence": "Side-by-side comparison of two clinical trial outcomes to validate a business thesis.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 11:46:15.472+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 45,
        "frameworkName": "comparison_frame"
      },
      {
        "matchId": "fc4041ba-3fea-44d0-a062-44a83a1a24c9",
        "evidence": "The slide uses a horizontal timeline structure to track project milestones over time.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 11:46:19.325+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 48,
        "frameworkName": "gantt-chart"
      },
      {
        "matchId": "0ac3f694-4d2c-4ba5-afb6-50ac7d8ae793",
        "evidence": "Comparing peer company performance metrics against internal projections.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 11:46:16.543+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 49,
        "frameworkName": "comparison_frame"
      },
      {
        "matchId": "6407fe20-dd36-4c09-ac39-44a3f091b1db",
        "evidence": "Compares historical M&A data against internal pipeline milestones to establish valuation potential.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 11:46:16.552+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 50,
        "frameworkName": "comparison_frame"
      },
      {
        "matchId": "e4f78b45-81bd-4c83-a26d-385126fc314b",
        "evidence": "Leveraging partner reputation to validate internal development",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 11:46:17.196+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 52,
        "frameworkName": "credibility-transfer"
      },
      {
        "matchId": "b062bcb0-3e9a-4e7e-ae11-f8ad490240ab",
        "evidence": "Visual representation of 5 key optimization pillars",
        "framework": null,
        "confidence": 0.8,
        "extraction": {
          "at": "2026-05-02 11:46:16.962+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 54,
        "frameworkName": "Pentagon Framework"
      },
      {
        "matchId": "89591c26-5439-4c90-9705-1378ea67a949",
        "evidence": "Visual flow of antibody recycling mechanism",
        "framework": null,
        "confidence": 0.8,
        "extraction": {
          "at": "2026-05-02 11:46:17.318+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 55,
        "frameworkName": "process"
      }
    ],
    "patterns": []
  },
  "storymakers": null,
  "score": null,
  "review": null,
  "activistThesis": null,
  "pitchdeck": {
    "metadata": null,
    "profile": null
  },
  "slides": [
    {
      "page": 1,
      "type": "setup",
      "function": "front_matter",
      "imagePath": "https://imgproxy.kitesheet.com/DW4xSllPctnzlqJ3bXDRgoZZDraFANLKCpS9ZLarT9A/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy84YzJkNjI5YTkwOTc0NzQzYmU3ZDE1ZjE2YTIzZTUwZi9wMDAxLmpwZw",
      "rawType": "cover",
      "block": null,
      "metadata": {
        "slideType": "cover",
        "slideTypeCanon": {
          "name": "Cover",
          "slug": "cover",
          "status": "active",
          "canonId": "019de52d-05f2-729d-9f93-e0504f0a2410",
          "version": 1,
          "description": null
        },
        "function": "front_matter",
        "functionCanon": {
          "name": "Front matter",
          "slug": "front_matter",
          "status": "active",
          "canonId": "019de52d-133d-73f0-9e26-201eda96b098",
          "version": 1,
          "description": null
        },
        "density": "sparse",
        "densityScore": 19,
        "componentCount": 4,
        "textChars": 59,
        "nDataPoints": 0,
        "notes": null,
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:46:09.725+00",
          "seconds": 2.63,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de075-3cec-7700-94db-076a5ce30d84/1",
        "deck": "/decks/019de075-3cec-7700-94db-076a5ce30d84",
        "deckAnchor": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-1",
        "deckJson": "/decks/019de075-3cec-7700-94db-076a5ce30d84.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.15,
            "w": 0.25,
            "x": 0.05,
            "y": 0.3
          },
          "kind": "image",
          "text": "Spyre Therapeutics logo",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Logo",
              "slug": "logo",
              "status": "active",
              "canonId": "019de52c-fdaf-743d-94c4-d7c6a0e55302",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "logo",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:09.725+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "709e3359-6f66-44dd-8ef6-c7f2a7a3455d",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.25,
            "x": 0.05,
            "y": 0.15
          },
          "kind": "image",
          "text": "Aeglea logo",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Logo",
              "slug": "logo",
              "status": "active",
              "canonId": "019de52c-fdaf-743d-94c4-d7c6a0e55302",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "logo",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:09.725+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "c224b5f7-a228-4608-8844-9018bb86fa48",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.1,
            "x": 0.4,
            "y": 0.65
          },
          "kind": "paragraph",
          "text": "Q3 2023",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:09.725+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "1a9f3fb2-6fe9-4af4-b720-56e5b8f5fd58",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.5,
            "x": 0.4,
            "y": 0.5
          },
          "kind": "title",
          "text": "CORPORATE OVERVIEW",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:09.725+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "46fe5ba8-1d1e-49e3-851e-5888612ffcb1",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [
        {
          "tool": {
            "name": "Slide recipe: Cover",
            "slug": "cover-slide",
            "status": "active",
            "bestFor": null,
            "canonId": "019df269-2a08-767d-9128-e7431e6fe8a3",
            "version": 1,
            "bodyDocId": "019df269-29e5-7738-b5fa-6892e5dc8e65",
            "description": "The first ten seconds. Build it deliberately.",
            "familyLabel": "slide-recipe",
            "categoryName": "Slide",
            "categorySlug": "slide"
          },
          "agent": "designer",
          "layer": "slide",
          "agents": [
            "designer"
          ],
          "matchId": "2cdb45f5-1b26-43ae-b700-b9d56c26c24b",
          "evidence": "CORPORATE OVERVIEW",
          "pageRefs": null,
          "priority": null,
          "whenToUse": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-07-17 00:26:45.650887+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 1,
          "whyItWorks": null,
          "antipattern": null,
          "cardinality": null,
          "narrativePurpose": null
        }
      ],
      "frameworks": [],
      "arcBeats": [
        {
          "to": 4,
          "arc": {
            "name": "Problem-Agitate-Solution",
            "slug": "problem-agitate-solution",
            "status": "active",
            "bestFor": "Sales pitches, urgency-driven, competitive displacement",
            "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
            "description": null,
            "familyLabel": null
          },
          "from": 1,
          "name": "Setup",
          "beatId": "e1ceccc7-d9f1-43f8-940e-04c5912c3a13",
          "matchId": "a1bcf76f-a4ea-452c-9399-8bc5a62efe28",
          "beatType": {
            "name": "Setup",
            "slug": "setup",
            "status": "active",
            "canonId": "019dd9b8-020e-7505-af9b-d9b9a4679bcc",
            "version": 1,
            "description": "Where the deck grounds the reader before doing anything else. Almost every arc opens here."
          },
          "evidence": "The document sets up the company and its mission",
          "position": 0,
          "isPrimaryArc": true,
          "parentBeatType": null,
          "alignedBlockIds": null,
          "matchConfidence": 0.9
        }
      ],
      "loops": [],
      "thumbSrc": "https://imgproxy.kitesheet.com/Ifin-1l1PPTIOZ4l_WUmp_0pjcQqQbtqDAQ3oWnMEco/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy84YzJkNjI5YTkwOTc0NzQzYmU3ZDE1ZjE2YTIzZTUwZi9wMDAxLmpwZw",
      "imagePathAlt": "https://imgproxy.kitesheet.com/alZYiUoE28WUarGjF85y2afTqU2-o5QEmFzDHm3p3gE/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy84YzJkNjI5YTkwOTc0NzQzYmU3ZDE1ZjE2YTIzZTUwZi9wMDAxLnBuZw",
      "thumbSrcAlt": "https://imgproxy.kitesheet.com/_ObmrCmtOWbpDEXBzluZ2mLnMnK7nP8D4QQGQ7kuhZU/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy84YzJkNjI5YTkwOTc0NzQzYmU3ZDE1ZjE2YTIzZTUwZi9wMDAxLnBuZw"
    },
    {
      "page": 2,
      "type": "setup",
      "function": "other",
      "rawType": "appendix_disclosure",
      "block": null,
      "metadata": {
        "slideType": "appendix_disclosure",
        "slideTypeCanon": {
          "name": "Appendix disclosure",
          "slug": "appendix_disclosure",
          "status": "active",
          "canonId": "019de52d-07b2-7549-8e8b-932a19f6e616",
          "version": 1,
          "description": null
        },
        "function": "other",
        "functionCanon": {
          "name": "Other (fallback)",
          "slug": "other",
          "status": "active",
          "canonId": "019de52d-15e1-75bc-99dc-07732380e2ce",
          "version": 1,
          "description": null
        },
        "density": "sparse",
        "densityScore": 18,
        "componentCount": 3,
        "textChars": 176,
        "nDataPoints": 0,
        "notes": null,
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:46:09.136+00",
          "seconds": 2.02,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de075-3cec-7700-94db-076a5ce30d84/2",
        "deck": "/decks/019de075-3cec-7700-94db-076a5ce30d84",
        "deckAnchor": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-2",
        "deckJson": "/decks/019de075-3cec-7700-94db-076a5ce30d84.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.75,
            "w": 0.9,
            "x": 0.05,
            "y": 0.15
          },
          "kind": "disclaimer",
          "text": "The information contained in this presentation has been prepared by Aeglea Biotherapeutics, Inc. and its affiliates, including Spyre Therapeutics, Inc. ...",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Disclaimer",
              "slug": "disclaimer",
              "status": "active",
              "canonId": "91173477-d91f-4024-bbaf-d4f93e3f82dc",
              "version": 1,
              "description": "Legal/cautionary text that occupies most of the body of its slide."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:09.136+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e531acf5-7512-466f-a908-249a7363f68f",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.1,
            "x": 0.05,
            "y": 0.93
          },
          "kind": "image",
          "text": "Spyre logo",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Logo",
              "slug": "logo",
              "status": "active",
              "canonId": "019de52c-fdaf-743d-94c4-d7c6a0e55302",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "logo",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:09.136+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "965e8cc5-a187-4b27-a54c-f7c3f4228a8e",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.2,
            "x": 0.05,
            "y": 0.05
          },
          "kind": "title",
          "text": "Disclosures",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:09.136+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "c8fa124c-a1d5-464b-be91-693117bebfa2",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [
        {
          "to": 4,
          "arc": {
            "name": "Problem-Agitate-Solution",
            "slug": "problem-agitate-solution",
            "status": "active",
            "bestFor": "Sales pitches, urgency-driven, competitive displacement",
            "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
            "description": null,
            "familyLabel": null
          },
          "from": 1,
          "name": "Setup",
          "beatId": "e1ceccc7-d9f1-43f8-940e-04c5912c3a13",
          "matchId": "a1bcf76f-a4ea-452c-9399-8bc5a62efe28",
          "beatType": {
            "name": "Setup",
            "slug": "setup",
            "status": "active",
            "canonId": "019dd9b8-020e-7505-af9b-d9b9a4679bcc",
            "version": 1,
            "description": "Where the deck grounds the reader before doing anything else. Almost every arc opens here."
          },
          "evidence": "The document sets up the company and its mission",
          "position": 0,
          "isPrimaryArc": true,
          "parentBeatType": null,
          "alignedBlockIds": null,
          "matchConfidence": 0.9
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 3,
      "type": "appendix",
      "title": "The slide details a corporate M&A event and associated private placement financing.",
      "function": "summarize",
      "rawType": "other",
      "block": null,
      "metadata": {
        "slideType": "other",
        "slideTypeCanon": {
          "name": "Other (fallback)",
          "slug": "other",
          "status": "active",
          "canonId": "019de52d-0af5-71ed-83de-d51ae245fc43",
          "version": 1,
          "description": null
        },
        "function": "summarize",
        "functionCanon": {
          "name": "Summarize",
          "slug": "summarize",
          "status": "active",
          "canonId": "019de52d-1541-704f-b86f-bf7b75056373",
          "version": 1,
          "description": null
        },
        "density": "balanced",
        "densityScore": 31,
        "componentCount": 3,
        "textChars": 315,
        "nDataPoints": 1,
        "notes": "The slide details a corporate M&A event and associated private placement financing.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:46:09.858+00",
          "seconds": 2.56,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de075-3cec-7700-94db-076a5ce30d84/3",
        "deck": "/decks/019de075-3cec-7700-94db-076a5ce30d84",
        "deckAnchor": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-3",
        "deckJson": "/decks/019de075-3cec-7700-94db-076a5ce30d84.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.08,
            "w": 0.46,
            "x": 0.27,
            "y": 0.13
          },
          "kind": "image",
          "text": "Aeglea to Spyre transition",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Logo",
              "slug": "logo",
              "status": "active",
              "canonId": "019de52c-fdaf-743d-94c4-d7c6a0e55302",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "logo",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:09.858+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "533c4dd9-fb41-40e2-9ddc-982b67d12d59",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.6,
            "w": 0.9,
            "x": 0.05,
            "y": 0.25
          },
          "kind": "list",
          "text": "Structure: The acquisition of Spyre was structured as a stock-for-stock transaction... Financing: Concurrent with the acquisition... Management and BOD: Continuing leadership includes... Primary use of proceeds: The proceeds from the private placement...",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:09.858+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "5b7c5f15-1f1a-4679-b812-f1fdde6c245f",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.45,
            "x": 0.05,
            "y": 0.05
          },
          "kind": "title",
          "text": "Aeglea-Spyre Transaction highlights",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:09.858+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "be05b148-4b20-49aa-85e9-956441aaae8f",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [
        {
          "to": 4,
          "arc": {
            "name": "Problem-Agitate-Solution",
            "slug": "problem-agitate-solution",
            "status": "active",
            "bestFor": "Sales pitches, urgency-driven, competitive displacement",
            "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
            "description": null,
            "familyLabel": null
          },
          "from": 1,
          "name": "Setup",
          "beatId": "e1ceccc7-d9f1-43f8-940e-04c5912c3a13",
          "matchId": "a1bcf76f-a4ea-452c-9399-8bc5a62efe28",
          "beatType": {
            "name": "Setup",
            "slug": "setup",
            "status": "active",
            "canonId": "019dd9b8-020e-7505-af9b-d9b9a4679bcc",
            "version": 1,
            "description": "Where the deck grounds the reader before doing anything else. Almost every arc opens here."
          },
          "evidence": "The document sets up the company and its mission",
          "position": 0,
          "isPrimaryArc": true,
          "parentBeatType": null,
          "alignedBlockIds": null,
          "matchConfidence": 0.9
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 4,
      "type": "analysis",
      "title": "The slide provides a breakdown of shares and conversion ratios related to a merger and concurrent financing.",
      "function": "analyze_data",
      "rawType": "appendix_data",
      "block": null,
      "metadata": {
        "slideType": "appendix_data",
        "slideTypeCanon": {
          "name": "Appendix data",
          "slug": "appendix_data",
          "status": "active",
          "canonId": "019de52d-078a-745b-9ee4-c15f2f539acd",
          "version": 1,
          "description": null
        },
        "function": "analyze_data",
        "functionCanon": {
          "name": "Analyze data",
          "slug": "analyze_data",
          "status": "active",
          "canonId": "019de52d-1590-7413-8c82-cc218cff40b4",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 52,
        "componentCount": 3,
        "textChars": 939,
        "nDataPoints": 9,
        "notes": "The slide provides a breakdown of shares and conversion ratios related to a merger and concurrent financing.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:46:10.387+00",
          "seconds": 3.089,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de075-3cec-7700-94db-076a5ce30d84/4",
        "deck": "/decks/019de075-3cec-7700-94db-076a5ce30d84",
        "deckAnchor": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-4",
        "deckJson": "/decks/019de075-3cec-7700-94db-076a5ce30d84.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.7,
            "w": 0.38,
            "x": 0.58,
            "y": 0.18
          },
          "kind": "list",
          "text": "Shares of common stock and preferred stock were issued to Spyre security holders in exchange for all of Spyre’s outstanding equity interests. Shares of preferred stock were issued to Spyre stockholders and to investors in the $210 million private placement. Each share of preferred stock will automatically convert into 1,000 shares of common stock upon stockholder approval, subject to certain beneficial ownership restrictions set by each holder. Please refer to the company’s SEC filings for additional information.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:10.387+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "4b8526a6-7aa2-4713-be49-3709aa40e92f",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.7,
            "w": 0.45,
            "x": 0.06,
            "y": 0.15
          },
          "kind": "table",
          "text": "As of 6/20/2023; Shares of common stock outstanding 65.4 million; Pre-funded warrants 28.9 million; Merger consideration; Shares of common 13.0 million; Shares of preferred 0.4 million; Preferred conversion ratio 1:1000; Total pre-financing common equivalent 472.2 million; Concurrent financing; Shares of preferred 0.7 million; Common equivalent 721.5 million; Total capitalization (Common) 1,193.6 million",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Table",
              "slug": "table",
              "status": "active",
              "canonId": "019de52c-f9c8-7148-8119-eaac9594cd28",
              "version": 1,
              "description": "Tabular data layout."
            },
            "tool": null,
            "subkind": {
              "name": "Data table",
              "slug": "data",
              "status": "active",
              "canonId": "019de52d-02d5-75b8-8abf-88e92bf63569",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "data",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:10.387+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "4744154d-e24c-4433-81e7-bead310a2ce5",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.23,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Capitalization",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:10.387+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "ee17989b-779f-4299-ab25-453c638f6f1f",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [
        {
          "to": 4,
          "arc": {
            "name": "Problem-Agitate-Solution",
            "slug": "problem-agitate-solution",
            "status": "active",
            "bestFor": "Sales pitches, urgency-driven, competitive displacement",
            "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
            "description": null,
            "familyLabel": null
          },
          "from": 1,
          "name": "Setup",
          "beatId": "e1ceccc7-d9f1-43f8-940e-04c5912c3a13",
          "matchId": "a1bcf76f-a4ea-452c-9399-8bc5a62efe28",
          "beatType": {
            "name": "Setup",
            "slug": "setup",
            "status": "active",
            "canonId": "019dd9b8-020e-7505-af9b-d9b9a4679bcc",
            "version": 1,
            "description": "Where the deck grounds the reader before doing anything else. Almost every arc opens here."
          },
          "evidence": "The document sets up the company and its mission",
          "position": 0,
          "isPrimaryArc": true,
          "parentBeatType": null,
          "alignedBlockIds": null,
          "matchConfidence": 0.9
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 5,
      "type": "resolution",
      "title": "The slide uses a pipeline table format to show the progression of various drug candidates (SPY001-SPY230) across discovery, IND-enabling, and clinical stages.",
      "function": "plan_implementation",
      "rawType": "roadmap",
      "block": null,
      "metadata": {
        "slideType": "roadmap",
        "slideTypeCanon": {
          "name": "Roadmap",
          "slug": "roadmap",
          "status": "active",
          "canonId": "019de52d-0a55-72bc-9b7b-a47ef109839c",
          "version": 1,
          "description": null
        },
        "function": "plan_implementation",
        "functionCanon": {
          "name": "Plan implementation",
          "slug": "plan_implementation",
          "status": "active",
          "canonId": "019de52d-14a2-77ea-b210-d6a95eed4823",
          "version": 1,
          "description": null
        },
        "density": "balanced",
        "densityScore": 41,
        "componentCount": 5,
        "textChars": 291,
        "nDataPoints": 0,
        "notes": "The slide uses a pipeline table format to show the progression of various drug candidates (SPY001-SPY230) across discovery, IND-enabling, and clinical stages.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:46:10.253+00",
          "seconds": 2.894,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de075-3cec-7700-94db-076a5ce30d84/5",
        "deck": "/decks/019de075-3cec-7700-94db-076a5ce30d84",
        "deckAnchor": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-5",
        "deckJson": "/decks/019de075-3cec-7700-94db-076a5ce30d84.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.05,
            "w": 0.6,
            "x": 0.35,
            "y": 0.19
          },
          "kind": "callout",
          "text": "PARALLEL LEAD PROGRAMS AGAINST HIGH VALUE TARGETS",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": null,
            "subkind": {
              "name": "Primary callout",
              "slug": "primary",
              "status": "active",
              "canonId": "019de52c-fbd1-70eb-a9ce-8997f8674c1d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "primary",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:10.253+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "dd425087-b091-46e7-b830-3bb97fe71c05",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.27,
            "x": 0.04,
            "y": 0.15
          },
          "kind": "image",
          "text": "SPYRE THERAPEUTICS",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Logo",
              "slug": "logo",
              "status": "active",
              "canonId": "019de52c-fdaf-743d-94c4-d7c6a0e55302",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "logo",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:10.253+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "a8ae1916-30a2-44a0-ad94-db894e0bccf0",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.5,
            "w": 0.25,
            "x": 0.11,
            "y": 0.35
          },
          "kind": "list",
          "text": "Opportunity for best-in-class Long-acting antibodies; Rational therapeutic combinations; Precision patient selection",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:10.253+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "89e43dc8-4b68-4e0e-8944-98c7842fcac7",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.7,
            "w": 0.65,
            "x": 0.33,
            "y": 0.18
          },
          "kind": "table",
          "text": "Pipeline table showing targets, programs, and development stages",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Table",
              "slug": "table",
              "status": "active",
              "canonId": "019de52c-f9c8-7148-8119-eaac9594cd28",
              "version": 1,
              "description": "Tabular data layout."
            },
            "tool": null,
            "subkind": {
              "name": "Data table",
              "slug": "data",
              "status": "active",
              "canonId": "019de52d-02d5-75b8-8abf-88e92bf63569",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "data",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:10.253+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "d411d71c-e32b-4e4e-9c92-a066e1fa142a",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.45,
            "x": 0.03,
            "y": 0.04
          },
          "kind": "title",
          "text": "Spyre aims to transform the treatment of IBD",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:10.253+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "9f5c9df5-23f7-48ae-a173-61bef5399f6c",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "504c094a-3407-4e0a-813d-922a03861770",
          "evidence": "Pipeline development timeline visualization",
          "framework": null,
          "confidence": 0.8,
          "extraction": {
            "at": "2026-05-02 11:46:10.253+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 5,
          "frameworkName": "gantt-chart"
        }
      ],
      "arcBeats": [
        {
          "to": 8,
          "arc": {
            "name": "Problem-Agitate-Solution",
            "slug": "problem-agitate-solution",
            "status": "active",
            "bestFor": "Sales pitches, urgency-driven, competitive displacement",
            "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
            "description": null,
            "familyLabel": null
          },
          "from": 5,
          "name": "Problem (Identify pain)",
          "beatId": "50cfb41c-c55f-4d71-bad7-662cc5ddaf6c",
          "matchId": "a1bcf76f-a4ea-452c-9399-8bc5a62efe28",
          "beatType": {
            "name": "Problem (Identify pain)",
            "slug": "problem-agitate-solution-problem-identify-pain",
            "status": "active",
            "canonId": "019dd9b8-0e78-74bb-b8f6-54348367a131",
            "version": 1,
            "description": null
          },
          "evidence": "The document identifies the problem and the need for new approaches",
          "position": 1,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Complication",
            "slug": "complication",
            "status": "active",
            "canonId": "019dd9b8-0275-7709-b2d6-4f77c3fc7579",
            "version": 1,
            "description": "The point in the narrative where the audience should feel discomfort. Required for argumentative arcs."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.9
        }
      ],
      "loops": [
        {
          "to": 12,
          "from": 5,
          "loop": {
            "name": "11_golden_circle",
            "slug": "11-golden-circle",
            "status": "active",
            "bestFor": "Visionary leadership, brand positioning, mission statements",
            "canonId": "019dd956-6a50-7202-882d-505fcb9922ed",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
            "description": "Invert the typical pitch by starting with why you exist, rather than what you do",
            "familyLabel": null
          },
          "matchId": "2c2ea794-d311-4166-8444-be0ff8d81ce6",
          "evidence": "The document uses the golden circle to explain the company's mission and vision",
          "position": 0,
          "objective": "Why is this important?",
          "confidence": 0.8,
          "extraction": {
            "at": "2026-07-16 22:34:50.584918+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 6,
      "type": "resolution",
      "title": "The slide uses a donut chart to compare 2021 and 2028 market sizes, highlighting growth.",
      "function": "size_opportunity",
      "rawType": "market_sizing",
      "block": null,
      "metadata": {
        "slideType": "market_sizing",
        "slideTypeCanon": {
          "name": "Market sizing",
          "slug": "market_sizing",
          "status": "active",
          "canonId": "019de52d-08c8-756c-8664-733b73a7ee7b",
          "version": 1,
          "description": null
        },
        "function": "size_opportunity",
        "functionCanon": {
          "name": "Size opportunity",
          "slug": "size_opportunity",
          "status": "active",
          "canonId": "019de52d-147b-7568-8828-a74a27697618",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 78,
        "componentCount": 8,
        "textChars": 511,
        "nDataPoints": 5,
        "notes": "The slide uses a donut chart to compare 2021 and 2028 market sizes, highlighting growth.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:46:10.605+00",
          "seconds": 3.027,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de075-3cec-7700-94db-076a5ce30d84/6",
        "deck": "/decks/019de075-3cec-7700-94db-076a5ce30d84",
        "deckAnchor": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-6",
        "deckJson": "/decks/019de075-3cec-7700-94db-076a5ce30d84.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.1,
            "w": 0.5,
            "x": 0.4,
            "y": 0.75
          },
          "kind": "callout",
          "text": "IBD represents a multi-billion dollar market opportunity for best-in-class biologics.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": null,
            "subkind": {
              "name": "Primary callout",
              "slug": "primary",
              "status": "active",
              "canonId": "019de52c-fbd1-70eb-a9ce-8997f8674c1d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "primary",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:10.605+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "97b85795-05c5-4bbd-a07d-c6552d030e6b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.4,
            "w": 0.5,
            "x": 0.45,
            "y": 0.25
          },
          "kind": "chart",
          "text": "2021 vs 2028 IBD Market Growth",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Chart",
              "slug": "chart",
              "status": "active",
              "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8",
              "version": 1,
              "description": "Quantitative chart."
            },
            "tool": null,
            "subkind": {
              "name": "Donut chart",
              "slug": "donut",
              "status": "active",
              "canonId": "019de52d-0006-752c-9528-0fef476b8004",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "donut",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:10.605+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "f062b2e0-1a0b-454c-a101-44195ba05cbe",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.2,
            "x": 0.05,
            "y": 0.35
          },
          "kind": "metric",
          "text": "~1.7M IBD patients diagnosed in the US.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Metric",
              "slug": "metric",
              "status": "active",
              "canonId": "019de52c-f923-73bf-8081-d0b1a8c5264d",
              "version": 1,
              "description": "Big-number or KPI value."
            },
            "tool": null,
            "subkind": {
              "name": "Big number",
              "slug": "big-number",
              "status": "active",
              "canonId": "019de52c-fc70-70c8-b965-0584548a9204",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "big-number",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:10.605+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "9259921f-87fd-4320-95f3-7363a46578a5",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.15,
            "x": 0.25,
            "y": 0.6
          },
          "kind": "metric",
          "text": "$29B+ estimated IBD market globally in 2028.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Metric",
              "slug": "metric",
              "status": "active",
              "canonId": "019de52c-f923-73bf-8081-d0b1a8c5264d",
              "version": 1,
              "description": "Big-number or KPI value."
            },
            "tool": null,
            "subkind": {
              "name": "Big number",
              "slug": "big-number",
              "status": "active",
              "canonId": "019de52c-fc70-70c8-b965-0584548a9204",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "big-number",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:10.605+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "bf58a7aa-7ed0-4d2d-a1ec-9be71cc33bc7",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.2,
            "x": 0.05,
            "y": 0.6
          },
          "kind": "paragraph",
          "text": "Biologics are the preferred modality for moderate-to-severe patients due to superior benefit-risk profile.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:10.605+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "7a2742bd-74c3-406b-9b78-f52b9c9b7971",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.15,
            "x": 0.25,
            "y": 0.35
          },
          "kind": "paragraph",
          "text": "IBD makes up 22% of the global $100B+ I&I market.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:10.605+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "ce806175-c74e-42d2-8072-0d12110e096d",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.3,
            "x": 0.05,
            "y": 0.9
          },
          "kind": "source-note",
          "text": "Sources: Global Data, Evaluate Pharma, UpToDate, SVB Leerink.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:10.605+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "72f07167-a2cc-4267-b1e8-01bdb17c1ce8",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.8,
            "x": 0.05,
            "y": 0.05
          },
          "kind": "title",
          "text": "Inflammatory bowel disease is a growing $21B market in which biologics are the preferred modality",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:10.605+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "b2ad6559-918d-4709-976f-2339f501d920",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [
        {
          "to": 8,
          "arc": {
            "name": "Problem-Agitate-Solution",
            "slug": "problem-agitate-solution",
            "status": "active",
            "bestFor": "Sales pitches, urgency-driven, competitive displacement",
            "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
            "description": null,
            "familyLabel": null
          },
          "from": 5,
          "name": "Problem (Identify pain)",
          "beatId": "50cfb41c-c55f-4d71-bad7-662cc5ddaf6c",
          "matchId": "a1bcf76f-a4ea-452c-9399-8bc5a62efe28",
          "beatType": {
            "name": "Problem (Identify pain)",
            "slug": "problem-agitate-solution-problem-identify-pain",
            "status": "active",
            "canonId": "019dd9b8-0e78-74bb-b8f6-54348367a131",
            "version": 1,
            "description": null
          },
          "evidence": "The document identifies the problem and the need for new approaches",
          "position": 1,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Complication",
            "slug": "complication",
            "status": "active",
            "canonId": "019dd9b8-0275-7709-b2d6-4f77c3fc7579",
            "version": 1,
            "description": "The point in the narrative where the audience should feel discomfort. Required for argumentative arcs."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.9
        }
      ],
      "loops": [
        {
          "to": 12,
          "from": 5,
          "loop": {
            "name": "11_golden_circle",
            "slug": "11-golden-circle",
            "status": "active",
            "bestFor": "Visionary leadership, brand positioning, mission statements",
            "canonId": "019dd956-6a50-7202-882d-505fcb9922ed",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
            "description": "Invert the typical pitch by starting with why you exist, rather than what you do",
            "familyLabel": null
          },
          "matchId": "2c2ea794-d311-4166-8444-be0ff8d81ce6",
          "evidence": "The document uses the golden circle to explain the company's mission and vision",
          "position": 0,
          "objective": "Why is this important?",
          "confidence": 0.8,
          "extraction": {
            "at": "2026-07-16 22:34:50.584918+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 7,
      "type": "resolution",
      "function": "size_opportunity",
      "rawType": "market_sizing",
      "block": null,
      "metadata": {
        "slideType": "market_sizing",
        "slideTypeCanon": {
          "name": "Market sizing",
          "slug": "market_sizing",
          "status": "active",
          "canonId": "019de52d-08c8-756c-8664-733b73a7ee7b",
          "version": 1,
          "description": null
        },
        "function": "size_opportunity",
        "functionCanon": {
          "name": "Size opportunity",
          "slug": "size_opportunity",
          "status": "active",
          "canonId": "019de52d-147b-7568-8828-a74a27697618",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 79,
        "componentCount": 8,
        "textChars": 546,
        "nDataPoints": 5,
        "notes": null,
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:46:14.413+00",
          "seconds": 6.651,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de075-3cec-7700-94db-076a5ce30d84/7",
        "deck": "/decks/019de075-3cec-7700-94db-076a5ce30d84",
        "deckAnchor": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-7",
        "deckJson": "/decks/019de075-3cec-7700-94db-076a5ce30d84.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.1,
            "w": 0.5,
            "x": 0.42,
            "y": 0.75
          },
          "kind": "callout",
          "text": "IBD represents a multi-billion dollar market opportunity for best-in-class biologics.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": null,
            "subkind": {
              "name": "Primary callout",
              "slug": "primary",
              "status": "active",
              "canonId": "019de52c-fbd1-70eb-a9ce-8997f8674c1d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "primary",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:14.413+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "bea95f4f-1a5c-43bd-98d4-7c80da035463",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.45,
            "w": 0.45,
            "x": 0.45,
            "y": 0.25
          },
          "kind": "chart",
          "text": "2021 Global IBD Market $21.1B vs 2028 Estimated IBD Market $29.1B",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Chart",
              "slug": "chart",
              "status": "active",
              "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8",
              "version": 1,
              "description": "Quantitative chart."
            },
            "tool": null,
            "subkind": {
              "name": "Donut chart",
              "slug": "donut",
              "status": "active",
              "canonId": "019de52d-0006-752c-9528-0fef476b8004",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "donut",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:14.413+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "51a07516-d437-4868-8c85-d92be1f7fca5",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.18,
            "x": 0.23,
            "y": 0.6
          },
          "kind": "metric",
          "text": "$29B+ estimated IBD market globally in 2028.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Metric",
              "slug": "metric",
              "status": "active",
              "canonId": "019de52c-f923-73bf-8081-d0b1a8c5264d",
              "version": 1,
              "description": "Big-number or KPI value."
            },
            "tool": null,
            "subkind": {
              "name": "Big number",
              "slug": "big-number",
              "status": "active",
              "canonId": "019de52c-fc70-70c8-b965-0584548a9204",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "big-number",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:14.413+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "8229d0a7-d2a9-457d-81a7-bdddc064c6be",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.18,
            "x": 0.05,
            "y": 0.33
          },
          "kind": "metric",
          "text": "~1.7M IBD patients diagnosed in the US.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Metric",
              "slug": "metric",
              "status": "active",
              "canonId": "019de52c-f923-73bf-8081-d0b1a8c5264d",
              "version": 1,
              "description": "Big-number or KPI value."
            },
            "tool": null,
            "subkind": {
              "name": "Big number",
              "slug": "big-number",
              "status": "active",
              "canonId": "019de52c-fc70-70c8-b965-0584548a9204",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "big-number",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:14.413+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "b25600d4-b052-4a16-9709-fc27a6531d84",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.18,
            "x": 0.23,
            "y": 0.33
          },
          "kind": "paragraph",
          "text": "IBD makes up 22% of the global $100B+ I&I market.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:14.413+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "4bf8abea-dacc-467a-8d91-9e5bc8cd237e",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.18,
            "x": 0.05,
            "y": 0.58
          },
          "kind": "paragraph",
          "text": "Biologics are the preferred modality for moderate-to-severe patients due to superior benefit-risk profile.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:14.413+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "d6d7337c-0770-46d8-8296-b1d7af655629",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.3,
            "x": 0.03,
            "y": 0.88
          },
          "kind": "source-note",
          "text": "Sources: Global Data, Evaluate Pharma, UpToDate, SVB Leerink.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:14.413+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "a3c89593-acfc-4379-ac1a-fd1fb1181975",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.85,
            "x": 0.03,
            "y": 0.04
          },
          "kind": "title",
          "text": "Inflammatory bowel disease is a growing $21B market in which biologics are the preferred modality",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:14.413+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e3bf2cbb-1e4d-464d-9920-e1a386a4b6d5",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [
        {
          "to": 8,
          "arc": {
            "name": "Problem-Agitate-Solution",
            "slug": "problem-agitate-solution",
            "status": "active",
            "bestFor": "Sales pitches, urgency-driven, competitive displacement",
            "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
            "description": null,
            "familyLabel": null
          },
          "from": 5,
          "name": "Problem (Identify pain)",
          "beatId": "50cfb41c-c55f-4d71-bad7-662cc5ddaf6c",
          "matchId": "a1bcf76f-a4ea-452c-9399-8bc5a62efe28",
          "beatType": {
            "name": "Problem (Identify pain)",
            "slug": "problem-agitate-solution-problem-identify-pain",
            "status": "active",
            "canonId": "019dd9b8-0e78-74bb-b8f6-54348367a131",
            "version": 1,
            "description": null
          },
          "evidence": "The document identifies the problem and the need for new approaches",
          "position": 1,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Complication",
            "slug": "complication",
            "status": "active",
            "canonId": "019dd9b8-0275-7709-b2d6-4f77c3fc7579",
            "version": 1,
            "description": "The point in the narrative where the audience should feel discomfort. Required for argumentative arcs."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.9
        }
      ],
      "loops": [
        {
          "to": 12,
          "from": 5,
          "loop": {
            "name": "11_golden_circle",
            "slug": "11-golden-circle",
            "status": "active",
            "bestFor": "Visionary leadership, brand positioning, mission statements",
            "canonId": "019dd956-6a50-7202-882d-505fcb9922ed",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
            "description": "Invert the typical pitch by starting with why you exist, rather than what you do",
            "familyLabel": null
          },
          "matchId": "2c2ea794-d311-4166-8444-be0ff8d81ce6",
          "evidence": "The document uses the golden circle to explain the company's mission and vision",
          "position": 0,
          "objective": "Why is this important?",
          "confidence": 0.8,
          "extraction": {
            "at": "2026-07-16 22:34:50.584918+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 8,
      "type": "tension",
      "title": "The chart uses a visual metaphor of a 'ceiling' (the 40% remission line) and an arrow to indicate the desired shift in therapeutic performance.",
      "function": "frame_problem",
      "rawType": "problem_statement",
      "block": null,
      "metadata": {
        "slideType": "problem_statement",
        "slideTypeCanon": {
          "name": "Problem statement",
          "slug": "problem_statement",
          "status": "active",
          "canonId": "019de52d-0879-768d-bba8-8da8a5a121d4",
          "version": 1,
          "description": null
        },
        "function": "frame_problem",
        "functionCanon": {
          "name": "Frame problem",
          "slug": "frame_problem",
          "status": "active",
          "canonId": "019de52d-13db-753e-ad70-e9b2d0dab398",
          "version": 1,
          "description": null
        },
        "density": "balanced",
        "densityScore": 39,
        "componentCount": 3,
        "textChars": 605,
        "nDataPoints": 0,
        "notes": "The chart uses a visual metaphor of a 'ceiling' (the 40% remission line) and an arrow to indicate the desired shift in therapeutic performance.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:46:10.922+00",
          "seconds": 3.052,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de075-3cec-7700-94db-076a5ce30d84/8",
        "deck": "/decks/019de075-3cec-7700-94db-076a5ce30d84",
        "deckAnchor": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-8",
        "deckJson": "/decks/019de075-3cec-7700-94db-076a5ce30d84.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.6,
            "w": 0.8,
            "x": 0.08,
            "y": 0.25
          },
          "kind": "chart",
          "text": "UC Maintenance Remission Rates (%) vs Maintenance dosing frequency (weeks)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Chart",
              "slug": "chart",
              "status": "active",
              "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8",
              "version": 1,
              "description": "Quantitative chart."
            },
            "tool": null,
            "subkind": {
              "name": "Scatter plot",
              "slug": "scatter",
              "status": "active",
              "canonId": "019de52d-007d-72ec-8689-c79fb78e21a2",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "scatter",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:10.922+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "c374dfee-ebca-40ed-ac5c-fb1570beabb5",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.9,
            "x": 0.05,
            "y": 0.85
          },
          "kind": "source-note",
          "text": "Summary data for select agents that randomize patients post response to induction; data from labels, company reports. Vedolizumab approved in US as Q8W IV – Q2W SC approval pending following CRL in 2019. TL1A maintenance data not available. Orals not shown (pbo-adj maintenance remission rates): Jaks - tofacitinib (27%), upadacitinib (30% 15mg, 40% 30mg); S1Ps: ozanimod (19%); etrasimod (25% - P3 Treat-through design).",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:10.922+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "38868dc8-110f-4ca2-8650-13af88ebfb41",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.85,
            "x": 0.05,
            "y": 0.05
          },
          "kind": "title",
          "text": "Despite advances, new approaches are needed to break the efficacy ceiling and improve convenience of biologics",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:10.922+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "f29e27a1-9e10-40ab-9532-cbe972188af2",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "bc506c21-6819-4419-b132-7afa4a88234c",
          "evidence": "Contrasts current SOC with future target to define the market gap.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 11:46:10.922+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 8,
          "frameworkName": "comparison-frame"
        }
      ],
      "arcBeats": [
        {
          "to": 8,
          "arc": {
            "name": "Problem-Agitate-Solution",
            "slug": "problem-agitate-solution",
            "status": "active",
            "bestFor": "Sales pitches, urgency-driven, competitive displacement",
            "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
            "description": null,
            "familyLabel": null
          },
          "from": 5,
          "name": "Problem (Identify pain)",
          "beatId": "50cfb41c-c55f-4d71-bad7-662cc5ddaf6c",
          "matchId": "a1bcf76f-a4ea-452c-9399-8bc5a62efe28",
          "beatType": {
            "name": "Problem (Identify pain)",
            "slug": "problem-agitate-solution-problem-identify-pain",
            "status": "active",
            "canonId": "019dd9b8-0e78-74bb-b8f6-54348367a131",
            "version": 1,
            "description": null
          },
          "evidence": "The document identifies the problem and the need for new approaches",
          "position": 1,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Complication",
            "slug": "complication",
            "status": "active",
            "canonId": "019dd9b8-0275-7709-b2d6-4f77c3fc7579",
            "version": 1,
            "description": "The point in the narrative where the audience should feel discomfort. Required for argumentative arcs."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.9
        }
      ],
      "loops": [
        {
          "to": 12,
          "from": 5,
          "loop": {
            "name": "11_golden_circle",
            "slug": "11-golden-circle",
            "status": "active",
            "bestFor": "Visionary leadership, brand positioning, mission statements",
            "canonId": "019dd956-6a50-7202-882d-505fcb9922ed",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
            "description": "Invert the typical pitch by starting with why you exist, rather than what you do",
            "familyLabel": null
          },
          "matchId": "2c2ea794-d311-4166-8444-be0ff8d81ce6",
          "evidence": "The document uses the golden circle to explain the company's mission and vision",
          "position": 0,
          "objective": "Why is this important?",
          "confidence": 0.8,
          "extraction": {
            "at": "2026-07-16 22:34:50.584918+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 9,
      "type": "resolution",
      "function": "present_solution",
      "rawType": "solution",
      "block": null,
      "metadata": {
        "slideType": "solution",
        "slideTypeCanon": {
          "name": "Solution",
          "slug": "solution",
          "status": "active",
          "canonId": "019de52d-0eb5-72ff-8b70-ba70a4199282",
          "version": 1,
          "description": null
        },
        "function": "present_solution",
        "functionCanon": {
          "name": "Present solution",
          "slug": "present_solution",
          "status": "active",
          "canonId": "019de52d-15b8-71da-bd23-2b767850cbce",
          "version": 1,
          "description": null
        },
        "density": "balanced",
        "densityScore": 33,
        "componentCount": 4,
        "textChars": 289,
        "nDataPoints": 0,
        "notes": null,
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:46:10.583+00",
          "seconds": 2.71,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de075-3cec-7700-94db-076a5ce30d84/9",
        "deck": "/decks/019de075-3cec-7700-94db-076a5ce30d84",
        "deckAnchor": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-9",
        "deckJson": "/decks/019de075-3cec-7700-94db-076a5ce30d84.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.25,
            "w": 0.72,
            "x": 0.14,
            "y": 0.45
          },
          "kind": "image",
          "text": "Antibody and patient group icons",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Illustration",
              "slug": "illustration",
              "status": "active",
              "canonId": "019de52c-fe76-7772-a5ac-c0b7294d7615",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "illustration",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:10.583+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "3b936cee-1fb2-49ea-9a3f-990aa8bdc61b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.45,
            "w": 0.86,
            "x": 0.07,
            "y": 0.35
          },
          "kind": "list",
          "text": "1. Best-in-class mAb engineering (With half-life extension technology) 2. Rational therapeutic combinations 3. Precision patient selection",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Numbered list",
              "slug": "numbered",
              "status": "active",
              "canonId": "019de52c-fcc0-7718-a284-a4250c805df2",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "numbered",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:10.583+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "9c6ae363-f2b9-439f-9de6-06bc7de44f67",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.04,
            "w": 0.58,
            "x": 0.21,
            "y": 0.24
          },
          "kind": "title",
          "text": "Three strategic pillars in an effort to create the preeminent IBD company",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:10.583+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "d5313986-25fc-4b50-9c3a-e1fc4554461b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.06,
            "w": 0.45,
            "x": 0.025,
            "y": 0.03
          },
          "kind": "title",
          "text": "Spyre's strategy to address unmet needs in IBD",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:10.583+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "6caccc7a-220e-45bf-908a-eb164ec14844",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "4547a060-1649-4565-a423-b9fa12681f52",
          "evidence": "The slide explicitly structures the strategy into three numbered pillars.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 11:46:10.583+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 9,
          "frameworkName": "strategic-pillars"
        }
      ],
      "arcBeats": [
        {
          "to": 12,
          "arc": {
            "name": "Problem-Agitate-Solution",
            "slug": "problem-agitate-solution",
            "status": "active",
            "bestFor": "Sales pitches, urgency-driven, competitive displacement",
            "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
            "description": null,
            "familyLabel": null
          },
          "from": 9,
          "name": "Agitate (Make it worse)",
          "beatId": "2c7f8b77-f27b-419f-a0e9-300e30f17da7",
          "matchId": "a1bcf76f-a4ea-452c-9399-8bc5a62efe28",
          "beatType": {
            "name": "Agitate (Make it worse)",
            "slug": "problem-agitate-solution-agitate-make-it-worse",
            "status": "active",
            "canonId": "019dd9b8-0f5a-71dd-bae7-8fadb0d09456",
            "version": 1,
            "description": null
          },
          "evidence": "The document agitates the problem, highlighting the limitations of current treatments",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Development",
            "slug": "development",
            "status": "active",
            "canonId": "019dd9b8-0332-7008-b3aa-11b0840a57b1",
            "version": 1,
            "description": "The middle stretch in arcs that have one. Often where length problems creep in."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.9
        }
      ],
      "loops": [
        {
          "to": 12,
          "from": 5,
          "loop": {
            "name": "11_golden_circle",
            "slug": "11-golden-circle",
            "status": "active",
            "bestFor": "Visionary leadership, brand positioning, mission statements",
            "canonId": "019dd956-6a50-7202-882d-505fcb9922ed",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
            "description": "Invert the typical pitch by starting with why you exist, rather than what you do",
            "familyLabel": null
          },
          "matchId": "2c2ea794-d311-4166-8444-be0ff8d81ce6",
          "evidence": "The document uses the golden circle to explain the company's mission and vision",
          "position": 0,
          "objective": "Why is this important?",
          "confidence": 0.8,
          "extraction": {
            "at": "2026-07-16 22:34:50.584918+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        },
        {
          "to": 12,
          "from": 9,
          "loop": {
            "name": "27_cost_of_inaction",
            "slug": "27-cost-of-inaction",
            "status": "active",
            "bestFor": "Urgent budget requests, compliance, risk mitigation",
            "canonId": "019dd956-70d1-7395-a15b-857ba858b394",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
            "description": "Quantify what happens if the audience does nothing",
            "familyLabel": null
          },
          "matchId": "f38e4bf0-5d35-4227-a5cd-f584d52537ff",
          "evidence": "The document highlights the limitations of current treatments and the need for new approaches",
          "position": 1,
          "objective": "What are the consequences of not acting?",
          "confidence": 0.7,
          "extraction": {
            "at": "2026-07-16 22:34:50.628606+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 10,
      "type": "resolution",
      "title": "The chart compares Cyno Half-Life vs Human Half-Life, showing YTE mAbs outperforming WT mAbs.",
      "function": "present_solution",
      "rawType": "solution",
      "block": null,
      "metadata": {
        "slideType": "solution",
        "slideTypeCanon": {
          "name": "Solution",
          "slug": "solution",
          "status": "active",
          "canonId": "019de52d-0eb5-72ff-8b70-ba70a4199282",
          "version": 1,
          "description": null
        },
        "function": "present_solution",
        "functionCanon": {
          "name": "Present solution",
          "slug": "present_solution",
          "status": "active",
          "canonId": "019de52d-15b8-71da-bd23-2b767850cbce",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 83,
        "componentCount": 8,
        "textChars": 628,
        "nDataPoints": 12,
        "notes": "The chart compares Cyno Half-Life vs Human Half-Life, showing YTE mAbs outperforming WT mAbs.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:46:11.431+00",
          "seconds": 3.557,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de075-3cec-7700-94db-076a5ce30d84/10",
        "deck": "/decks/019de075-3cec-7700-94db-076a5ce30d84",
        "deckAnchor": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-10",
        "deckJson": "/decks/019de075-3cec-7700-94db-076a5ce30d84.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.6,
            "w": 0.3,
            "x": 0.65,
            "y": 0.25
          },
          "kind": "chart",
          "text": "Clinical Precedent: Human Half-Life vs Cyno Half-Life",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Chart",
              "slug": "chart",
              "status": "active",
              "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8",
              "version": 1,
              "description": "Quantitative chart."
            },
            "tool": null,
            "subkind": {
              "name": "Scatter plot",
              "slug": "scatter",
              "status": "active",
              "canonId": "019de52d-007d-72ec-8689-c79fb78e21a2",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "scatter",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:11.431+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "8eee82ce-3856-498f-a6e2-479711fa9140",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.45,
            "w": 0.25,
            "x": 0.17,
            "y": 0.35
          },
          "kind": "image",
          "text": "Antibody structure diagram",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Illustration",
              "slug": "illustration",
              "status": "active",
              "canonId": "019de52c-fe76-7772-a5ac-c0b7294d7615",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "illustration",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:11.431+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "7b9d6650-6ff0-40af-97df-bab1ff03fe87",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.2,
            "x": 0.42,
            "y": 0.36
          },
          "kind": "list",
          "text": "Potential for IP into 2040s: Novel dosing profile, Improved manufacturability, Coverage of diverse back-up series",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:11.431+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "0d099bbf-aefa-4b57-af41-aa651612cb43",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.2,
            "x": 0.42,
            "y": 0.59
          },
          "kind": "list",
          "text": "Significantly extended half-life: Q8-Q12W dosing based on validated half-life extension technology",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:11.431+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "56baa772-8b90-4149-be06-5f93f1f255ab",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.18,
            "x": 0.02,
            "y": 0.32
          },
          "kind": "list",
          "text": "Epitopes maintained: Validated pharmacology, Equivalent or better potency",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:11.431+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "80c7a0e4-16b7-40ac-a8fe-35aaebe16d9f",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.2,
            "x": 0.02,
            "y": 0.62
          },
          "kind": "list",
          "text": "High concentration SQ: Ability to formulate at >150 mg/mL with low viscosity, Citrate-free formulation",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:11.431+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "c08f4d1f-3459-419e-bd7e-73b42e68c840",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.6,
            "x": 0.2,
            "y": 0.22
          },
          "kind": "title",
          "text": "Spyre mAbs introduce significant improvements over 1st generation mAbs",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:11.431+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "3688dd83-538b-49ce-a373-a3a7bf93768d",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.8,
            "x": 0.02,
            "y": 0.04
          },
          "kind": "title",
          "text": "Spyre mAbs exploit validated biology with modifications designed for best-in-class properties",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:11.431+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "174b16d1-245f-4f9e-a0a6-9b3c0130eb12",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "f478f9bc-8b5e-4a1c-9cd6-ac243fee6d13",
          "evidence": "Comparison of clinical data points against biological properties",
          "framework": null,
          "confidence": 0.8,
          "extraction": {
            "at": "2026-05-02 11:46:11.431+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 10,
          "frameworkName": "evidence-matrix"
        }
      ],
      "arcBeats": [
        {
          "to": 12,
          "arc": {
            "name": "Problem-Agitate-Solution",
            "slug": "problem-agitate-solution",
            "status": "active",
            "bestFor": "Sales pitches, urgency-driven, competitive displacement",
            "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
            "description": null,
            "familyLabel": null
          },
          "from": 9,
          "name": "Agitate (Make it worse)",
          "beatId": "2c7f8b77-f27b-419f-a0e9-300e30f17da7",
          "matchId": "a1bcf76f-a4ea-452c-9399-8bc5a62efe28",
          "beatType": {
            "name": "Agitate (Make it worse)",
            "slug": "problem-agitate-solution-agitate-make-it-worse",
            "status": "active",
            "canonId": "019dd9b8-0f5a-71dd-bae7-8fadb0d09456",
            "version": 1,
            "description": null
          },
          "evidence": "The document agitates the problem, highlighting the limitations of current treatments",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Development",
            "slug": "development",
            "status": "active",
            "canonId": "019dd9b8-0332-7008-b3aa-11b0840a57b1",
            "version": 1,
            "description": "The middle stretch in arcs that have one. Often where length problems creep in."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.9
        }
      ],
      "loops": [
        {
          "to": 12,
          "from": 5,
          "loop": {
            "name": "11_golden_circle",
            "slug": "11-golden-circle",
            "status": "active",
            "bestFor": "Visionary leadership, brand positioning, mission statements",
            "canonId": "019dd956-6a50-7202-882d-505fcb9922ed",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
            "description": "Invert the typical pitch by starting with why you exist, rather than what you do",
            "familyLabel": null
          },
          "matchId": "2c2ea794-d311-4166-8444-be0ff8d81ce6",
          "evidence": "The document uses the golden circle to explain the company's mission and vision",
          "position": 0,
          "objective": "Why is this important?",
          "confidence": 0.8,
          "extraction": {
            "at": "2026-07-16 22:34:50.584918+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        },
        {
          "to": 12,
          "from": 9,
          "loop": {
            "name": "27_cost_of_inaction",
            "slug": "27-cost-of-inaction",
            "status": "active",
            "bestFor": "Urgent budget requests, compliance, risk mitigation",
            "canonId": "019dd956-70d1-7395-a15b-857ba858b394",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
            "description": "Quantify what happens if the audience does nothing",
            "familyLabel": null
          },
          "matchId": "f38e4bf0-5d35-4227-a5cd-f584d52537ff",
          "evidence": "The document highlights the limitations of current treatments and the need for new approaches",
          "position": 1,
          "objective": "What are the consequences of not acting?",
          "confidence": 0.7,
          "extraction": {
            "at": "2026-07-16 22:34:50.628606+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 11,
      "type": "resolution",
      "title": "The slide uses a 'before-after' logic to justify the combination strategy.",
      "function": "present_solution",
      "rawType": "solution",
      "block": null,
      "metadata": {
        "slideType": "solution",
        "slideTypeCanon": {
          "name": "Solution",
          "slug": "solution",
          "status": "active",
          "canonId": "019de52d-0eb5-72ff-8b70-ba70a4199282",
          "version": 1,
          "description": null
        },
        "function": "present_solution",
        "functionCanon": {
          "name": "Present solution",
          "slug": "present_solution",
          "status": "active",
          "canonId": "019de52d-15b8-71da-bd23-2b767850cbce",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 60,
        "componentCount": 6,
        "textChars": 375,
        "nDataPoints": 3,
        "notes": "The slide uses a 'before-after' logic to justify the combination strategy.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:46:10.901+00",
          "seconds": 2.942,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de075-3cec-7700-94db-076a5ce30d84/11",
        "deck": "/decks/019de075-3cec-7700-94db-076a5ce30d84",
        "deckAnchor": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-11",
        "deckJson": "/decks/019de075-3cec-7700-94db-076a5ce30d84.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.8,
            "w": 0.32,
            "x": 0.64,
            "y": 0.21
          },
          "kind": "chart",
          "text": "CLINICAL PRECEDENT JNJ VEGA Ph2a study",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Chart",
              "slug": "chart",
              "status": "active",
              "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8",
              "version": 1,
              "description": "Quantitative chart."
            },
            "tool": null,
            "subkind": {
              "name": "Vertical bar chart",
              "slug": "bar-vertical",
              "status": "active",
              "canonId": "019de52c-fe9d-70f2-b3b7-a9ae294f5917",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bar-vertical",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:10.901+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "d18cbeeb-f78c-4e7b-afba-bebceb1fd9ff",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.6,
            "w": 0.45,
            "x": 0.05,
            "y": 0.25
          },
          "kind": "diagram",
          "text": "Rational therapeutic combinations",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Diagram",
              "slug": "diagram",
              "status": "active",
              "canonId": "019de52c-f9f0-734a-81de-15382ff28c65",
              "version": 1,
              "description": "Schematic or relational diagram."
            },
            "tool": null,
            "subkind": {
              "name": "Process flow",
              "slug": "process",
              "status": "active",
              "canonId": "019de52d-039c-718f-ad3a-efe9c4b3c838",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "process",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:10.901+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "14cd81ce-e765-42a6-8149-7fb5aecb1e5d",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.2,
            "x": 0.05,
            "y": 0.49
          },
          "kind": "list",
          "text": "Strong single-agent maintenance efficacy; Superior safety profile",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:10.901+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "40a2e903-67a1-4ea1-9fd2-f401163bf96b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.2,
            "x": 0.5,
            "y": 0.49
          },
          "kind": "list",
          "text": "Strong single-agent induction efficacy; Orthogonal MOA",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:10.901+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "a66a8385-5868-4b07-8aea-16ceef3d7111",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.02,
            "y": 0.95
          },
          "kind": "source-note",
          "text": "Source: Feagan, B. G. et al. Lancet Gastroenterol. Hepatol. 8, 307–320 (2023)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:10.901+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "dcf2c0f0-350b-490a-bb6e-d7da6944edeb",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.85,
            "x": 0.02,
            "y": 0.04
          },
          "kind": "title",
          "text": "Spyre is rapidly developing combination products given clinical evidence of substantial efficacy enhancement",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:10.901+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "36448e70-30d3-477c-9f8d-676172fc8502",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "ced833a9-6852-4be1-8028-ba32bf24294d",
          "evidence": "Shows single agents leading to a combined, more effective outcome.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 11:46:10.901+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 11,
          "frameworkName": "before-after-framing"
        }
      ],
      "arcBeats": [
        {
          "to": 12,
          "arc": {
            "name": "Problem-Agitate-Solution",
            "slug": "problem-agitate-solution",
            "status": "active",
            "bestFor": "Sales pitches, urgency-driven, competitive displacement",
            "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
            "description": null,
            "familyLabel": null
          },
          "from": 9,
          "name": "Agitate (Make it worse)",
          "beatId": "2c7f8b77-f27b-419f-a0e9-300e30f17da7",
          "matchId": "a1bcf76f-a4ea-452c-9399-8bc5a62efe28",
          "beatType": {
            "name": "Agitate (Make it worse)",
            "slug": "problem-agitate-solution-agitate-make-it-worse",
            "status": "active",
            "canonId": "019dd9b8-0f5a-71dd-bae7-8fadb0d09456",
            "version": 1,
            "description": null
          },
          "evidence": "The document agitates the problem, highlighting the limitations of current treatments",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Development",
            "slug": "development",
            "status": "active",
            "canonId": "019dd9b8-0332-7008-b3aa-11b0840a57b1",
            "version": 1,
            "description": "The middle stretch in arcs that have one. Often where length problems creep in."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.9
        }
      ],
      "loops": [
        {
          "to": 12,
          "from": 5,
          "loop": {
            "name": "11_golden_circle",
            "slug": "11-golden-circle",
            "status": "active",
            "bestFor": "Visionary leadership, brand positioning, mission statements",
            "canonId": "019dd956-6a50-7202-882d-505fcb9922ed",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
            "description": "Invert the typical pitch by starting with why you exist, rather than what you do",
            "familyLabel": null
          },
          "matchId": "2c2ea794-d311-4166-8444-be0ff8d81ce6",
          "evidence": "The document uses the golden circle to explain the company's mission and vision",
          "position": 0,
          "objective": "Why is this important?",
          "confidence": 0.8,
          "extraction": {
            "at": "2026-07-16 22:34:50.584918+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        },
        {
          "to": 12,
          "from": 9,
          "loop": {
            "name": "27_cost_of_inaction",
            "slug": "27-cost-of-inaction",
            "status": "active",
            "bestFor": "Urgent budget requests, compliance, risk mitigation",
            "canonId": "019dd956-70d1-7395-a15b-857ba858b394",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
            "description": "Quantify what happens if the audience does nothing",
            "familyLabel": null
          },
          "matchId": "f38e4bf0-5d35-4227-a5cd-f584d52537ff",
          "evidence": "The document highlights the limitations of current treatments and the need for new approaches",
          "position": 1,
          "objective": "What are the consequences of not acting?",
          "confidence": 0.7,
          "extraction": {
            "at": "2026-07-16 22:34:50.628606+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 12,
      "type": "resolution",
      "title": "Uses a Venn diagram to show target overlap and a bar chart to show clinical efficacy improvement.",
      "function": "present_solution",
      "rawType": "solution",
      "block": null,
      "metadata": {
        "slideType": "solution",
        "slideTypeCanon": {
          "name": "Solution",
          "slug": "solution",
          "status": "active",
          "canonId": "019de52d-0eb5-72ff-8b70-ba70a4199282",
          "version": 1,
          "description": null
        },
        "function": "present_solution",
        "functionCanon": {
          "name": "Present solution",
          "slug": "present_solution",
          "status": "active",
          "canonId": "019de52d-15b8-71da-bd23-2b767850cbce",
          "version": 1,
          "description": null
        },
        "density": "balanced",
        "densityScore": 41,
        "componentCount": 4,
        "textChars": 313,
        "nDataPoints": 4,
        "notes": "Uses a Venn diagram to show target overlap and a bar chart to show clinical efficacy improvement.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:46:11.188+00",
          "seconds": 3.175,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de075-3cec-7700-94db-076a5ce30d84/12",
        "deck": "/decks/019de075-3cec-7700-94db-076a5ce30d84",
        "deckAnchor": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-12",
        "deckJson": "/decks/019de075-3cec-7700-94db-076a5ce30d84.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.6,
            "w": 0.3,
            "x": 0.65,
            "y": 0.25
          },
          "kind": "chart",
          "text": "Clinical Precedent TL1A studies showing All-comers vs CDx+ remission rates",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Chart",
              "slug": "chart",
              "status": "active",
              "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8",
              "version": 1,
              "description": "Quantitative chart."
            },
            "tool": null,
            "subkind": {
              "name": "Grouped bar chart",
              "slug": "bar-grouped",
              "status": "active",
              "canonId": "019de52c-ff3b-751e-a8ff-f21ff11097b1",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bar-grouped",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:11.188+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "05f85f5e-acf7-4f56-9268-211d8e19aa80",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.4,
            "w": 0.4,
            "x": 0.05,
            "y": 0.35
          },
          "kind": "diagram",
          "text": "Venn diagram showing TL1A, IL-23, and alpha4beta7 overlap",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Diagram",
              "slug": "diagram",
              "status": "active",
              "canonId": "019de52c-f9f0-734a-81de-15382ff28c65",
              "version": 1,
              "description": "Schematic or relational diagram."
            },
            "tool": null,
            "subkind": {
              "name": "Venn diagram",
              "slug": "venn",
              "status": "active",
              "canonId": "019de52d-0463-710d-b529-cce18d828d2f",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "venn",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:11.188+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "84a7ce01-f5e0-4fe8-aa2b-1c66a7e7c45d",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.4,
            "x": 0.05,
            "y": 0.28
          },
          "kind": "paragraph",
          "text": "Genetic companion diagnostic (CDx) leveraging large-scale human genomic datasets",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:11.188+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e8770a18-5494-48f5-a5b9-f285cee0e1f0",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.8,
            "x": 0.02,
            "y": 0.04
          },
          "kind": "title",
          "text": "Spyre leverages genetically-driven patient selection to match disease drivers with therapeutic targets",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:11.188+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "2a4d7b24-d5e0-4d1f-bb07-a7e7324e92c8",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "e0e7dfad-e88e-40d7-85f9-fbb3e4068f88",
          "evidence": "Uses clinical precedent data to validate the efficacy of the proposed genetic selection method.",
          "framework": null,
          "confidence": 0.8,
          "extraction": {
            "at": "2026-05-02 11:46:11.188+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 12,
          "frameworkName": "authority-citation"
        }
      ],
      "arcBeats": [
        {
          "to": 12,
          "arc": {
            "name": "Problem-Agitate-Solution",
            "slug": "problem-agitate-solution",
            "status": "active",
            "bestFor": "Sales pitches, urgency-driven, competitive displacement",
            "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
            "description": null,
            "familyLabel": null
          },
          "from": 9,
          "name": "Agitate (Make it worse)",
          "beatId": "2c7f8b77-f27b-419f-a0e9-300e30f17da7",
          "matchId": "a1bcf76f-a4ea-452c-9399-8bc5a62efe28",
          "beatType": {
            "name": "Agitate (Make it worse)",
            "slug": "problem-agitate-solution-agitate-make-it-worse",
            "status": "active",
            "canonId": "019dd9b8-0f5a-71dd-bae7-8fadb0d09456",
            "version": 1,
            "description": null
          },
          "evidence": "The document agitates the problem, highlighting the limitations of current treatments",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Development",
            "slug": "development",
            "status": "active",
            "canonId": "019dd9b8-0332-7008-b3aa-11b0840a57b1",
            "version": 1,
            "description": "The middle stretch in arcs that have one. Often where length problems creep in."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.9
        }
      ],
      "loops": [
        {
          "to": 12,
          "from": 5,
          "loop": {
            "name": "11_golden_circle",
            "slug": "11-golden-circle",
            "status": "active",
            "bestFor": "Visionary leadership, brand positioning, mission statements",
            "canonId": "019dd956-6a50-7202-882d-505fcb9922ed",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
            "description": "Invert the typical pitch by starting with why you exist, rather than what you do",
            "familyLabel": null
          },
          "matchId": "2c2ea794-d311-4166-8444-be0ff8d81ce6",
          "evidence": "The document uses the golden circle to explain the company's mission and vision",
          "position": 0,
          "objective": "Why is this important?",
          "confidence": 0.8,
          "extraction": {
            "at": "2026-07-16 22:34:50.584918+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        },
        {
          "to": 12,
          "from": 9,
          "loop": {
            "name": "27_cost_of_inaction",
            "slug": "27-cost-of-inaction",
            "status": "active",
            "bestFor": "Urgent budget requests, compliance, risk mitigation",
            "canonId": "019dd956-70d1-7395-a15b-857ba858b394",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
            "description": "Quantify what happens if the audience does nothing",
            "familyLabel": null
          },
          "matchId": "f38e4bf0-5d35-4227-a5cd-f584d52537ff",
          "evidence": "The document highlights the limitations of current treatments and the need for new approaches",
          "position": 1,
          "objective": "What are the consequences of not acting?",
          "confidence": 0.7,
          "extraction": {
            "at": "2026-07-16 22:34:50.628606+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 13,
      "type": "resolution",
      "title": "The slide uses a Gantt-style visualization to show the progress of various drug candidates (SPY001-SPY230).",
      "function": "plan_implementation",
      "rawType": "roadmap",
      "block": null,
      "metadata": {
        "slideType": "roadmap",
        "slideTypeCanon": {
          "name": "Roadmap",
          "slug": "roadmap",
          "status": "active",
          "canonId": "019de52d-0a55-72bc-9b7b-a47ef109839c",
          "version": 1,
          "description": null
        },
        "function": "plan_implementation",
        "functionCanon": {
          "name": "Plan implementation",
          "slug": "plan_implementation",
          "status": "active",
          "canonId": "019de52d-14a2-77ea-b210-d6a95eed4823",
          "version": 1,
          "description": null
        },
        "density": "balanced",
        "densityScore": 37,
        "componentCount": 4,
        "textChars": 367,
        "nDataPoints": 0,
        "notes": "The slide uses a Gantt-style visualization to show the progress of various drug candidates (SPY001-SPY230).",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:46:11.421+00",
          "seconds": 3.361,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de075-3cec-7700-94db-076a5ce30d84/13",
        "deck": "/decks/019de075-3cec-7700-94db-076a5ce30d84",
        "deckAnchor": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-13",
        "deckJson": "/decks/019de075-3cec-7700-94db-076a5ce30d84.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.7,
            "w": 0.9,
            "x": 0.05,
            "y": 0.2
          },
          "kind": "chart",
          "text": "Pipeline development status for SPY001 through SPY230",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Chart",
              "slug": "chart",
              "status": "active",
              "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8",
              "version": 1,
              "description": "Quantitative chart."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": "gantt-chart",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:11.421+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "f8afde03-5cb6-4afb-853a-e4dc6bb558b5",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.8,
            "x": 0.12,
            "y": 0.93
          },
          "kind": "disclaimer",
          "text": "1Spyre holds an option to license worldwide rights from Paragon Therapeutics, Inc. for all programs. SPY003 license is restricted to IBD, all other program licenses are indication agnostic",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Disclaimer",
              "slug": "disclaimer",
              "status": "active",
              "canonId": "91173477-d91f-4024-bbaf-d4f93e3f82dc",
              "version": 1,
              "description": "Legal/cautionary text that occupies most of the body of its slide."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:11.421+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "7f70dc2a-82d4-49a2-9239-177480d31af5",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.1,
            "x": 0.79,
            "y": 0.175
          },
          "kind": "legend",
          "text": "Co-lead programs",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Legend",
              "slug": "legend",
              "status": "active",
              "canonId": "31361933-3d22-4c70-bbad-0801e9fffc0c",
              "version": 1,
              "description": "Color/symbol decoder placed adjacent to a chart or diagram."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:11.421+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "39711fe3-8821-4abd-bd65-9ffa82e7a39c",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.85,
            "x": 0.02,
            "y": 0.04
          },
          "kind": "title",
          "text": "Spyre is building a potentially best-in-class IBD pipeline with next-generation mAbs and rational combinations",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:11.421+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "d83ac621-b386-491d-b2bb-c8e20429b436",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "131aa868-fdb4-43f1-b6d1-f5e66ec68b57",
          "evidence": "Visual representation of project timelines and stages",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 11:46:11.421+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 13,
          "frameworkName": "gantt-chart"
        }
      ],
      "arcBeats": [
        {
          "to": 30,
          "arc": {
            "name": "Problem-Agitate-Solution",
            "slug": "problem-agitate-solution",
            "status": "active",
            "bestFor": "Sales pitches, urgency-driven, competitive displacement",
            "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
            "description": null,
            "familyLabel": null
          },
          "from": 13,
          "name": "Solution (Provide relief)",
          "beatId": "5fcb9464-3068-4031-9434-ce301bbe9fd3",
          "matchId": "a1bcf76f-a4ea-452c-9399-8bc5a62efe28",
          "beatType": {
            "name": "Solution (Provide relief)",
            "slug": "problem-agitate-solution-solution-provide-relief",
            "status": "active",
            "canonId": "019dd9b8-0fee-73e9-9ae5-799c7f3895cd",
            "version": 1,
            "description": null
          },
          "evidence": "The document presents the company's solution, including its pipeline and strategy",
          "position": 3,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Resolution",
            "slug": "resolution",
            "status": "active",
            "canonId": "019dd9b8-045d-703b-8dd7-e92aba3ba91b",
            "version": 1,
            "description": "How the deck ends. Required in 19/20 arcs. The exception (Sparkline) ends with new bliss which is functionally a resolution."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.9
        }
      ],
      "loops": [
        {
          "to": 30,
          "from": 13,
          "loop": {
            "name": "47_quick_win_big_bet",
            "slug": "47-quick-win-big-bet",
            "status": "active",
            "bestFor": "Transformation planning, 100-day plans, resource allocation",
            "canonId": "019dd956-790d-708d-983e-ef9bbc68f741",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap",
            "description": "Separate initiatives into immediate wins and longer-term strategic bets",
            "familyLabel": null
          },
          "matchId": "1d2b0809-4269-4aea-a725-b67c9452d570",
          "evidence": "The document presents the company's solution, including its pipeline and strategy",
          "position": 2,
          "objective": "What is the company's solution?",
          "confidence": 0.8,
          "extraction": {
            "at": "2026-07-16 22:34:50.673683+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 14,
      "type": "resolution",
      "title": "The slide uses a Gantt-style visualization to show the status of various drug development programs.",
      "function": "plan_implementation",
      "rawType": "roadmap",
      "block": null,
      "metadata": {
        "slideType": "roadmap",
        "slideTypeCanon": {
          "name": "Roadmap",
          "slug": "roadmap",
          "status": "active",
          "canonId": "019de52d-0a55-72bc-9b7b-a47ef109839c",
          "version": 1,
          "description": null
        },
        "function": "plan_implementation",
        "functionCanon": {
          "name": "Plan implementation",
          "slug": "plan_implementation",
          "status": "active",
          "canonId": "019de52d-14a2-77ea-b210-d6a95eed4823",
          "version": 1,
          "description": null
        },
        "density": "balanced",
        "densityScore": 25,
        "componentCount": 3,
        "textChars": 179,
        "nDataPoints": 4,
        "notes": "The slide uses a Gantt-style visualization to show the status of various drug development programs.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:46:10.917+00",
          "seconds": 2.602,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de075-3cec-7700-94db-076a5ce30d84/14",
        "deck": "/decks/019de075-3cec-7700-94db-076a5ce30d84",
        "deckAnchor": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-14",
        "deckJson": "/decks/019de075-3cec-7700-94db-076a5ce30d84.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.7,
            "w": 0.9,
            "x": 0.05,
            "y": 0.2
          },
          "kind": "chart",
          "text": "Pipeline development status for SPY001 through SPY230",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Chart",
              "slug": "chart",
              "status": "active",
              "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8",
              "version": 1,
              "description": "Quantitative chart."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": "gantt-chart",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:10.917+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "1e10d93e-b473-49e0-8a3e-c43e491024aa",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.12,
            "x": 0.79,
            "y": 0.17
          },
          "kind": "legend",
          "text": "Co-lead programs",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Legend",
              "slug": "legend",
              "status": "active",
              "canonId": "31361933-3d22-4c70-bbad-0801e9fffc0c",
              "version": 1,
              "description": "Color/symbol decoder placed adjacent to a chart or diagram."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:10.917+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "847a7c0b-d42e-4e31-9a92-269854ea8d6e",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.85,
            "x": 0.02,
            "y": 0.04
          },
          "kind": "title",
          "text": "Spyre is building a potentially best-in-class IBD pipeline with next-generation mAbs and rational combinations",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:10.917+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "f32a521f-b980-4eac-ad27-1ac9c1a39ba7",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "e35b22bc-dade-4ecf-8be5-874ce6ee8a40",
          "evidence": "Visual representation of project timelines and stages",
          "framework": null,
          "confidence": 1,
          "extraction": {
            "at": "2026-05-02 11:46:10.917+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 14,
          "frameworkName": "gantt-chart"
        }
      ],
      "arcBeats": [
        {
          "to": 30,
          "arc": {
            "name": "Problem-Agitate-Solution",
            "slug": "problem-agitate-solution",
            "status": "active",
            "bestFor": "Sales pitches, urgency-driven, competitive displacement",
            "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
            "description": null,
            "familyLabel": null
          },
          "from": 13,
          "name": "Solution (Provide relief)",
          "beatId": "5fcb9464-3068-4031-9434-ce301bbe9fd3",
          "matchId": "a1bcf76f-a4ea-452c-9399-8bc5a62efe28",
          "beatType": {
            "name": "Solution (Provide relief)",
            "slug": "problem-agitate-solution-solution-provide-relief",
            "status": "active",
            "canonId": "019dd9b8-0fee-73e9-9ae5-799c7f3895cd",
            "version": 1,
            "description": null
          },
          "evidence": "The document presents the company's solution, including its pipeline and strategy",
          "position": 3,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Resolution",
            "slug": "resolution",
            "status": "active",
            "canonId": "019dd9b8-045d-703b-8dd7-e92aba3ba91b",
            "version": 1,
            "description": "How the deck ends. Required in 19/20 arcs. The exception (Sparkline) ends with new bliss which is functionally a resolution."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.9
        }
      ],
      "loops": [
        {
          "to": 30,
          "from": 13,
          "loop": {
            "name": "47_quick_win_big_bet",
            "slug": "47-quick-win-big-bet",
            "status": "active",
            "bestFor": "Transformation planning, 100-day plans, resource allocation",
            "canonId": "019dd956-790d-708d-983e-ef9bbc68f741",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap",
            "description": "Separate initiatives into immediate wins and longer-term strategic bets",
            "familyLabel": null
          },
          "matchId": "1d2b0809-4269-4aea-a725-b67c9452d570",
          "evidence": "The document presents the company's solution, including its pipeline and strategy",
          "position": 2,
          "objective": "What is the company's solution?",
          "confidence": 0.8,
          "extraction": {
            "at": "2026-07-16 22:34:50.673683+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 15,
      "type": "evidence",
      "title": "Includes a KOL quote and specific market share metrics for US/EU regions.",
      "function": "show_traction",
      "rawType": "traction",
      "block": null,
      "metadata": {
        "slideType": "traction",
        "slideTypeCanon": {
          "name": "Traction",
          "slug": "traction",
          "status": "active",
          "canonId": "019de52d-0edd-72ab-820f-3ebc71a9c542",
          "version": 1,
          "description": null
        },
        "function": "show_traction",
        "functionCanon": {
          "name": "Show traction",
          "slug": "show_traction",
          "status": "active",
          "canonId": "019de52d-16a8-756a-9b38-a7d35420561d",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 74,
        "componentCount": 7,
        "textChars": 480,
        "nDataPoints": 20,
        "notes": "Includes a KOL quote and specific market share metrics for US/EU regions.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:46:11.573+00",
          "seconds": 3.229,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de075-3cec-7700-94db-076a5ce30d84/15",
        "deck": "/decks/019de075-3cec-7700-94db-076a5ce30d84",
        "deckAnchor": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-15",
        "deckJson": "/decks/019de075-3cec-7700-94db-076a5ce30d84.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.4,
            "w": 0.45,
            "x": 0.05,
            "y": 0.4
          },
          "kind": "chart",
          "text": "Entyvio Global sales (2014-28F)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Chart",
              "slug": "chart",
              "status": "active",
              "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8",
              "version": 1,
              "description": "Quantitative chart."
            },
            "tool": null,
            "subkind": {
              "name": "Vertical bar chart",
              "slug": "bar-vertical",
              "status": "active",
              "canonId": "019de52c-fe9d-70f2-b3b7-a9ae294f5917",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bar-vertical",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:11.573+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "37b83702-a79d-4416-9672-0ee287b89369",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.4,
            "w": 0.45,
            "x": 0.52,
            "y": 0.4
          },
          "kind": "chart",
          "text": "Entyvio US/EU % market share (June 2014-June 2022)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Chart",
              "slug": "chart",
              "status": "active",
              "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8",
              "version": 1,
              "description": "Quantitative chart."
            },
            "tool": null,
            "subkind": {
              "name": "Line chart",
              "slug": "line",
              "status": "active",
              "canonId": "019de52c-ff62-778f-8f6c-a952ceae8677",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "line",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:11.573+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "01e649b4-fc84-4ae3-a590-e62afc5df388",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.9,
            "x": 0.05,
            "y": 0.84
          },
          "kind": "disclaimer",
          "text": "1. Takeda JPM 2023 presentation. Note that Takeda's FY22 is April 2022-March 2023. Sales forecast in figure: EvaluatePharma consensus",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Disclaimer",
              "slug": "disclaimer",
              "status": "active",
              "canonId": "91173477-d91f-4024-bbaf-d4f93e3f82dc",
              "version": 1,
              "description": "Legal/cautionary text that occupies most of the body of its slide."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:11.573+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "0d65b805-cfda-431d-b1a9-b006419a057a",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.45,
            "x": 0.52,
            "y": 0.28
          },
          "kind": "list",
          "text": "Significant market share: ~36% of UC market share and ~20% of CD market share in US.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:11.573+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "0d5e8a7f-49ac-4d12-99bb-d5b2eb79fc6d",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.45,
            "x": 0.05,
            "y": 0.28
          },
          "kind": "list",
          "text": "Vedolizumab estimated $5.4B revenues WW in FY22. Projected to sell $7.5-9.0B at peak WW.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:11.573+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "ca00b188-cc94-4de6-a5eb-541c6474d2f6",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.4,
            "x": 0.3,
            "y": 0.18
          },
          "kind": "quote",
          "text": "Biologic of choice for UC is Entyvio. – US KOL",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:11.573+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "2234d39b-4a42-4cd3-aa64-a7d9b1760775",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.7,
            "x": 0.05,
            "y": 0.04
          },
          "kind": "title",
          "text": "Vedolizumab is a mega-blockbuster product in IBD",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:11.573+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "f31d8fde-6c05-47f9-9bb7-4fd8fdb3f5c0",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [
        {
          "to": 30,
          "arc": {
            "name": "Problem-Agitate-Solution",
            "slug": "problem-agitate-solution",
            "status": "active",
            "bestFor": "Sales pitches, urgency-driven, competitive displacement",
            "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
            "description": null,
            "familyLabel": null
          },
          "from": 13,
          "name": "Solution (Provide relief)",
          "beatId": "5fcb9464-3068-4031-9434-ce301bbe9fd3",
          "matchId": "a1bcf76f-a4ea-452c-9399-8bc5a62efe28",
          "beatType": {
            "name": "Solution (Provide relief)",
            "slug": "problem-agitate-solution-solution-provide-relief",
            "status": "active",
            "canonId": "019dd9b8-0fee-73e9-9ae5-799c7f3895cd",
            "version": 1,
            "description": null
          },
          "evidence": "The document presents the company's solution, including its pipeline and strategy",
          "position": 3,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Resolution",
            "slug": "resolution",
            "status": "active",
            "canonId": "019dd9b8-045d-703b-8dd7-e92aba3ba91b",
            "version": 1,
            "description": "How the deck ends. Required in 19/20 arcs. The exception (Sparkline) ends with new bliss which is functionally a resolution."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.9
        }
      ],
      "loops": [
        {
          "to": 30,
          "from": 13,
          "loop": {
            "name": "47_quick_win_big_bet",
            "slug": "47-quick-win-big-bet",
            "status": "active",
            "bestFor": "Transformation planning, 100-day plans, resource allocation",
            "canonId": "019dd956-790d-708d-983e-ef9bbc68f741",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap",
            "description": "Separate initiatives into immediate wins and longer-term strategic bets",
            "familyLabel": null
          },
          "matchId": "1d2b0809-4269-4aea-a725-b67c9452d570",
          "evidence": "The document presents the company's solution, including its pipeline and strategy",
          "position": 2,
          "objective": "What is the company's solution?",
          "confidence": 0.8,
          "extraction": {
            "at": "2026-07-16 22:34:50.673683+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 16,
      "type": "setup",
      "title": "The chart uses a dual-axis approach to imply a safety-efficacy trade-off, positioning vedolizumab as the 'safest' and highly effective.",
      "function": "compare_peers",
      "rawType": "competitive_analysis",
      "block": null,
      "metadata": {
        "slideType": "competitive_analysis",
        "slideTypeCanon": {
          "name": "Competitive analysis",
          "slug": "competitive_analysis",
          "status": "active",
          "canonId": "019de52d-093e-776b-94c6-c1573f5f1a31",
          "version": 1,
          "description": null
        },
        "function": "compare_peers",
        "functionCanon": {
          "name": "Compare peers",
          "slug": "compare_peers",
          "status": "active",
          "canonId": "019de52d-1453-72ba-a367-9ba3d34c1630",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 68,
        "componentCount": 5,
        "textChars": 859,
        "nDataPoints": 9,
        "notes": "The chart uses a dual-axis approach to imply a safety-efficacy trade-off, positioning vedolizumab as the 'safest' and highly effective.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:46:11.432+00",
          "seconds": 3.04,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de075-3cec-7700-94db-076a5ce30d84/16",
        "deck": "/decks/019de075-3cec-7700-94db-076a5ce30d84",
        "deckAnchor": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-16",
        "deckJson": "/decks/019de075-3cec-7700-94db-076a5ce30d84.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.55,
            "w": 0.45,
            "x": 0.52,
            "y": 0.21
          },
          "kind": "chart",
          "text": "UC Maintenance Efficacy Pbo-adjusted clinical remission %",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Chart",
              "slug": "chart",
              "status": "active",
              "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8",
              "version": 1,
              "description": "Quantitative chart."
            },
            "tool": null,
            "subkind": {
              "name": "Horizontal bar chart",
              "slug": "bar-horizontal",
              "status": "active",
              "canonId": "019de52c-fec4-7221-986b-1cb5f5e84b1f",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bar-horizontal",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:11.432+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e6777e83-31dc-4f78-9cbf-73ec5687fdc0",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.35,
            "w": 0.45,
            "x": 0.03,
            "y": 0.33
          },
          "kind": "list",
          "text": "Vedolizumab specifically binds α4β7 integrin, selectively blocking gut lymphocyte trafficking. Leading maintenance efficacy data in UC replicated in two P3 studies; efficacy on par with upadacitinib 15mg dose; superior head-to-head vs adalimumab (Humira) in UC. Clean safety profile since approval in 2014. #1 biologic in IBD bio-naïve patients in the US.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:11.432+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "f8e3239a-eccf-410b-9e4f-93e39bc69bef",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.45,
            "x": 0.03,
            "y": 0.21
          },
          "kind": "quote",
          "text": "“Entyvio (vedolizumab) is the safest drug and one of the most effective for UC.” – US KOL",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Pull quote",
              "slug": "pull-quote",
              "status": "active",
              "canonId": "019de52c-fbf9-76fe-97e1-a0b7540445c9",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "pull-quote",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:11.432+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "4fd9f929-9f55-425f-aae8-879455f6f501",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.95,
            "x": 0.03,
            "y": 0.84
          },
          "kind": "source-note",
          "text": "1. Takeda JPM 2023 presentation. Figure data sources: Vedolizumab IV and SC data from VISIBLE 1 P3 study. Ustekinumab, adalimumab, infliximab, golimumab, ozanimod, tofacitinib, upadacitinib data from labels. Mirikizumab data from phase 3 LUCENT-2 study.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:11.432+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "14f48b1e-6514-489a-8f21-bc4058fc90d6",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.85,
            "x": 0.02,
            "y": 0.04
          },
          "kind": "title",
          "text": "Vedolizumab maintenance efficacy and exquisite safety make it preferred biologic in moderate-to-severe UC",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:11.432+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "fda50922-a8e1-458e-9f90-02938754cba8",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "7bef0963-153d-4e2c-ae7c-ea8654f92ab0",
          "evidence": "Compares efficacy and safety of multiple drugs in a single chart.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 11:46:11.432+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 16,
          "frameworkName": "comparison_frame"
        }
      ],
      "arcBeats": [
        {
          "to": 30,
          "arc": {
            "name": "Problem-Agitate-Solution",
            "slug": "problem-agitate-solution",
            "status": "active",
            "bestFor": "Sales pitches, urgency-driven, competitive displacement",
            "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
            "description": null,
            "familyLabel": null
          },
          "from": 13,
          "name": "Solution (Provide relief)",
          "beatId": "5fcb9464-3068-4031-9434-ce301bbe9fd3",
          "matchId": "a1bcf76f-a4ea-452c-9399-8bc5a62efe28",
          "beatType": {
            "name": "Solution (Provide relief)",
            "slug": "problem-agitate-solution-solution-provide-relief",
            "status": "active",
            "canonId": "019dd9b8-0fee-73e9-9ae5-799c7f3895cd",
            "version": 1,
            "description": null
          },
          "evidence": "The document presents the company's solution, including its pipeline and strategy",
          "position": 3,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Resolution",
            "slug": "resolution",
            "status": "active",
            "canonId": "019dd9b8-045d-703b-8dd7-e92aba3ba91b",
            "version": 1,
            "description": "How the deck ends. Required in 19/20 arcs. The exception (Sparkline) ends with new bliss which is functionally a resolution."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.9
        }
      ],
      "loops": [
        {
          "to": 30,
          "from": 13,
          "loop": {
            "name": "47_quick_win_big_bet",
            "slug": "47-quick-win-big-bet",
            "status": "active",
            "bestFor": "Transformation planning, 100-day plans, resource allocation",
            "canonId": "019dd956-790d-708d-983e-ef9bbc68f741",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap",
            "description": "Separate initiatives into immediate wins and longer-term strategic bets",
            "familyLabel": null
          },
          "matchId": "1d2b0809-4269-4aea-a725-b67c9452d570",
          "evidence": "The document presents the company's solution, including its pipeline and strategy",
          "position": 2,
          "objective": "What is the company's solution?",
          "confidence": 0.8,
          "extraction": {
            "at": "2026-07-16 22:34:50.673683+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 17,
      "type": "setup",
      "title": "The slide uses a checkmark/empty circle matrix to highlight competitive differentiation.",
      "function": "compare_peers",
      "rawType": "competitive_analysis",
      "block": null,
      "metadata": {
        "slideType": "competitive_analysis",
        "slideTypeCanon": {
          "name": "Competitive analysis",
          "slug": "competitive_analysis",
          "status": "active",
          "canonId": "019de52d-093e-776b-94c6-c1573f5f1a31",
          "version": 1,
          "description": null
        },
        "function": "compare_peers",
        "functionCanon": {
          "name": "Compare peers",
          "slug": "compare_peers",
          "status": "active",
          "canonId": "019de52d-1453-72ba-a367-9ba3d34c1630",
          "version": 1,
          "description": null
        },
        "density": "sparse",
        "densityScore": 20,
        "componentCount": 3,
        "textChars": 215,
        "nDataPoints": 0,
        "notes": "The slide uses a checkmark/empty circle matrix to highlight competitive differentiation.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:46:11.797+00",
          "seconds": 2.64,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de075-3cec-7700-94db-076a5ce30d84/17",
        "deck": "/decks/019de075-3cec-7700-94db-076a5ce30d84",
        "deckAnchor": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-17",
        "deckJson": "/decks/019de075-3cec-7700-94db-076a5ce30d84.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.05,
            "w": 0.4,
            "x": 0.02,
            "y": 0.91
          },
          "kind": "disclaimer",
          "text": "*Entyvio SC US BLA resubmitted April 2023 following CRL in 2019.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Disclaimer",
              "slug": "disclaimer",
              "status": "active",
              "canonId": "91173477-d91f-4024-bbaf-d4f93e3f82dc",
              "version": 1,
              "description": "Legal/cautionary text that occupies most of the body of its slide."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:11.797+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "4de7054e-9cff-4bb8-95f1-e3048cb5be46",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.75,
            "w": 0.9,
            "x": 0.05,
            "y": 0.15
          },
          "kind": "table",
          "text": "Comparison matrix of Entyvio IV, Entyvio SC, and SPY001 across 8 clinical/convenience attributes.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Table",
              "slug": "table",
              "status": "active",
              "canonId": "019de52c-f9c8-7148-8119-eaac9594cd28",
              "version": 1,
              "description": "Tabular data layout."
            },
            "tool": null,
            "subkind": {
              "name": "Data table",
              "slug": "data",
              "status": "active",
              "canonId": "019de52d-02d5-75b8-8abf-88e92bf63569",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "data",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:11.797+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "b6abd241-fe0f-4bcb-8688-f37cdf217d12",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.85,
            "x": 0.02,
            "y": 0.03
          },
          "kind": "title",
          "text": "SPY001 is designed to be a best-in-class anti-α4β7 mAb",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:11.797+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "75afd848-2764-4839-b888-e37d7ba66ca8",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [
        {
          "tool": {
            "name": "2x2 matrix",
            "slug": "matrix-2x2",
            "status": "active",
            "bestFor": null,
            "canonId": "019dd9e1-50ab-72d1-8afb-3ab0a38e32a8",
            "version": 1,
            "bodyDocId": null,
            "description": "BCG matrix, importance/urgency, any axes-and-quadrants frame.",
            "familyLabel": null,
            "categoryName": null,
            "categorySlug": null
          },
          "agent": null,
          "layer": "slide",
          "agents": null,
          "matchId": "c286e321-5d61-4a4e-93f5-a528e43faae1",
          "evidence": "Comparison matrix of Entyvio IV, Entyvio SC, and SPY001 across 8 clinical/convenience attributes.",
          "pageRefs": null,
          "priority": null,
          "whenToUse": null,
          "confidence": 0.7,
          "extraction": {
            "at": "2026-07-17 00:26:46.791036+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 17,
          "whyItWorks": null,
          "antipattern": null,
          "cardinality": "common",
          "narrativePurpose": null
        }
      ],
      "frameworks": [
        {
          "matchId": "d526653a-acca-4d5d-8c46-541a2d06d417",
          "evidence": "Feature-by-feature comparison table against competitors",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 11:46:11.797+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 17,
          "frameworkName": "comparison_frame"
        }
      ],
      "arcBeats": [
        {
          "to": 30,
          "arc": {
            "name": "Problem-Agitate-Solution",
            "slug": "problem-agitate-solution",
            "status": "active",
            "bestFor": "Sales pitches, urgency-driven, competitive displacement",
            "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
            "description": null,
            "familyLabel": null
          },
          "from": 13,
          "name": "Solution (Provide relief)",
          "beatId": "5fcb9464-3068-4031-9434-ce301bbe9fd3",
          "matchId": "a1bcf76f-a4ea-452c-9399-8bc5a62efe28",
          "beatType": {
            "name": "Solution (Provide relief)",
            "slug": "problem-agitate-solution-solution-provide-relief",
            "status": "active",
            "canonId": "019dd9b8-0fee-73e9-9ae5-799c7f3895cd",
            "version": 1,
            "description": null
          },
          "evidence": "The document presents the company's solution, including its pipeline and strategy",
          "position": 3,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Resolution",
            "slug": "resolution",
            "status": "active",
            "canonId": "019dd9b8-045d-703b-8dd7-e92aba3ba91b",
            "version": 1,
            "description": "How the deck ends. Required in 19/20 arcs. The exception (Sparkline) ends with new bliss which is functionally a resolution."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.9
        }
      ],
      "loops": [
        {
          "to": 30,
          "from": 13,
          "loop": {
            "name": "47_quick_win_big_bet",
            "slug": "47-quick-win-big-bet",
            "status": "active",
            "bestFor": "Transformation planning, 100-day plans, resource allocation",
            "canonId": "019dd956-790d-708d-983e-ef9bbc68f741",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap",
            "description": "Separate initiatives into immediate wins and longer-term strategic bets",
            "familyLabel": null
          },
          "matchId": "1d2b0809-4269-4aea-a725-b67c9452d570",
          "evidence": "The document presents the company's solution, including its pipeline and strategy",
          "position": 2,
          "objective": "What is the company's solution?",
          "confidence": 0.8,
          "extraction": {
            "at": "2026-07-16 22:34:50.673683+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 18,
      "type": "resolution",
      "title": "The slide uses a central antibody diagram to annotate specific technical improvements over 1st generation mAbs.",
      "function": "present_solution",
      "rawType": "solution",
      "block": null,
      "metadata": {
        "slideType": "solution",
        "slideTypeCanon": {
          "name": "Solution",
          "slug": "solution",
          "status": "active",
          "canonId": "019de52d-0eb5-72ff-8b70-ba70a4199282",
          "version": 1,
          "description": null
        },
        "function": "present_solution",
        "functionCanon": {
          "name": "Present solution",
          "slug": "present_solution",
          "status": "active",
          "canonId": "019de52d-15b8-71da-bd23-2b767850cbce",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 75,
        "componentCount": 7,
        "textChars": 586,
        "nDataPoints": 4,
        "notes": "The slide uses a central antibody diagram to annotate specific technical improvements over 1st generation mAbs.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:46:12.058+00",
          "seconds": 2.895,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de075-3cec-7700-94db-076a5ce30d84/18",
        "deck": "/decks/019de075-3cec-7700-94db-076a5ce30d84",
        "deckAnchor": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-18",
        "deckJson": "/decks/019de075-3cec-7700-94db-076a5ce30d84.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.85,
            "w": 0.3,
            "x": 0.175,
            "y": 0.28
          },
          "kind": "image",
          "text": "Antibody diagram",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Illustration",
              "slug": "illustration",
              "status": "active",
              "canonId": "019de52c-fe76-7772-a5ac-c0b7294d7615",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "illustration",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:12.058+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "263e6c7b-58da-48ff-83fe-e8d922aa12ee",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.2,
            "x": 0.52,
            "y": 0.6
          },
          "kind": "list",
          "text": "Significantly extended half-life: Q8-Q12W dosing based on validated half-life extension technology",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:12.058+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "4bc56fe6-3f45-49ee-af8c-0a3e70d5c36b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.2,
            "x": 0.52,
            "y": 0.32
          },
          "kind": "list",
          "text": "Potential for IP into 2040s: Diverse coverage of lead and backup series",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:12.058+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "5ec36942-84f3-4db9-9693-a97abb044cdd",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.2,
            "x": 0.02,
            "y": 0.28
          },
          "kind": "list",
          "text": "Epitope maintained: Validated pharmacology, Equivalent potency",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:12.058+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "87925cee-5d24-4f99-bf8c-f33dd05160c9",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.2,
            "w": 0.2,
            "x": 0.02,
            "y": 0.6
          },
          "kind": "list",
          "text": "High concentration SC: Ability to formulate at >150 mg/mL with low viscosity, Citrate-free formulation may improve patient comfort",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:12.058+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "a50cd32d-2afe-4b9a-a73d-398855165af8",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.4,
            "w": 0.25,
            "x": 0.7,
            "y": 0.36
          },
          "kind": "table",
          "text": "SPY001 target profile: Efficacy >= vedolizumab, Citrate-free subcutaneous 300 mg dose, Q8W or Q12W dosing interval",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Table",
              "slug": "table",
              "status": "active",
              "canonId": "019de52c-f9c8-7148-8119-eaac9594cd28",
              "version": 1,
              "description": "Tabular data layout."
            },
            "tool": null,
            "subkind": {
              "name": "KPI table",
              "slug": "kpi",
              "status": "active",
              "canonId": "019de52d-0324-7799-a84e-d0885a8ad400",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "kpi",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:12.058+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "4e7354b7-9442-4968-a540-1592169686de",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.85,
            "x": 0.02,
            "y": 0.04
          },
          "kind": "title",
          "text": "SPY001 exploits validated α4β7 biology with modifications designed for best-in-class properties",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:12.058+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "7a237594-16ad-4c1b-af4f-4a9745d28453",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [
        {
          "tool": {
            "name": "List presentation",
            "slug": "list-presentation",
            "status": "active",
            "bestFor": null,
            "canonId": "019dd9e1-4ef7-777d-ba68-9074c2b3bcf1",
            "version": 1,
            "bodyDocId": null,
            "description": "Bulleted, numbered, or checklist enumerations.",
            "familyLabel": null,
            "categoryName": null,
            "categorySlug": null
          },
          "agent": null,
          "layer": "slide",
          "agents": null,
          "matchId": "57971335-dbd9-472b-a17b-3ca6288d4cab",
          "evidence": "list/bullet: High concentration SC: Ability to formulate at >150 mg/mL with low viscosity, Citrate-free formulation may improve patient comfort",
          "pageRefs": null,
          "priority": null,
          "whenToUse": null,
          "confidence": 0.8,
          "extraction": {
            "at": "2026-07-17 00:26:46.861455+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 18,
          "whyItWorks": null,
          "antipattern": null,
          "cardinality": "common",
          "narrativePurpose": null
        }
      ],
      "frameworks": [],
      "arcBeats": [
        {
          "to": 30,
          "arc": {
            "name": "Problem-Agitate-Solution",
            "slug": "problem-agitate-solution",
            "status": "active",
            "bestFor": "Sales pitches, urgency-driven, competitive displacement",
            "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
            "description": null,
            "familyLabel": null
          },
          "from": 13,
          "name": "Solution (Provide relief)",
          "beatId": "5fcb9464-3068-4031-9434-ce301bbe9fd3",
          "matchId": "a1bcf76f-a4ea-452c-9399-8bc5a62efe28",
          "beatType": {
            "name": "Solution (Provide relief)",
            "slug": "problem-agitate-solution-solution-provide-relief",
            "status": "active",
            "canonId": "019dd9b8-0fee-73e9-9ae5-799c7f3895cd",
            "version": 1,
            "description": null
          },
          "evidence": "The document presents the company's solution, including its pipeline and strategy",
          "position": 3,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Resolution",
            "slug": "resolution",
            "status": "active",
            "canonId": "019dd9b8-045d-703b-8dd7-e92aba3ba91b",
            "version": 1,
            "description": "How the deck ends. Required in 19/20 arcs. The exception (Sparkline) ends with new bliss which is functionally a resolution."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.9
        }
      ],
      "loops": [
        {
          "to": 30,
          "from": 13,
          "loop": {
            "name": "47_quick_win_big_bet",
            "slug": "47-quick-win-big-bet",
            "status": "active",
            "bestFor": "Transformation planning, 100-day plans, resource allocation",
            "canonId": "019dd956-790d-708d-983e-ef9bbc68f741",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap",
            "description": "Separate initiatives into immediate wins and longer-term strategic bets",
            "familyLabel": null
          },
          "matchId": "1d2b0809-4269-4aea-a725-b67c9452d570",
          "evidence": "The document presents the company's solution, including its pipeline and strategy",
          "position": 2,
          "objective": "What is the company's solution?",
          "confidence": 0.8,
          "extraction": {
            "at": "2026-07-16 22:34:50.673683+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 19,
      "type": "resolution",
      "title": "Includes structural biology visualization and dose-response curves for two different adhesion targets.",
      "function": "present_solution",
      "rawType": "solution",
      "block": null,
      "metadata": {
        "slideType": "solution",
        "slideTypeCanon": {
          "name": "Solution",
          "slug": "solution",
          "status": "active",
          "canonId": "019de52d-0eb5-72ff-8b70-ba70a4199282",
          "version": 1,
          "description": null
        },
        "function": "present_solution",
        "functionCanon": {
          "name": "Present solution",
          "slug": "present_solution",
          "status": "active",
          "canonId": "019de52d-15b8-71da-bd23-2b767850cbce",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 51,
        "componentCount": 5,
        "textChars": 356,
        "nDataPoints": 2,
        "notes": "Includes structural biology visualization and dose-response curves for two different adhesion targets.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:46:15.168+00",
          "seconds": 5.947,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de075-3cec-7700-94db-076a5ce30d84/19",
        "deck": "/decks/019de075-3cec-7700-94db-076a5ce30d84",
        "deckAnchor": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-19",
        "deckJson": "/decks/019de075-3cec-7700-94db-076a5ce30d84.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.5,
            "w": 0.3,
            "x": 0.315,
            "y": 0.35
          },
          "kind": "chart",
          "text": "Blocking MADCAM-1 Adhesion dose-response curve",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Chart",
              "slug": "chart",
              "status": "active",
              "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8",
              "version": 1,
              "description": "Quantitative chart."
            },
            "tool": null,
            "subkind": {
              "name": "Line chart",
              "slug": "line",
              "status": "active",
              "canonId": "019de52c-ff62-778f-8f6c-a952ceae8677",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "line",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:15.168+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "2e1b4074-99e3-43e0-b816-3032e4dffb68",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.5,
            "w": 0.3,
            "x": 0.65,
            "y": 0.35
          },
          "kind": "chart",
          "text": "Blocking VCAM-1 Adhesion dose-response curve",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Chart",
              "slug": "chart",
              "status": "active",
              "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8",
              "version": 1,
              "description": "Quantitative chart."
            },
            "tool": null,
            "subkind": {
              "name": "Line chart",
              "slug": "line",
              "status": "active",
              "canonId": "019de52c-ff62-778f-8f6c-a952ceae8677",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "line",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:15.168+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "8bf92389-8448-47b0-bdf2-dcfbd475e9b9",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.5,
            "w": 0.25,
            "x": 0.04,
            "y": 0.38
          },
          "kind": "image",
          "text": "3D molecular structure of α4β7 integrin with SPY001 epitope highlighted",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Illustration",
              "slug": "illustration",
              "status": "active",
              "canonId": "019de52c-fe76-7772-a5ac-c0b7294d7615",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "illustration",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:15.168+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "625b447b-ea1f-4756-94fa-32c9b4ece90d",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.96,
            "x": 0.02,
            "y": 0.185
          },
          "kind": "list",
          "text": "SPY001 binds the same α4β7 epitope as vedolizumab. SPY001 is comparable to vedolizumab in potency... ...and avoids unwanted interactions with α4β1.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:15.168+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "4e3462fa-238e-46d1-bf65-18e3cab71eb5",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.7,
            "x": 0.02,
            "y": 0.03
          },
          "kind": "title",
          "text": "SPY001 is as potent and selective as vedolizumab",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:15.168+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "eb9dd716-7d8b-44dc-ba24-54385e02c45e",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [
        {
          "tool": {
            "name": "Chart Selection Guide",
            "slug": "chart-selection-guide",
            "status": "active",
            "bestFor": null,
            "canonId": "019dd956-b1a0-700b-ba17-0e16c4d5bcae",
            "version": 1,
            "bodyDocId": null,
            "description": "Choosing the right chart type for your data and message",
            "familyLabel": null,
            "categoryName": "Slide",
            "categorySlug": "slide"
          },
          "agent": "Designer",
          "layer": "slide",
          "agents": [
            "Designer"
          ],
          "matchId": "2e8697b4-3e25-4cb6-b8b9-51479d4e166a",
          "evidence": "chart/line: Blocking MADCAM-1 Adhesion dose-response curve",
          "pageRefs": null,
          "priority": null,
          "whenToUse": null,
          "confidence": 0.7,
          "extraction": {
            "at": "2026-07-17 00:26:46.930903+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 19,
          "whyItWorks": null,
          "antipattern": null,
          "cardinality": null,
          "narrativePurpose": null
        }
      ],
      "frameworks": [],
      "arcBeats": [
        {
          "to": 30,
          "arc": {
            "name": "Problem-Agitate-Solution",
            "slug": "problem-agitate-solution",
            "status": "active",
            "bestFor": "Sales pitches, urgency-driven, competitive displacement",
            "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
            "description": null,
            "familyLabel": null
          },
          "from": 13,
          "name": "Solution (Provide relief)",
          "beatId": "5fcb9464-3068-4031-9434-ce301bbe9fd3",
          "matchId": "a1bcf76f-a4ea-452c-9399-8bc5a62efe28",
          "beatType": {
            "name": "Solution (Provide relief)",
            "slug": "problem-agitate-solution-solution-provide-relief",
            "status": "active",
            "canonId": "019dd9b8-0fee-73e9-9ae5-799c7f3895cd",
            "version": 1,
            "description": null
          },
          "evidence": "The document presents the company's solution, including its pipeline and strategy",
          "position": 3,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Resolution",
            "slug": "resolution",
            "status": "active",
            "canonId": "019dd9b8-045d-703b-8dd7-e92aba3ba91b",
            "version": 1,
            "description": "How the deck ends. Required in 19/20 arcs. The exception (Sparkline) ends with new bliss which is functionally a resolution."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.9
        }
      ],
      "loops": [
        {
          "to": 30,
          "from": 13,
          "loop": {
            "name": "47_quick_win_big_bet",
            "slug": "47-quick-win-big-bet",
            "status": "active",
            "bestFor": "Transformation planning, 100-day plans, resource allocation",
            "canonId": "019dd956-790d-708d-983e-ef9bbc68f741",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap",
            "description": "Separate initiatives into immediate wins and longer-term strategic bets",
            "familyLabel": null
          },
          "matchId": "1d2b0809-4269-4aea-a725-b67c9452d570",
          "evidence": "The document presents the company's solution, including its pipeline and strategy",
          "position": 2,
          "objective": "What is the company's solution?",
          "confidence": 0.8,
          "extraction": {
            "at": "2026-07-16 22:34:50.673683+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 20,
      "type": "setup",
      "title": "The slide demonstrates bio-equivalence in binding affinity to a specific T-cell population.",
      "function": "present_solution",
      "rawType": "product_demo",
      "block": null,
      "metadata": {
        "slideType": "product_demo",
        "slideTypeCanon": {
          "name": "Product demo",
          "slug": "product_demo",
          "status": "active",
          "canonId": "019de52d-0f06-7288-84f2-7568c1020fce",
          "version": 1,
          "description": null
        },
        "function": "present_solution",
        "functionCanon": {
          "name": "Present solution",
          "slug": "present_solution",
          "status": "active",
          "canonId": "019de52d-15b8-71da-bd23-2b767850cbce",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 65,
        "componentCount": 5,
        "textChars": 646,
        "nDataPoints": 18,
        "notes": "The slide demonstrates bio-equivalence in binding affinity to a specific T-cell population.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:46:12.545+00",
          "seconds": 3.324,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de075-3cec-7700-94db-076a5ce30d84/20",
        "deck": "/decks/019de075-3cec-7700-94db-076a5ce30d84",
        "deckAnchor": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-20",
        "deckJson": "/decks/019de075-3cec-7700-94db-076a5ce30d84.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.6,
            "w": 0.45,
            "x": 0.05,
            "y": 0.22
          },
          "kind": "chart",
          "text": "Binding curve showing Cell Binding (MFI) vs Antibody Concentration (nM) for SPY001 and Vedolizumab across 3 donors.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Chart",
              "slug": "chart",
              "status": "active",
              "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8",
              "version": 1,
              "description": "Quantitative chart."
            },
            "tool": null,
            "subkind": {
              "name": "Line chart",
              "slug": "line",
              "status": "active",
              "canonId": "019de52c-ff62-778f-8f6c-a952ceae8677",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "line",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:12.545+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "aa2366a7-162d-49ed-86c2-a212974f2f08",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.3,
            "w": 0.4,
            "x": 0.52,
            "y": 0.52
          },
          "kind": "list",
          "text": "PBMCs from three human donors were isolated and stained with either vedolizumab or SPY001, as well as a basic immunophenotyping T-cell panel. Both vedolizumab and SPY001 exhibited binding on the memory T-helper CD3+CD4+CD45RO+ population. EC50 values for both antibodies corresponded well with what has previously been reported for binding to the same population: EC50 ~ 0.3 nM.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:12.545+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "9e029306-d7e0-4e3f-b11e-33ff5c9c9f3f",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.15,
            "x": 0.05,
            "y": 0.9
          },
          "kind": "source-note",
          "text": "1. Soler, et. al. (2009)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:12.545+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "3fdfe30c-00c0-442d-89b2-32d638a07bfa",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.25,
            "w": 0.4,
            "x": 0.52,
            "y": 0.22
          },
          "kind": "table",
          "text": "EC50 (nM) values for Vedolizumab and SPY001 across Donor 1, 2, and 3.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Table",
              "slug": "table",
              "status": "active",
              "canonId": "019de52c-f9c8-7148-8119-eaac9594cd28",
              "version": 1,
              "description": "Tabular data layout."
            },
            "tool": null,
            "subkind": {
              "name": "Data table",
              "slug": "data",
              "status": "active",
              "canonId": "019de52d-02d5-75b8-8abf-88e92bf63569",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "data",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:12.545+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "bcf62219-ab94-45b7-9e91-957027b7a90d",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.7,
            "x": 0.05,
            "y": 0.05
          },
          "kind": "title",
          "text": "SPY001 binds to memory T-helper cells as well as vedolizumab",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:12.545+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e6dd238d-cbaa-4836-86d8-c6c0404ee25a",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [
        {
          "tool": {
            "name": "Data Story Arc",
            "slug": "data-story-arc",
            "status": "active",
            "bestFor": null,
            "canonId": "019dd956-9c30-728e-b974-d3fb123dcf5a",
            "version": 1,
            "bodyDocId": null,
            "description": "Context → Conflict → Insight → Implication structure for data narratives",
            "familyLabel": null,
            "categoryName": "Loop",
            "categorySlug": "loop"
          },
          "agent": "Storyteller",
          "layer": "slide",
          "agents": [
            "Storyteller"
          ],
          "matchId": "a26e1205-6922-46d0-89de-716f7abfa4d6",
          "evidence": "chart/line: Binding curve showing Cell Binding (MFI) vs Antibody Concentration (nM) for SPY001 and Vedolizumab across 3 donors.",
          "pageRefs": null,
          "priority": "Core",
          "whenToUse": null,
          "confidence": 0.6,
          "extraction": {
            "at": "2026-07-17 00:26:47.000208+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 20,
          "whyItWorks": null,
          "antipattern": null,
          "cardinality": null,
          "narrativePurpose": null
        }
      ],
      "frameworks": [],
      "arcBeats": [
        {
          "to": 30,
          "arc": {
            "name": "Problem-Agitate-Solution",
            "slug": "problem-agitate-solution",
            "status": "active",
            "bestFor": "Sales pitches, urgency-driven, competitive displacement",
            "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
            "description": null,
            "familyLabel": null
          },
          "from": 13,
          "name": "Solution (Provide relief)",
          "beatId": "5fcb9464-3068-4031-9434-ce301bbe9fd3",
          "matchId": "a1bcf76f-a4ea-452c-9399-8bc5a62efe28",
          "beatType": {
            "name": "Solution (Provide relief)",
            "slug": "problem-agitate-solution-solution-provide-relief",
            "status": "active",
            "canonId": "019dd9b8-0fee-73e9-9ae5-799c7f3895cd",
            "version": 1,
            "description": null
          },
          "evidence": "The document presents the company's solution, including its pipeline and strategy",
          "position": 3,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Resolution",
            "slug": "resolution",
            "status": "active",
            "canonId": "019dd9b8-045d-703b-8dd7-e92aba3ba91b",
            "version": 1,
            "description": "How the deck ends. Required in 19/20 arcs. The exception (Sparkline) ends with new bliss which is functionally a resolution."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.9
        }
      ],
      "loops": [
        {
          "to": 30,
          "from": 13,
          "loop": {
            "name": "47_quick_win_big_bet",
            "slug": "47-quick-win-big-bet",
            "status": "active",
            "bestFor": "Transformation planning, 100-day plans, resource allocation",
            "canonId": "019dd956-790d-708d-983e-ef9bbc68f741",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap",
            "description": "Separate initiatives into immediate wins and longer-term strategic bets",
            "familyLabel": null
          },
          "matchId": "1d2b0809-4269-4aea-a725-b67c9452d570",
          "evidence": "The document presents the company's solution, including its pipeline and strategy",
          "position": 2,
          "objective": "What is the company's solution?",
          "confidence": 0.8,
          "extraction": {
            "at": "2026-07-16 22:34:50.673683+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 21,
      "type": "evidence",
      "title": "The chart compares SPY001 against two vedolizumab datasets (internal and Takeda).",
      "function": "show_traction",
      "rawType": "traction",
      "block": null,
      "metadata": {
        "slideType": "traction",
        "slideTypeCanon": {
          "name": "Traction",
          "slug": "traction",
          "status": "active",
          "canonId": "019de52d-0edd-72ab-820f-3ebc71a9c542",
          "version": 1,
          "description": null
        },
        "function": "show_traction",
        "functionCanon": {
          "name": "Show traction",
          "slug": "show_traction",
          "status": "active",
          "canonId": "019de52d-16a8-756a-9b38-a7d35420561d",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 51,
        "componentCount": 4,
        "textChars": 553,
        "nDataPoints": 3,
        "notes": "The chart compares SPY001 against two vedolizumab datasets (internal and Takeda).",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:46:15.48+00",
          "seconds": 6.014,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de075-3cec-7700-94db-076a5ce30d84/21",
        "deck": "/decks/019de075-3cec-7700-94db-076a5ce30d84",
        "deckAnchor": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-21",
        "deckJson": "/decks/019de075-3cec-7700-94db-076a5ce30d84.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.7,
            "w": 0.64,
            "x": 0.02,
            "y": 0.195
          },
          "kind": "chart",
          "text": "Pharmacokinetics in NHP, IV Bolus",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Chart",
              "slug": "chart",
              "status": "active",
              "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8",
              "version": 1,
              "description": "Quantitative chart."
            },
            "tool": null,
            "subkind": {
              "name": "Line chart",
              "slug": "line",
              "status": "active",
              "canonId": "019de52c-ff62-778f-8f6c-a952ceae8677",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "line",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:15.48+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "6ddc079a-67de-4956-8792-b3856304cad0",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.25,
            "w": 0.28,
            "x": 0.68,
            "y": 0.24
          },
          "kind": "list",
          "text": "β-elimination half-life of SPY001 observed at ~17 days, 70% longer than observed for vedolizumab. Spyre vedolizumab data matches half-life observed in Takeda studies.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:15.48+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "da9070ae-4224-4966-bfb5-5e498f7c9f57",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.06,
            "w": 0.65,
            "x": 0.12,
            "y": 0.93
          },
          "kind": "source-note",
          "text": "NOTE: 1BLA 125476, Vedolizumab. 2Crawford, D. and Friedman, M. (2019). In all cases, PK data was normalized to Cmax and fit to a biphasic exponential decay curve from which the β-elimination half-life was determined. SOURCE: Data on file.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:15.48+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "2ee0bb28-53bb-4a8d-bd08-6cc76a906c04",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.85,
            "x": 0.02,
            "y": 0.04
          },
          "kind": "title",
          "text": "SPY001 has exhibited a 17-day half-life in NHPs, nearly 2x the half-life of vedolizumab observed in multiple studies",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:15.48+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "0dd64cb5-780d-4e4a-a36d-aee09a67a0b5",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [
        {
          "tool": {
            "name": "Chart Selection Guide",
            "slug": "chart-selection-guide",
            "status": "active",
            "bestFor": null,
            "canonId": "019dd956-b1a0-700b-ba17-0e16c4d5bcae",
            "version": 1,
            "bodyDocId": null,
            "description": "Choosing the right chart type for your data and message",
            "familyLabel": null,
            "categoryName": "Slide",
            "categorySlug": "slide"
          },
          "agent": "Designer",
          "layer": "slide",
          "agents": [
            "Designer"
          ],
          "matchId": "efb522bb-5653-401e-9e9c-3e9a39b0ce00",
          "evidence": "chart/line: Pharmacokinetics in NHP, IV Bolus",
          "pageRefs": null,
          "priority": null,
          "whenToUse": null,
          "confidence": 0.7,
          "extraction": {
            "at": "2026-07-17 00:26:47.069103+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 21,
          "whyItWorks": null,
          "antipattern": null,
          "cardinality": null,
          "narrativePurpose": null
        }
      ],
      "frameworks": [],
      "arcBeats": [
        {
          "to": 30,
          "arc": {
            "name": "Problem-Agitate-Solution",
            "slug": "problem-agitate-solution",
            "status": "active",
            "bestFor": "Sales pitches, urgency-driven, competitive displacement",
            "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
            "description": null,
            "familyLabel": null
          },
          "from": 13,
          "name": "Solution (Provide relief)",
          "beatId": "5fcb9464-3068-4031-9434-ce301bbe9fd3",
          "matchId": "a1bcf76f-a4ea-452c-9399-8bc5a62efe28",
          "beatType": {
            "name": "Solution (Provide relief)",
            "slug": "problem-agitate-solution-solution-provide-relief",
            "status": "active",
            "canonId": "019dd9b8-0fee-73e9-9ae5-799c7f3895cd",
            "version": 1,
            "description": null
          },
          "evidence": "The document presents the company's solution, including its pipeline and strategy",
          "position": 3,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Resolution",
            "slug": "resolution",
            "status": "active",
            "canonId": "019dd9b8-045d-703b-8dd7-e92aba3ba91b",
            "version": 1,
            "description": "How the deck ends. Required in 19/20 arcs. The exception (Sparkline) ends with new bliss which is functionally a resolution."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.9
        }
      ],
      "loops": [
        {
          "to": 30,
          "from": 13,
          "loop": {
            "name": "47_quick_win_big_bet",
            "slug": "47-quick-win-big-bet",
            "status": "active",
            "bestFor": "Transformation planning, 100-day plans, resource allocation",
            "canonId": "019dd956-790d-708d-983e-ef9bbc68f741",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap",
            "description": "Separate initiatives into immediate wins and longer-term strategic bets",
            "familyLabel": null
          },
          "matchId": "1d2b0809-4269-4aea-a725-b67c9452d570",
          "evidence": "The document presents the company's solution, including its pipeline and strategy",
          "position": 2,
          "objective": "What is the company's solution?",
          "confidence": 0.8,
          "extraction": {
            "at": "2026-07-16 22:34:50.673683+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 22,
      "type": "setup",
      "title": "Uses YTE modification as a mechanism for half-life extension.",
      "function": "compare_peers",
      "rawType": "competitive_analysis",
      "block": null,
      "metadata": {
        "slideType": "competitive_analysis",
        "slideTypeCanon": {
          "name": "Competitive analysis",
          "slug": "competitive_analysis",
          "status": "active",
          "canonId": "019de52d-093e-776b-94c6-c1573f5f1a31",
          "version": 1,
          "description": null
        },
        "function": "compare_peers",
        "functionCanon": {
          "name": "Compare peers",
          "slug": "compare_peers",
          "status": "active",
          "canonId": "019de52d-1453-72ba-a367-9ba3d34c1630",
          "version": 1,
          "description": null
        },
        "density": "balanced",
        "densityScore": 43,
        "componentCount": 4,
        "textChars": 339,
        "nDataPoints": 6,
        "notes": "Uses YTE modification as a mechanism for half-life extension.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:46:12.5+00",
          "seconds": 2.974,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de075-3cec-7700-94db-076a5ce30d84/22",
        "deck": "/decks/019de075-3cec-7700-94db-076a5ce30d84",
        "deckAnchor": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-22",
        "deckJson": "/decks/019de075-3cec-7700-94db-076a5ce30d84.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.45,
            "w": 0.9,
            "x": 0.05,
            "y": 0.25
          },
          "kind": "chart",
          "text": "Comparison of NHP and predicted human half-life",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Chart",
              "slug": "chart",
              "status": "active",
              "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8",
              "version": 1,
              "description": "Quantitative chart."
            },
            "tool": null,
            "subkind": {
              "name": "Horizontal bar chart",
              "slug": "bar-horizontal",
              "status": "active",
              "canonId": "019de52c-fec4-7221-986b-1cb5f5e84b1f",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bar-horizontal",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:12.5+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "8d46e369-e245-4e57-9ab9-5a91eb3cc0d5",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.9,
            "x": 0.05,
            "y": 0.72
          },
          "kind": "list",
          "text": "YTE modification typically increases mAb half-life by 2-4x versus wild-type in both NHP and human. Human YTE mAb half-life is on average 3.1x of NHP half-life.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:12.5+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "1274b916-b125-4122-8d9f-a8cfccc1770c",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.2,
            "x": 0.02,
            "y": 0.92
          },
          "kind": "source-note",
          "text": "Source: Rosario, M, et. al. (2017).",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:12.5+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "255503b9-9246-4a33-83d3-9e3e26bedbc5",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.75,
            "x": 0.02,
            "y": 0.04
          },
          "kind": "title",
          "text": "SPY001 NHP half-life and increased dose suggest potential for significant improvement over Entyvio",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:12.5+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "3786e327-b0a4-46e8-a6ff-7376b3894e8b",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [
        {
          "to": 30,
          "arc": {
            "name": "Problem-Agitate-Solution",
            "slug": "problem-agitate-solution",
            "status": "active",
            "bestFor": "Sales pitches, urgency-driven, competitive displacement",
            "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
            "description": null,
            "familyLabel": null
          },
          "from": 13,
          "name": "Solution (Provide relief)",
          "beatId": "5fcb9464-3068-4031-9434-ce301bbe9fd3",
          "matchId": "a1bcf76f-a4ea-452c-9399-8bc5a62efe28",
          "beatType": {
            "name": "Solution (Provide relief)",
            "slug": "problem-agitate-solution-solution-provide-relief",
            "status": "active",
            "canonId": "019dd9b8-0fee-73e9-9ae5-799c7f3895cd",
            "version": 1,
            "description": null
          },
          "evidence": "The document presents the company's solution, including its pipeline and strategy",
          "position": 3,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Resolution",
            "slug": "resolution",
            "status": "active",
            "canonId": "019dd9b8-045d-703b-8dd7-e92aba3ba91b",
            "version": 1,
            "description": "How the deck ends. Required in 19/20 arcs. The exception (Sparkline) ends with new bliss which is functionally a resolution."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.9
        }
      ],
      "loops": [
        {
          "to": 30,
          "from": 13,
          "loop": {
            "name": "47_quick_win_big_bet",
            "slug": "47-quick-win-big-bet",
            "status": "active",
            "bestFor": "Transformation planning, 100-day plans, resource allocation",
            "canonId": "019dd956-790d-708d-983e-ef9bbc68f741",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap",
            "description": "Separate initiatives into immediate wins and longer-term strategic bets",
            "familyLabel": null
          },
          "matchId": "1d2b0809-4269-4aea-a725-b67c9452d570",
          "evidence": "The document presents the company's solution, including its pipeline and strategy",
          "position": 2,
          "objective": "What is the company's solution?",
          "confidence": 0.8,
          "extraction": {
            "at": "2026-07-16 22:34:50.673683+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 23,
      "type": "setup",
      "title": "The slide uses a visual timeline/comparison to contrast the competitor's high-frequency, citrate-containing formulation with the company's low-frequency, citrat",
      "function": "compare_peers",
      "rawType": "comparison_table",
      "block": null,
      "metadata": {
        "slideType": "comparison_table",
        "slideTypeCanon": {
          "name": "Comparison table",
          "slug": "comparison_table",
          "status": "active",
          "canonId": "019de52d-0a06-73f8-8813-fe022fab1de2",
          "version": 1,
          "description": null
        },
        "function": "compare_peers",
        "functionCanon": {
          "name": "Compare peers",
          "slug": "compare_peers",
          "status": "active",
          "canonId": "019de52d-1453-72ba-a367-9ba3d34c1630",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 57,
        "componentCount": 6,
        "textChars": 303,
        "nDataPoints": 4,
        "notes": "The slide uses a visual timeline/comparison to contrast the competitor's high-frequency, citrate-containing formulation with the company's low-frequency, citrate-free formulation.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:46:12.588+00",
          "seconds": 3.006,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de075-3cec-7700-94db-076a5ce30d84/23",
        "deck": "/decks/019de075-3cec-7700-94db-076a5ce30d84",
        "deckAnchor": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-23",
        "deckJson": "/decks/019de075-3cec-7700-94db-076a5ce30d84.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.2,
            "w": 0.7,
            "x": 0.2,
            "y": 0.25
          },
          "kind": "chart",
          "text": "26 injections per year",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Chart",
              "slug": "chart",
              "status": "active",
              "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8",
              "version": 1,
              "description": "Quantitative chart."
            },
            "tool": null,
            "subkind": {
              "name": "Horizontal bar chart",
              "slug": "bar-horizontal",
              "status": "active",
              "canonId": "019de52c-fec4-7221-986b-1cb5f5e84b1f",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bar-horizontal",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:12.588+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "5c814bb2-57c8-4341-a6bf-204858e51435",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.2,
            "w": 0.7,
            "x": 0.2,
            "y": 0.6
          },
          "kind": "chart",
          "text": "Seasonal or every other month injections",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Chart",
              "slug": "chart",
              "status": "active",
              "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8",
              "version": 1,
              "description": "Quantitative chart."
            },
            "tool": null,
            "subkind": {
              "name": "Horizontal bar chart",
              "slug": "bar-horizontal",
              "status": "active",
              "canonId": "019de52c-fec4-7221-986b-1cb5f5e84b1f",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bar-horizontal",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:12.588+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "8b0e31e2-d492-4b08-beec-898a65353c9e",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.15,
            "x": 0.05,
            "y": 0.66
          },
          "kind": "paragraph",
          "text": "SPY001 SC 300 mg Citrate Free",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:12.588+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "4643e63b-3676-4065-b09e-9a624e390d50",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.15,
            "x": 0.03,
            "y": 0.3
          },
          "kind": "paragraph",
          "text": "Vedolizumab SC 108 mg 20 mM Citrate",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:12.588+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "da0a4998-0585-48ea-bad1-c67ece6e22df",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.5,
            "x": 0.02,
            "y": 0.9
          },
          "kind": "source-note",
          "text": "Note: Vedolizumab SC approved in EU. US BLA resubmitted April 2023 following CRL in 2019.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:12.588+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "47968413-f8ac-41a8-af04-605512bf8751",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.8,
            "x": 0.02,
            "y": 0.04
          },
          "kind": "title",
          "text": "SPY001 is specifically formulated to maximize dosing without sacrificing patient comfort",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:12.588+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "cf5e50d1-0827-4e0e-891e-4a601f44da0d",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [
        {
          "tool": {
            "name": "Comparison frame",
            "slug": "comparison-frame",
            "status": "active",
            "bestFor": null,
            "canonId": "019dd9e1-484b-7399-a4fc-d14644b99f93",
            "version": 1,
            "bodyDocId": null,
            "description": "Two or more states/subjects placed side by side to expose a gap.",
            "familyLabel": null,
            "categoryName": null,
            "categorySlug": null
          },
          "agent": null,
          "layer": "slide",
          "agents": null,
          "matchId": "92742dd5-05ce-4be9-b87c-68805d5600d2",
          "evidence": "chart/bar-horizontal: Seasonal or every other month injections",
          "pageRefs": null,
          "priority": null,
          "whenToUse": null,
          "confidence": 0.6,
          "extraction": {
            "at": "2026-07-17 00:26:47.172286+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 23,
          "whyItWorks": null,
          "antipattern": null,
          "cardinality": "common",
          "narrativePurpose": null
        }
      ],
      "frameworks": [
        {
          "matchId": "549a5507-1539-4fc9-bdea-63abcc53d606",
          "evidence": "Direct visual comparison of two products across key metrics (dosing frequency, comfort).",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 11:46:12.588+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 23,
          "frameworkName": "comparison-frame"
        }
      ],
      "arcBeats": [
        {
          "to": 30,
          "arc": {
            "name": "Problem-Agitate-Solution",
            "slug": "problem-agitate-solution",
            "status": "active",
            "bestFor": "Sales pitches, urgency-driven, competitive displacement",
            "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
            "description": null,
            "familyLabel": null
          },
          "from": 13,
          "name": "Solution (Provide relief)",
          "beatId": "5fcb9464-3068-4031-9434-ce301bbe9fd3",
          "matchId": "a1bcf76f-a4ea-452c-9399-8bc5a62efe28",
          "beatType": {
            "name": "Solution (Provide relief)",
            "slug": "problem-agitate-solution-solution-provide-relief",
            "status": "active",
            "canonId": "019dd9b8-0fee-73e9-9ae5-799c7f3895cd",
            "version": 1,
            "description": null
          },
          "evidence": "The document presents the company's solution, including its pipeline and strategy",
          "position": 3,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Resolution",
            "slug": "resolution",
            "status": "active",
            "canonId": "019dd9b8-045d-703b-8dd7-e92aba3ba91b",
            "version": 1,
            "description": "How the deck ends. Required in 19/20 arcs. The exception (Sparkline) ends with new bliss which is functionally a resolution."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.9
        }
      ],
      "loops": [
        {
          "to": 30,
          "from": 13,
          "loop": {
            "name": "47_quick_win_big_bet",
            "slug": "47-quick-win-big-bet",
            "status": "active",
            "bestFor": "Transformation planning, 100-day plans, resource allocation",
            "canonId": "019dd956-790d-708d-983e-ef9bbc68f741",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap",
            "description": "Separate initiatives into immediate wins and longer-term strategic bets",
            "familyLabel": null
          },
          "matchId": "1d2b0809-4269-4aea-a725-b67c9452d570",
          "evidence": "The document presents the company's solution, including its pipeline and strategy",
          "position": 2,
          "objective": "What is the company's solution?",
          "confidence": 0.8,
          "extraction": {
            "at": "2026-07-16 22:34:50.673683+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 24,
      "type": "setup",
      "title": "The chart compares benchmark induction remission rates with vedolizumab exposure quartiles.",
      "function": "argue_timing",
      "rawType": "why_now",
      "block": null,
      "metadata": {
        "slideType": "why_now",
        "slideTypeCanon": {
          "name": "Why now",
          "slug": "why_now",
          "status": "active",
          "canonId": "019de52d-0f2e-718d-b8ad-256dd87582d0",
          "version": 1,
          "description": null
        },
        "function": "argue_timing",
        "functionCanon": {
          "name": "Argue timing (why now)",
          "slug": "argue_timing",
          "status": "active",
          "canonId": "019de52d-16f8-74de-9ec2-900be07d90dd",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 77,
        "componentCount": 6,
        "textChars": 945,
        "nDataPoints": 10,
        "notes": "The chart compares benchmark induction remission rates with vedolizumab exposure quartiles.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:46:13.514+00",
          "seconds": 3.421,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de075-3cec-7700-94db-076a5ce30d84/24",
        "deck": "/decks/019de075-3cec-7700-94db-076a5ce30d84",
        "deckAnchor": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-24",
        "deckJson": "/decks/019de075-3cec-7700-94db-076a5ce30d84.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.08,
            "w": 0.38,
            "x": 0.6,
            "y": 0.75
          },
          "kind": "callout",
          "text": "Superior time to onset could position SPY001 as the preferred starting therapy vs. vedolizumab",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": null,
            "subkind": {
              "name": "Primary callout",
              "slug": "primary",
              "status": "active",
              "canonId": "019de52c-fbd1-70eb-a9ce-8997f8674c1d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "primary",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:13.514+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "0c534056-8fcc-4f0d-95a6-4e9f9552c075",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.55,
            "w": 0.55,
            "x": 0.02,
            "y": 0.23
          },
          "kind": "chart",
          "text": "UC induction clinical remission rates",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Chart",
              "slug": "chart",
              "status": "active",
              "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8",
              "version": 1,
              "description": "Quantitative chart."
            },
            "tool": null,
            "subkind": {
              "name": "Vertical bar chart",
              "slug": "bar-vertical",
              "status": "active",
              "canonId": "019de52c-fe9d-70f2-b3b7-a9ae294f5917",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bar-vertical",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:13.514+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "4767e7f0-fa4c-4fe0-8371-b48e012e2129",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.3,
            "w": 0.38,
            "x": 0.6,
            "y": 0.25
          },
          "kind": "list",
          "text": "Slow onset of vedolizumab efficacy may be explained by insufficient dosing. Clear exposure-efficacy relationship observed at Week 6: Highest quartile achieved a remarkable 37.1% remission rate. Lowest exposure quartile did not separate from placebo.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:13.514+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "04ed51b8-4afb-43df-aec4-4dd3142f73f0",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.38,
            "x": 0.6,
            "y": 0.6
          },
          "kind": "paragraph",
          "text": "FDA noted \"significant exposure-response relationship\" and recommended exploring higher doses to improve remission rates.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:13.514+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "bda0e2a3-4e4b-4664-9190-41d5f77749b7",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.95,
            "x": 0.02,
            "y": 0.88
          },
          "kind": "source-note",
          "text": "1. Rosario, M., et. al. (2017). 2. Vedolizumab FDA Clinical Pharmacology Review. Figure sources: Multi-MOA benchmark data from adalimumab label (TNFa), ustekinumab label (IL-12/23), mirikizumab LUCENT-1 study (IL-23), PRA023 P2b (TL1A), and vedolizumab VARSITY study (a4b7). Vedolizumab exposure-response data from Rosario, M., et. et. (2017).",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:13.514+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "bbd185c0-baa9-4825-812c-e5b49014968a",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.85,
            "x": 0.02,
            "y": 0.04
          },
          "kind": "title",
          "text": "Vedolizumab appears underdosed in induction; opportunity for SPY001 to achieve superior time to onset",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:13.514+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "86c6a5f8-80e8-4e14-bca1-4574d675cae4",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [
        {
          "tool": {
            "name": "Problem-Agitate-Solve (PAS)",
            "slug": "problem-agitate-solve-pas",
            "status": "active",
            "bestFor": null,
            "canonId": "019dd956-869f-7564-8d42-de54ed29ab90",
            "version": 1,
            "bodyDocId": null,
            "description": "Identify problem, agitate the pain, present the solution",
            "familyLabel": null,
            "categoryName": "Block",
            "categorySlug": "block"
          },
          "agent": "Storyteller",
          "layer": "slide",
          "agents": [
            "Storyteller"
          ],
          "matchId": "3365a66c-9b8d-4c40-95d4-ed51193f75f1",
          "evidence": "list/bullet: Slow onset of vedolizumab efficacy may be explained by insufficient dosing.",
          "pageRefs": null,
          "priority": null,
          "whenToUse": null,
          "confidence": 0.6,
          "extraction": {
            "at": "2026-07-17 00:26:47.241501+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 24,
          "whyItWorks": null,
          "antipattern": null,
          "cardinality": null,
          "narrativePurpose": null
        }
      ],
      "frameworks": [],
      "arcBeats": [
        {
          "to": 30,
          "arc": {
            "name": "Problem-Agitate-Solution",
            "slug": "problem-agitate-solution",
            "status": "active",
            "bestFor": "Sales pitches, urgency-driven, competitive displacement",
            "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
            "description": null,
            "familyLabel": null
          },
          "from": 13,
          "name": "Solution (Provide relief)",
          "beatId": "5fcb9464-3068-4031-9434-ce301bbe9fd3",
          "matchId": "a1bcf76f-a4ea-452c-9399-8bc5a62efe28",
          "beatType": {
            "name": "Solution (Provide relief)",
            "slug": "problem-agitate-solution-solution-provide-relief",
            "status": "active",
            "canonId": "019dd9b8-0fee-73e9-9ae5-799c7f3895cd",
            "version": 1,
            "description": null
          },
          "evidence": "The document presents the company's solution, including its pipeline and strategy",
          "position": 3,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Resolution",
            "slug": "resolution",
            "status": "active",
            "canonId": "019dd9b8-045d-703b-8dd7-e92aba3ba91b",
            "version": 1,
            "description": "How the deck ends. Required in 19/20 arcs. The exception (Sparkline) ends with new bliss which is functionally a resolution."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.9
        }
      ],
      "loops": [
        {
          "to": 30,
          "from": 13,
          "loop": {
            "name": "47_quick_win_big_bet",
            "slug": "47-quick-win-big-bet",
            "status": "active",
            "bestFor": "Transformation planning, 100-day plans, resource allocation",
            "canonId": "019dd956-790d-708d-983e-ef9bbc68f741",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap",
            "description": "Separate initiatives into immediate wins and longer-term strategic bets",
            "familyLabel": null
          },
          "matchId": "1d2b0809-4269-4aea-a725-b67c9452d570",
          "evidence": "The document presents the company's solution, including its pipeline and strategy",
          "position": 2,
          "objective": "What is the company's solution?",
          "confidence": 0.8,
          "extraction": {
            "at": "2026-07-16 22:34:50.673683+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 25,
      "type": "analysis",
      "title": "Data from GEMINI 1 study; highlights that higher drug concentration does not necessarily correlate with higher efficacy in maintenance.",
      "function": "analyze_data",
      "rawType": "appendix_data",
      "block": null,
      "metadata": {
        "slideType": "appendix_data",
        "slideTypeCanon": {
          "name": "Appendix data",
          "slug": "appendix_data",
          "status": "active",
          "canonId": "019de52d-078a-745b-9ee4-c15f2f539acd",
          "version": 1,
          "description": null
        },
        "function": "analyze_data",
        "functionCanon": {
          "name": "Analyze data",
          "slug": "analyze_data",
          "status": "active",
          "canonId": "019de52d-1590-7413-8c82-cc218cff40b4",
          "version": 1,
          "description": null
        },
        "density": "balanced",
        "densityScore": 48,
        "componentCount": 4,
        "textChars": 427,
        "nDataPoints": 8,
        "notes": "Data from GEMINI 1 study; highlights that higher drug concentration does not necessarily correlate with higher efficacy in maintenance.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:46:13.903+00",
          "seconds": 3.771,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de075-3cec-7700-94db-076a5ce30d84/25",
        "deck": "/decks/019de075-3cec-7700-94db-076a5ce30d84",
        "deckAnchor": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-25",
        "deckJson": "/decks/019de075-3cec-7700-94db-076a5ce30d84.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.6,
            "w": 0.55,
            "x": 0.04,
            "y": 0.23
          },
          "kind": "chart",
          "text": "Vedolizumab maintenance of clinical remission by exposure quartile % at week 52 (GEMINI 1)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Chart",
              "slug": "chart",
              "status": "active",
              "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8",
              "version": 1,
              "description": "Quantitative chart."
            },
            "tool": null,
            "subkind": {
              "name": "Vertical bar chart",
              "slug": "bar-vertical",
              "status": "active",
              "canonId": "019de52c-fe9d-70f2-b3b7-a9ae294f5917",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bar-vertical",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:13.903+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "20005976-5e82-458f-abc6-b0319560e401",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.3,
            "w": 0.35,
            "x": 0.62,
            "y": 0.35
          },
          "kind": "list",
          "text": "Minimal difference in maintenance of clinical remission between vedolizumab IV Q4W (44.8%) or Q8W (41.8%).\nCtrough ≥ 6 µg/mL is a conservative target to maintain long-term efficacy with potent anti-α4β7 mAbs.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:13.903+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "574eec32-0f76-40cd-bcfc-294fcad51872",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.15,
            "x": 0.02,
            "y": 0.95
          },
          "kind": "source-note",
          "text": "Source: Feagan, et. al. (2013).",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:13.903+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "83e5fd36-2831-45d3-bf39-6a551d0c015c",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.75,
            "x": 0.02,
            "y": 0.04
          },
          "kind": "title",
          "text": "Once induction is achieved, very low exposures of vedolizumab are sufficient to maintain remission",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:13.903+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "d3f4a329-c2c6-4ae6-9420-4fdf19999d43",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [
        {
          "to": 30,
          "arc": {
            "name": "Problem-Agitate-Solution",
            "slug": "problem-agitate-solution",
            "status": "active",
            "bestFor": "Sales pitches, urgency-driven, competitive displacement",
            "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
            "description": null,
            "familyLabel": null
          },
          "from": 13,
          "name": "Solution (Provide relief)",
          "beatId": "5fcb9464-3068-4031-9434-ce301bbe9fd3",
          "matchId": "a1bcf76f-a4ea-452c-9399-8bc5a62efe28",
          "beatType": {
            "name": "Solution (Provide relief)",
            "slug": "problem-agitate-solution-solution-provide-relief",
            "status": "active",
            "canonId": "019dd9b8-0fee-73e9-9ae5-799c7f3895cd",
            "version": 1,
            "description": null
          },
          "evidence": "The document presents the company's solution, including its pipeline and strategy",
          "position": 3,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Resolution",
            "slug": "resolution",
            "status": "active",
            "canonId": "019dd9b8-045d-703b-8dd7-e92aba3ba91b",
            "version": 1,
            "description": "How the deck ends. Required in 19/20 arcs. The exception (Sparkline) ends with new bliss which is functionally a resolution."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.9
        }
      ],
      "loops": [
        {
          "to": 30,
          "from": 13,
          "loop": {
            "name": "47_quick_win_big_bet",
            "slug": "47-quick-win-big-bet",
            "status": "active",
            "bestFor": "Transformation planning, 100-day plans, resource allocation",
            "canonId": "019dd956-790d-708d-983e-ef9bbc68f741",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap",
            "description": "Separate initiatives into immediate wins and longer-term strategic bets",
            "familyLabel": null
          },
          "matchId": "1d2b0809-4269-4aea-a725-b67c9452d570",
          "evidence": "The document presents the company's solution, including its pipeline and strategy",
          "position": 2,
          "objective": "What is the company's solution?",
          "confidence": 0.8,
          "extraction": {
            "at": "2026-07-16 22:34:50.673683+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 26,
      "type": "resolution",
      "title": "The slide uses a standard 2x2 grid for program summary and a simple timeline for catalysts.",
      "function": "present_solution",
      "rawType": "solution",
      "block": null,
      "metadata": {
        "slideType": "solution",
        "slideTypeCanon": {
          "name": "Solution",
          "slug": "solution",
          "status": "active",
          "canonId": "019de52d-0eb5-72ff-8b70-ba70a4199282",
          "version": 1,
          "description": null
        },
        "function": "present_solution",
        "functionCanon": {
          "name": "Present solution",
          "slug": "present_solution",
          "status": "active",
          "canonId": "019de52d-15b8-71da-bd23-2b767850cbce",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 75,
        "componentCount": 7,
        "textChars": 582,
        "nDataPoints": 3,
        "notes": "The slide uses a standard 2x2 grid for program summary and a simple timeline for catalysts.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:46:13.155+00",
          "seconds": 3.007,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de075-3cec-7700-94db-076a5ce30d84/26",
        "deck": "/decks/019de075-3cec-7700-94db-076a5ce30d84",
        "deckAnchor": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-26",
        "deckJson": "/decks/019de075-3cec-7700-94db-076a5ce30d84.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.12,
            "w": 0.45,
            "x": 0.4,
            "y": 0.77
          },
          "kind": "chart",
          "text": "Upcoming catalysts: 2Q2024 IND/CTN, YE2024 Human PK/PD",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Chart",
              "slug": "chart",
              "status": "active",
              "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8",
              "version": 1,
              "description": "Quantitative chart."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": "timeline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:13.155+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "1c3b1383-6589-4b76-9f26-8f5d5b492c78",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.55,
            "w": 0.28,
            "x": 0.03,
            "y": 0.25
          },
          "kind": "image",
          "text": "Antibody diagram",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Illustration",
              "slug": "illustration",
              "status": "active",
              "canonId": "019de52c-fe76-7772-a5ac-c0b7294d7615",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "illustration",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:13.155+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "987f0f02-4f35-4ae8-8b3c-0656eaf3f8ca",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.22,
            "w": 0.28,
            "x": 0.36,
            "y": 0.235
          },
          "kind": "list",
          "text": "Preferred target in large market: Vedolizumab is the preferred biologic in UC with >$5B in annual sales",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:13.155+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "9f93bc41-3777-42fd-ace9-bc7bb9e1d725",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.22,
            "w": 0.28,
            "x": 0.66,
            "y": 0.465
          },
          "kind": "list",
          "text": "Promising early data: SPY001 observed to match vedolizumab's potency and selectivity and has ~2x half-life in NHPs",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:13.155+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "a5509d82-be0c-47e2-a56e-1329072fe842",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.22,
            "w": 0.28,
            "x": 0.66,
            "y": 0.235
          },
          "kind": "list",
          "text": "Clinically validated pharmacology: SPY001 observed to maintain vedolizumab's epitope with similar potency",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:13.155+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "cbbc0aef-3b18-499a-afb8-4c2a92080599",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.22,
            "w": 0.28,
            "x": 0.36,
            "y": 0.465
          },
          "kind": "list",
          "text": "Designed for differentiation: Q8W+ dosing, faster time to onset, patient-friendly formulation",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:13.155+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "d3ca2830-f600-43bd-a44b-38e1e9128429",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.85,
            "x": 0.03,
            "y": 0.04
          },
          "kind": "title",
          "text": "SPY001 is a potentially best-in-class anti-α4β7 mAb with near-term de-risking studies anticipated",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:13.155+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "1e36a9f9-8626-4a3b-aba8-abf4a6eb4606",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [
        {
          "tool": {
            "name": "Thesis archetype",
            "slug": "thesis-archetype",
            "status": "active",
            "bestFor": null,
            "canonId": "019dd9e1-4b0b-7428-9b26-f171d1e753fb",
            "version": 1,
            "bodyDocId": null,
            "description": "A canonical investment / activist thesis shape (breakup, fraud, governance).",
            "familyLabel": null,
            "categoryName": null,
            "categorySlug": null
          },
          "agent": null,
          "layer": "slide",
          "agents": null,
          "matchId": "daae947d-1004-4fcf-96ed-ca8adc2f7c2f",
          "evidence": "list/bullet: Promising early data: SPY001 observed to match vedolizumab's potency and selectivity and has ~2x half-life in NHPs",
          "pageRefs": null,
          "priority": null,
          "whenToUse": null,
          "confidence": 0.7,
          "extraction": {
            "at": "2026-07-17 00:26:47.344792+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 26,
          "whyItWorks": null,
          "antipattern": null,
          "cardinality": "optional",
          "narrativePurpose": null
        }
      ],
      "frameworks": [
        {
          "matchId": "0783aa15-4946-4614-96c8-6e4e421a85e2",
          "evidence": "Upcoming catalysts section uses a linear timeline representation",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 11:46:13.155+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 26,
          "frameworkName": "timeline"
        }
      ],
      "arcBeats": [
        {
          "to": 30,
          "arc": {
            "name": "Problem-Agitate-Solution",
            "slug": "problem-agitate-solution",
            "status": "active",
            "bestFor": "Sales pitches, urgency-driven, competitive displacement",
            "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
            "description": null,
            "familyLabel": null
          },
          "from": 13,
          "name": "Solution (Provide relief)",
          "beatId": "5fcb9464-3068-4031-9434-ce301bbe9fd3",
          "matchId": "a1bcf76f-a4ea-452c-9399-8bc5a62efe28",
          "beatType": {
            "name": "Solution (Provide relief)",
            "slug": "problem-agitate-solution-solution-provide-relief",
            "status": "active",
            "canonId": "019dd9b8-0fee-73e9-9ae5-799c7f3895cd",
            "version": 1,
            "description": null
          },
          "evidence": "The document presents the company's solution, including its pipeline and strategy",
          "position": 3,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Resolution",
            "slug": "resolution",
            "status": "active",
            "canonId": "019dd9b8-045d-703b-8dd7-e92aba3ba91b",
            "version": 1,
            "description": "How the deck ends. Required in 19/20 arcs. The exception (Sparkline) ends with new bliss which is functionally a resolution."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.9
        }
      ],
      "loops": [
        {
          "to": 30,
          "from": 13,
          "loop": {
            "name": "47_quick_win_big_bet",
            "slug": "47-quick-win-big-bet",
            "status": "active",
            "bestFor": "Transformation planning, 100-day plans, resource allocation",
            "canonId": "019dd956-790d-708d-983e-ef9bbc68f741",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap",
            "description": "Separate initiatives into immediate wins and longer-term strategic bets",
            "familyLabel": null
          },
          "matchId": "1d2b0809-4269-4aea-a725-b67c9452d570",
          "evidence": "The document presents the company's solution, including its pipeline and strategy",
          "position": 2,
          "objective": "What is the company's solution?",
          "confidence": 0.8,
          "extraction": {
            "at": "2026-07-16 22:34:50.673683+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 27,
      "type": "setup",
      "title": "Uses historical peer data (Morphic, Prometheus) to project value inflection points for SPY001.",
      "function": "compare_peers",
      "rawType": "peer_benchmark",
      "block": null,
      "metadata": {
        "slideType": "peer_benchmark",
        "slideTypeCanon": {
          "name": "Peer benchmark",
          "slug": "peer_benchmark",
          "status": "active",
          "canonId": "019de52d-08f0-7158-a78d-d7b5331fefaf",
          "version": 1,
          "description": null
        },
        "function": "compare_peers",
        "functionCanon": {
          "name": "Compare peers",
          "slug": "compare_peers",
          "status": "active",
          "canonId": "019de52d-1453-72ba-a367-9ba3d34c1630",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 67,
        "componentCount": 6,
        "textChars": 513,
        "nDataPoints": 6,
        "notes": "Uses historical peer data (Morphic, Prometheus) to project value inflection points for SPY001.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:46:14.256+00",
          "seconds": 4.028,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de075-3cec-7700-94db-076a5ce30d84/27",
        "deck": "/decks/019de075-3cec-7700-94db-076a5ce30d84",
        "deckAnchor": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-27",
        "deckJson": "/decks/019de075-3cec-7700-94db-076a5ce30d84.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.08,
            "w": 0.2,
            "x": 0.38,
            "y": 0.245
          },
          "kind": "callout",
          "text": "Morphic oral α4β7: Value at Phase 1 data",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": null,
            "subkind": {
              "name": "Primary callout",
              "slug": "primary",
              "status": "active",
              "canonId": "019de52c-fbd1-70eb-a9ce-8997f8674c1d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "primary",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:14.256+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "63cd35a0-da66-4487-9ece-61ffcd915135",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.2,
            "x": 0.68,
            "y": 0.16
          },
          "kind": "callout",
          "text": "Further step-up in value with induction Phase 2 data",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": null,
            "subkind": {
              "name": "Primary callout",
              "slug": "primary",
              "status": "active",
              "canonId": "019de52c-fbd1-70eb-a9ce-8997f8674c1d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "primary",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:14.256+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "ed6302f5-0d5e-49a5-89a9-3b780b8d5c03",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.38,
            "w": 0.92,
            "x": 0.04,
            "y": 0.17
          },
          "kind": "chart",
          "text": "Market cap comps at key events: Projected",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Chart",
              "slug": "chart",
              "status": "active",
              "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8",
              "version": 1,
              "description": "Quantitative chart."
            },
            "tool": null,
            "subkind": {
              "name": "Grouped bar chart",
              "slug": "bar-grouped",
              "status": "active",
              "canonId": "019de52c-ff3b-751e-a8ff-f21ff11097b1",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bar-grouped",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:14.256+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "8d5c47c2-e942-45d2-8a4d-5bcf4035b0e7",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.32,
            "w": 0.96,
            "x": 0.02,
            "y": 0.58
          },
          "kind": "diagram",
          "text": "Projected 2023, 2024, 2025+ timeline with SPY001 clinical phases",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Diagram",
              "slug": "diagram",
              "status": "active",
              "canonId": "019de52c-f9f0-734a-81de-15382ff28c65",
              "version": 1,
              "description": "Schematic or relational diagram."
            },
            "tool": null,
            "subkind": {
              "name": "Timeline",
              "slug": "timeline",
              "status": "active",
              "canonId": "019de52d-03c5-73fc-84aa-4180cbf0f5cf",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "timeline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:14.256+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "f4ed9449-08f6-477d-b9a4-7c4c103ee019",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.75,
            "x": 0.12,
            "y": 0.94
          },
          "kind": "source-note",
          "text": "Source: FactSet 30-d average market caps after event date. 1 Morphic Phase 2a single arm UC data; Prometheus RCT (UC) and single arm (CD) Phase 2.; Prometheus ultimately acquired for $10.8B after Phase 2 data",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:14.256+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "4e49f791-610c-4eff-8700-0614e8638947",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.85,
            "x": 0.02,
            "y": 0.03
          },
          "kind": "title",
          "text": "Key value inflection in ~18 months with Phase 1 PK data anticipated to validate SPY001 as “long-acting Vedo”",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:14.256+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "4359a66f-889e-4fb9-b0e6-e6b85ad23766",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [
        {
          "tool": {
            "name": "Slide recipe: the peer-gap chart",
            "slug": "peer-gap-chart-recipe",
            "status": "active",
            "bestFor": null,
            "canonId": "019df269-2b04-75bc-ad85-e0179264bdd7",
            "version": 1,
            "bodyDocId": "019df269-2ae1-771d-9cd1-193a2e25f21c",
            "description": "The single most-copied slide in activism. This is the exact layout, used",
            "familyLabel": "slide-recipe",
            "categoryName": "Slide",
            "categorySlug": "slide"
          },
          "agent": "designer",
          "layer": "slide",
          "agents": [
            "designer"
          ],
          "matchId": "8fdaaf4e-219c-406e-8580-d42854a76124",
          "evidence": "chart/bar-grouped: Market cap comps at key events: Projected",
          "pageRefs": null,
          "priority": null,
          "whenToUse": null,
          "confidence": 0.6,
          "extraction": {
            "at": "2026-07-17 00:26:47.414348+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 27,
          "whyItWorks": null,
          "antipattern": null,
          "cardinality": null,
          "narrativePurpose": null
        }
      ],
      "frameworks": [
        {
          "matchId": "fcf1c03d-fc0b-4e3d-b38d-e934d3fd3681",
          "evidence": "The slide uses a horizontal timeline to map clinical milestones to projected value inflection points.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 11:46:14.256+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 27,
          "frameworkName": "timeline"
        }
      ],
      "arcBeats": [
        {
          "to": 30,
          "arc": {
            "name": "Problem-Agitate-Solution",
            "slug": "problem-agitate-solution",
            "status": "active",
            "bestFor": "Sales pitches, urgency-driven, competitive displacement",
            "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
            "description": null,
            "familyLabel": null
          },
          "from": 13,
          "name": "Solution (Provide relief)",
          "beatId": "5fcb9464-3068-4031-9434-ce301bbe9fd3",
          "matchId": "a1bcf76f-a4ea-452c-9399-8bc5a62efe28",
          "beatType": {
            "name": "Solution (Provide relief)",
            "slug": "problem-agitate-solution-solution-provide-relief",
            "status": "active",
            "canonId": "019dd9b8-0fee-73e9-9ae5-799c7f3895cd",
            "version": 1,
            "description": null
          },
          "evidence": "The document presents the company's solution, including its pipeline and strategy",
          "position": 3,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Resolution",
            "slug": "resolution",
            "status": "active",
            "canonId": "019dd9b8-045d-703b-8dd7-e92aba3ba91b",
            "version": 1,
            "description": "How the deck ends. Required in 19/20 arcs. The exception (Sparkline) ends with new bliss which is functionally a resolution."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.9
        }
      ],
      "loops": [
        {
          "to": 30,
          "from": 13,
          "loop": {
            "name": "47_quick_win_big_bet",
            "slug": "47-quick-win-big-bet",
            "status": "active",
            "bestFor": "Transformation planning, 100-day plans, resource allocation",
            "canonId": "019dd956-790d-708d-983e-ef9bbc68f741",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap",
            "description": "Separate initiatives into immediate wins and longer-term strategic bets",
            "familyLabel": null
          },
          "matchId": "1d2b0809-4269-4aea-a725-b67c9452d570",
          "evidence": "The document presents the company's solution, including its pipeline and strategy",
          "position": 2,
          "objective": "What is the company's solution?",
          "confidence": 0.8,
          "extraction": {
            "at": "2026-07-16 22:34:50.673683+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 28,
      "type": "setup",
      "title": "The slide uses a comparison table to establish competitive positioning.",
      "function": "compare_peers",
      "rawType": "comparison_table",
      "block": null,
      "metadata": {
        "slideType": "comparison_table",
        "slideTypeCanon": {
          "name": "Comparison table",
          "slug": "comparison_table",
          "status": "active",
          "canonId": "019de52d-0a06-73f8-8813-fe022fab1de2",
          "version": 1,
          "description": null
        },
        "function": "compare_peers",
        "functionCanon": {
          "name": "Compare peers",
          "slug": "compare_peers",
          "status": "active",
          "canonId": "019de52d-1453-72ba-a367-9ba3d34c1630",
          "version": 1,
          "description": null
        },
        "density": "balanced",
        "densityScore": 27,
        "componentCount": 3,
        "textChars": 238,
        "nDataPoints": 2,
        "notes": "The slide uses a comparison table to establish competitive positioning.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:46:13.217+00",
          "seconds": 2.833,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de075-3cec-7700-94db-076a5ce30d84/28",
        "deck": "/decks/019de075-3cec-7700-94db-076a5ce30d84",
        "deckAnchor": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-28",
        "deckJson": "/decks/019de075-3cec-7700-94db-076a5ce30d84.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.03,
            "w": 0.2,
            "x": 0.02,
            "y": 0.92
          },
          "kind": "source-note",
          "text": "Note: *Comparable efficacy to Entyvio",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:13.217+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "a3ee36bd-1484-44f2-bf49-957552ef73a8",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.68,
            "w": 0.92,
            "x": 0.04,
            "y": 0.22
          },
          "kind": "table",
          "text": "Agent, MOA, Indication, Administration, Efficacy, Safety for SPY001, Entyvio IV, Entyvio SC, MORF-057",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Table",
              "slug": "table",
              "status": "active",
              "canonId": "019de52c-f9c8-7148-8119-eaac9594cd28",
              "version": 1,
              "description": "Tabular data layout."
            },
            "tool": null,
            "subkind": {
              "name": "Data table",
              "slug": "data",
              "status": "active",
              "canonId": "019de52d-02d5-75b8-8abf-88e92bf63569",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "data",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:13.217+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "153ba779-1d1d-4f48-a80e-d7eb907df32b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.85,
            "x": 0.02,
            "y": 0.04
          },
          "kind": "title",
          "text": "The base case* SPY001 profile was conservatively compared to Takeda's Entyvio and Morphic's MORF-057",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:13.217+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e075b998-c3d5-4ec0-a5ed-74cf9f45d58c",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "723704dd-0bcc-43f3-95c1-114e4dc3a0e5",
          "evidence": "The slide explicitly compares the company's asset against two key competitors across standardized clinical metrics.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 11:46:13.217+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 28,
          "frameworkName": "comparison_frame"
        }
      ],
      "arcBeats": [
        {
          "to": 30,
          "arc": {
            "name": "Problem-Agitate-Solution",
            "slug": "problem-agitate-solution",
            "status": "active",
            "bestFor": "Sales pitches, urgency-driven, competitive displacement",
            "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
            "description": null,
            "familyLabel": null
          },
          "from": 13,
          "name": "Solution (Provide relief)",
          "beatId": "5fcb9464-3068-4031-9434-ce301bbe9fd3",
          "matchId": "a1bcf76f-a4ea-452c-9399-8bc5a62efe28",
          "beatType": {
            "name": "Solution (Provide relief)",
            "slug": "problem-agitate-solution-solution-provide-relief",
            "status": "active",
            "canonId": "019dd9b8-0fee-73e9-9ae5-799c7f3895cd",
            "version": 1,
            "description": null
          },
          "evidence": "The document presents the company's solution, including its pipeline and strategy",
          "position": 3,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Resolution",
            "slug": "resolution",
            "status": "active",
            "canonId": "019dd9b8-045d-703b-8dd7-e92aba3ba91b",
            "version": 1,
            "description": "How the deck ends. Required in 19/20 arcs. The exception (Sparkline) ends with new bliss which is functionally a resolution."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.9
        }
      ],
      "loops": [
        {
          "to": 30,
          "from": 13,
          "loop": {
            "name": "47_quick_win_big_bet",
            "slug": "47-quick-win-big-bet",
            "status": "active",
            "bestFor": "Transformation planning, 100-day plans, resource allocation",
            "canonId": "019dd956-790d-708d-983e-ef9bbc68f741",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap",
            "description": "Separate initiatives into immediate wins and longer-term strategic bets",
            "familyLabel": null
          },
          "matchId": "1d2b0809-4269-4aea-a725-b67c9452d570",
          "evidence": "The document presents the company's solution, including its pipeline and strategy",
          "position": 2,
          "objective": "What is the company's solution?",
          "confidence": 0.8,
          "extraction": {
            "at": "2026-07-16 22:34:50.673683+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 29,
      "type": "evidence",
      "title": "The slide uses qualitative expert feedback to support quantitative preference share data.",
      "function": "illustrate_case",
      "rawType": "testimonial",
      "block": null,
      "metadata": {
        "slideType": "testimonial",
        "slideTypeCanon": {
          "name": "Testimonial",
          "slug": "testimonial",
          "status": "active",
          "canonId": "019de52d-0a2d-7782-8a48-7e84df92cc97",
          "version": 1,
          "description": null
        },
        "function": "illustrate_case",
        "functionCanon": {
          "name": "Illustrate case",
          "slug": "illustrate_case",
          "status": "active",
          "canonId": "019de52d-13b4-772c-bb73-1873612a7463",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 70,
        "componentCount": 6,
        "textChars": 573,
        "nDataPoints": 7,
        "notes": "The slide uses qualitative expert feedback to support quantitative preference share data.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:46:17.315+00",
          "seconds": 6.677,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de075-3cec-7700-94db-076a5ce30d84/29",
        "deck": "/decks/019de075-3cec-7700-94db-076a5ce30d84",
        "deckAnchor": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-29",
        "deckJson": "/decks/019de075-3cec-7700-94db-076a5ce30d84.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.6,
            "w": 0.4,
            "x": 0.05,
            "y": 0.21
          },
          "kind": "chart",
          "text": "Preference class share in naïve and experienced patients",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Chart",
              "slug": "chart",
              "status": "active",
              "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8",
              "version": 1,
              "description": "Quantitative chart."
            },
            "tool": null,
            "subkind": {
              "name": "Stacked bar chart",
              "slug": "bar-stacked",
              "status": "active",
              "canonId": "019de52c-feec-74bf-9028-15b74f84f0a7",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bar-stacked",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:17.315+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "276e64f3-4fdf-4a91-867e-42f99f11da76",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.4,
            "x": 0.55,
            "y": 0.65
          },
          "kind": "quote",
          "text": "The denominator will also increase with this profile, I would expect more patients to go to [SPY001] rather than Stelara after TNF failure",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:17.315+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "134cbc6b-4c09-4a73-8df3-a31ddf299eaf",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.4,
            "x": 0.55,
            "y": 0.25
          },
          "kind": "quote",
          "text": "Oral agents typically have an advantage except in this case ... one shot every three months will have the advantage",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:17.315+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "95d88d7a-57c2-455d-8eba-994d4ec95190",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.4,
            "x": 0.55,
            "y": 0.45
          },
          "kind": "quote",
          "text": "Infrequent injections are more beneficial than orals, patients will forget to take the orals daily",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:17.315+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "b5aad4a3-ef4a-403a-8083-63b8a12f5e51",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.4,
            "x": 0.02,
            "y": 0.9
          },
          "kind": "source-note",
          "text": "Source: Expert calls with N=14 gastroenterologists conducted in May 2023",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:17.315+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "f55cb876-7f72-492f-97c4-a4b12d1f6f07",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.8,
            "x": 0.02,
            "y": 0.04
          },
          "kind": "title",
          "text": "Assuming equivalent efficacy and safety, a quarterly injectable would be the preferred profile",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:17.315+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "32fc3bc6-9b29-4d19-96b8-d86791f25752",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [
        {
          "tool": {
            "name": "Audience Definition",
            "slug": "audience-definition",
            "status": "active",
            "bestFor": null,
            "canonId": "019dd956-7f2a-775d-aeee-ff099bcb7756",
            "version": 1,
            "bodyDocId": null,
            "description": "Six key questions: Who are they? What do they know? What do they believe? What do they care about? What do they fear? What decisions can they make?",
            "familyLabel": null,
            "categoryName": "Block",
            "categorySlug": "block"
          },
          "agent": "Storyteller",
          "layer": "slide",
          "agents": [
            "Storyteller"
          ],
          "matchId": "187c366a-ad52-4186-a14f-0778141e5bc3",
          "evidence": "The slide mentions expert calls with N=14 gastroenterologists, indicating a specific audience.",
          "pageRefs": null,
          "priority": "Core",
          "whenToUse": null,
          "confidence": 0.7,
          "extraction": {
            "at": "2026-07-17 00:26:47.064203+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 29,
          "whyItWorks": null,
          "antipattern": null,
          "cardinality": null,
          "narrativePurpose": null
        }
      ],
      "frameworks": [
        {
          "matchId": "1294e997-0420-4e4e-ab7d-1d518bb9852c",
          "evidence": "Use of KOL quotes to validate market preference",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 11:46:17.315+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 29,
          "frameworkName": "authority-citation"
        }
      ],
      "arcBeats": [
        {
          "to": 30,
          "arc": {
            "name": "Problem-Agitate-Solution",
            "slug": "problem-agitate-solution",
            "status": "active",
            "bestFor": "Sales pitches, urgency-driven, competitive displacement",
            "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
            "description": null,
            "familyLabel": null
          },
          "from": 13,
          "name": "Solution (Provide relief)",
          "beatId": "5fcb9464-3068-4031-9434-ce301bbe9fd3",
          "matchId": "a1bcf76f-a4ea-452c-9399-8bc5a62efe28",
          "beatType": {
            "name": "Solution (Provide relief)",
            "slug": "problem-agitate-solution-solution-provide-relief",
            "status": "active",
            "canonId": "019dd9b8-0fee-73e9-9ae5-799c7f3895cd",
            "version": 1,
            "description": null
          },
          "evidence": "The document presents the company's solution, including its pipeline and strategy",
          "position": 3,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Resolution",
            "slug": "resolution",
            "status": "active",
            "canonId": "019dd9b8-045d-703b-8dd7-e92aba3ba91b",
            "version": 1,
            "description": "How the deck ends. Required in 19/20 arcs. The exception (Sparkline) ends with new bliss which is functionally a resolution."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.9
        }
      ],
      "loops": [
        {
          "to": 30,
          "from": 13,
          "loop": {
            "name": "47_quick_win_big_bet",
            "slug": "47-quick-win-big-bet",
            "status": "active",
            "bestFor": "Transformation planning, 100-day plans, resource allocation",
            "canonId": "019dd956-790d-708d-983e-ef9bbc68f741",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap",
            "description": "Separate initiatives into immediate wins and longer-term strategic bets",
            "familyLabel": null
          },
          "matchId": "1d2b0809-4269-4aea-a725-b67c9452d570",
          "evidence": "The document presents the company's solution, including its pipeline and strategy",
          "position": 2,
          "objective": "What is the company's solution?",
          "confidence": 0.8,
          "extraction": {
            "at": "2026-07-16 22:34:50.673683+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 30,
      "type": "resolution",
      "title": "The slide uses a table-like layout to represent a drug development pipeline.",
      "function": "plan_implementation",
      "rawType": "roadmap",
      "block": null,
      "metadata": {
        "slideType": "roadmap",
        "slideTypeCanon": {
          "name": "Roadmap",
          "slug": "roadmap",
          "status": "active",
          "canonId": "019de52d-0a55-72bc-9b7b-a47ef109839c",
          "version": 1,
          "description": null
        },
        "function": "plan_implementation",
        "functionCanon": {
          "name": "Plan implementation",
          "slug": "plan_implementation",
          "status": "active",
          "canonId": "019de52d-14a2-77ea-b210-d6a95eed4823",
          "version": 1,
          "description": null
        },
        "density": "sparse",
        "densityScore": 22,
        "componentCount": 3,
        "textChars": 234,
        "nDataPoints": 0,
        "notes": "The slide uses a table-like layout to represent a drug development pipeline.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:46:13.156+00",
          "seconds": 2.418,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de075-3cec-7700-94db-076a5ce30d84/30",
        "deck": "/decks/019de075-3cec-7700-94db-076a5ce30d84",
        "deckAnchor": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-30",
        "deckJson": "/decks/019de075-3cec-7700-94db-076a5ce30d84.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.03,
            "w": 0.1,
            "x": 0.79,
            "y": 0.175
          },
          "kind": "legend",
          "text": "Co-lead programs",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Legend",
              "slug": "legend",
              "status": "active",
              "canonId": "31361933-3d22-4c70-bbad-0801e9fffc0c",
              "version": 1,
              "description": "Color/symbol decoder placed adjacent to a chart or diagram."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:13.156+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "73b525fe-458f-45d4-b695-bf49e2d3c85f",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.7,
            "w": 0.9,
            "x": 0.05,
            "y": 0.215
          },
          "kind": "table",
          "text": "Pipeline table showing Strategy, Target, Program, and Development Stages (Discovery, IND-Enabling, Clinical)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Table",
              "slug": "table",
              "status": "active",
              "canonId": "019de52c-f9c8-7148-8119-eaac9594cd28",
              "version": 1,
              "description": "Tabular data layout."
            },
            "tool": null,
            "subkind": {
              "name": "Data table",
              "slug": "data",
              "status": "active",
              "canonId": "019de52d-02d5-75b8-8abf-88e92bf63569",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "data",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:13.156+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "843c52e6-9e01-46b9-ad10-06b175b0a547",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.85,
            "x": 0.02,
            "y": 0.04
          },
          "kind": "title",
          "text": "Spyre is building a potentially best-in-class IBD pipeline with next-generation mAbs and rational combinations",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:13.156+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "3f45085e-b00e-4e17-989d-11f5087e3e2c",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "f4fa3973-3fff-4570-960d-eb5247fb56d4",
          "evidence": "Pipeline development stages over time",
          "framework": null,
          "confidence": 0.8,
          "extraction": {
            "at": "2026-05-02 11:46:13.156+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 30,
          "frameworkName": "gantt-chart"
        }
      ],
      "arcBeats": [
        {
          "to": 30,
          "arc": {
            "name": "Problem-Agitate-Solution",
            "slug": "problem-agitate-solution",
            "status": "active",
            "bestFor": "Sales pitches, urgency-driven, competitive displacement",
            "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
            "description": null,
            "familyLabel": null
          },
          "from": 13,
          "name": "Solution (Provide relief)",
          "beatId": "5fcb9464-3068-4031-9434-ce301bbe9fd3",
          "matchId": "a1bcf76f-a4ea-452c-9399-8bc5a62efe28",
          "beatType": {
            "name": "Solution (Provide relief)",
            "slug": "problem-agitate-solution-solution-provide-relief",
            "status": "active",
            "canonId": "019dd9b8-0fee-73e9-9ae5-799c7f3895cd",
            "version": 1,
            "description": null
          },
          "evidence": "The document presents the company's solution, including its pipeline and strategy",
          "position": 3,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Resolution",
            "slug": "resolution",
            "status": "active",
            "canonId": "019dd9b8-045d-703b-8dd7-e92aba3ba91b",
            "version": 1,
            "description": "How the deck ends. Required in 19/20 arcs. The exception (Sparkline) ends with new bliss which is functionally a resolution."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.9
        }
      ],
      "loops": [
        {
          "to": 30,
          "from": 13,
          "loop": {
            "name": "47_quick_win_big_bet",
            "slug": "47-quick-win-big-bet",
            "status": "active",
            "bestFor": "Transformation planning, 100-day plans, resource allocation",
            "canonId": "019dd956-790d-708d-983e-ef9bbc68f741",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap",
            "description": "Separate initiatives into immediate wins and longer-term strategic bets",
            "familyLabel": null
          },
          "matchId": "1d2b0809-4269-4aea-a725-b67c9452d570",
          "evidence": "The document presents the company's solution, including its pipeline and strategy",
          "position": 2,
          "objective": "What is the company's solution?",
          "confidence": 0.8,
          "extraction": {
            "at": "2026-07-16 22:34:50.673683+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 31,
      "type": "setup",
      "title": "The chart uses a horizontal bar format to compare clinical remission percentages across different drug targets (TL1A, a4b7, IL-23s, TNFa, S1P1s, JAKs).",
      "function": "compare_peers",
      "rawType": "comparison_table",
      "block": null,
      "metadata": {
        "slideType": "comparison_table",
        "slideTypeCanon": {
          "name": "Comparison table",
          "slug": "comparison_table",
          "status": "active",
          "canonId": "019de52d-0a06-73f8-8813-fe022fab1de2",
          "version": 1,
          "description": null
        },
        "function": "compare_peers",
        "functionCanon": {
          "name": "Compare peers",
          "slug": "compare_peers",
          "status": "active",
          "canonId": "019de52d-1453-72ba-a367-9ba3d34c1630",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 76,
        "componentCount": 6,
        "textChars": 820,
        "nDataPoints": 12,
        "notes": "The chart uses a horizontal bar format to compare clinical remission percentages across different drug targets (TL1A, a4b7, IL-23s, TNFa, S1P1s, JAKs).",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:46:14.146+00",
          "seconds": 3.014,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de075-3cec-7700-94db-076a5ce30d84/31",
        "deck": "/decks/019de075-3cec-7700-94db-076a5ce30d84",
        "deckAnchor": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-31",
        "deckJson": "/decks/019de075-3cec-7700-94db-076a5ce30d84.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.1,
            "w": 0.45,
            "x": 0.03,
            "y": 0.68
          },
          "kind": "callout",
          "text": "First-generation anti-TL1A antibodies provide blueprint for a next-generation best-in-class agent from Spyre.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": null,
            "subkind": {
              "name": "Primary callout",
              "slug": "primary",
              "status": "active",
              "canonId": "019de52c-fbd1-70eb-a9ce-8997f8674c1d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "primary",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:14.146+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "68fbc630-aa7c-44b1-9747-9c39e826ee63",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.45,
            "x": 0.03,
            "y": 0.52
          },
          "kind": "callout",
          "text": "Phase 2 results in UC and CD with PRA023 was a key factor in Prometheus’ $10.8B acquisition by Merck.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": null,
            "subkind": {
              "name": "Primary callout",
              "slug": "primary",
              "status": "active",
              "canonId": "019de52c-fbd1-70eb-a9ce-8997f8674c1d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "primary",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:14.146+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "d0f707d5-dd9f-4c38-818e-3d43bad02b1f",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.65,
            "w": 0.45,
            "x": 0.52,
            "y": 0.18
          },
          "kind": "chart",
          "text": "UC Induction Efficacy Pbo-adjusted clinical remission %",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Chart",
              "slug": "chart",
              "status": "active",
              "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8",
              "version": 1,
              "description": "Quantitative chart."
            },
            "tool": null,
            "subkind": {
              "name": "Horizontal bar chart",
              "slug": "bar-horizontal",
              "status": "active",
              "canonId": "019de52c-fec4-7221-986b-1cb5f5e84b1f",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bar-horizontal",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:14.146+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "350f6d3a-a86a-4357-8e4f-8459d232d538",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.25,
            "w": 0.45,
            "x": 0.03,
            "y": 0.22
          },
          "kind": "list",
          "text": "TL1A is involved in chronic inflammation and fibrosis pathways and is genetically associated with IBD. Clinical results from first-generation anti-TL1A antibodies suggest potential for highest induction efficacy across target classes.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:14.146+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "0ab95c47-c03d-4ee1-a37f-3c4369d9c2bc",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.95,
            "x": 0.03,
            "y": 0.85
          },
          "kind": "source-note",
          "text": "Figure data sources: PRA023 P2b study. RVT-3101 P2b study. Vedolizumab GEMINI 1 P3 study. Ustekinumab, adalimumab, infliximab, risankizumab golimumab, ozanimod, tofacitinib, upadacitinib data from labels. Mirikizumab data from phase 3 LUCENT-1 study.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:14.146+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "9c4726ba-ae6e-4503-9bd3-121a8edda3e1",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.8,
            "x": 0.03,
            "y": 0.05
          },
          "kind": "title",
          "text": "TL1A has emerged as one of the most promising targets in both UC and CD",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:14.146+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "1718665d-1f8b-409d-89ae-35fa594dfead",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [
        {
          "tool": {
            "name": "Analytical method",
            "slug": "analytical-method",
            "status": "active",
            "bestFor": null,
            "canonId": "b42c4911-7946-49b5-951c-5f3d23f4e2bd",
            "version": 1,
            "bodyDocId": null,
            "description": "Diagnostic / structuring methods (5-whys, fishbone, issue tree, hypothesis-driven).",
            "familyLabel": null,
            "categoryName": null,
            "categorySlug": null
          },
          "agent": null,
          "layer": "slide",
          "agents": null,
          "matchId": "f1e3ea7f-43f6-4d27-a630-9c761c4f43c1",
          "evidence": "The slide presents data from multiple studies, indicating an analytical approach.",
          "pageRefs": null,
          "priority": null,
          "whenToUse": null,
          "confidence": 0.7,
          "extraction": {
            "at": "2026-07-17 00:26:47.170925+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 31,
          "whyItWorks": null,
          "antipattern": null,
          "cardinality": "common",
          "narrativePurpose": null
        }
      ],
      "frameworks": [
        {
          "matchId": "c114ba61-99a1-4201-9031-cda16099effa",
          "evidence": "Comparing efficacy of different drug classes against a benchmark",
          "framework": null,
          "confidence": 0.8,
          "extraction": {
            "at": "2026-05-02 11:46:14.146+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 31,
          "frameworkName": "comparison_frame"
        }
      ],
      "arcBeats": [
        {
          "to": 44,
          "arc": {
            "name": "Problem-Agitate-Solution",
            "slug": "problem-agitate-solution",
            "status": "active",
            "bestFor": "Sales pitches, urgency-driven, competitive displacement",
            "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
            "description": null,
            "familyLabel": null
          },
          "from": 31,
          "name": "Evidence",
          "beatId": "5c590fe3-bdd5-4bd1-85d4-420b5f2a4608",
          "matchId": "a1bcf76f-a4ea-452c-9399-8bc5a62efe28",
          "beatType": {
            "name": "Evidence",
            "slug": "evidence",
            "status": "active",
            "canonId": "019dd9b8-03f9-772a-b84a-4f07b415b77a",
            "version": 1,
            "description": "A dedicated proof beat exists in only ~4 arcs (Gambit, Sequoia, AIDA, Monroes). Other arcs embed evidence inline within development."
          },
          "evidence": "The document provides evidence to support the company's solution",
          "position": 4,
          "isPrimaryArc": true,
          "parentBeatType": null,
          "alignedBlockIds": null,
          "matchConfidence": 0.9
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 32,
      "type": "setup",
      "title": "The slide uses a checkmark matrix to highlight the superiority of SPY002.",
      "function": "compare_peers",
      "rawType": "competitive_analysis",
      "block": null,
      "metadata": {
        "slideType": "competitive_analysis",
        "slideTypeCanon": {
          "name": "Competitive analysis",
          "slug": "competitive_analysis",
          "status": "active",
          "canonId": "019de52d-093e-776b-94c6-c1573f5f1a31",
          "version": 1,
          "description": null
        },
        "function": "compare_peers",
        "functionCanon": {
          "name": "Compare peers",
          "slug": "compare_peers",
          "status": "active",
          "canonId": "019de52d-1453-72ba-a367-9ba3d34c1630",
          "version": 1,
          "description": null
        },
        "density": "balanced",
        "densityScore": 30,
        "componentCount": 3,
        "textChars": 392,
        "nDataPoints": 0,
        "notes": "The slide uses a checkmark matrix to highlight the superiority of SPY002.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:46:14.084+00",
          "seconds": 2.927,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de075-3cec-7700-94db-076a5ce30d84/32",
        "deck": "/decks/019de075-3cec-7700-94db-076a5ce30d84",
        "deckAnchor": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-32",
        "deckJson": "/decks/019de075-3cec-7700-94db-076a5ce30d84.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.1,
            "w": 0.8,
            "x": 0.02,
            "y": 0.86
          },
          "kind": "source-note",
          "text": "1. Prometheus PRA023 P2 ARTEMIS-UC and P2a APOLLO-CD data readouts, December 7, 2022. Q4W IV tested in Phase 2, Phase 3 SC dosing to be determined. 2. Roivant RVT-3101 Release Deck, January 4, 2023. 3. Teva's TEV-48574 TL1A is currently in Phase 2 IBD studies.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:14.084+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "5ea6b189-cf85-44d8-8a65-f63f07e7c0a1",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.65,
            "w": 0.96,
            "x": 0.02,
            "y": 0.2
          },
          "kind": "table",
          "text": "Comparison matrix of SPY002 vs PRA023, RVT-3101, TEV-48574 across 7 attributes",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Table",
              "slug": "table",
              "status": "active",
              "canonId": "019de52c-f9c8-7148-8119-eaac9594cd28",
              "version": 1,
              "description": "Tabular data layout."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": "comparison",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:14.084+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "051f8d03-df86-44f2-8329-bf264397d1b1",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.6,
            "x": 0.02,
            "y": 0.03
          },
          "kind": "title",
          "text": "SPY002 is designed to be a best-in-class anti-TL1A mAb",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:14.084+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "0bda4953-1fd9-4672-9222-e79dd9cc4c0b",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [
        {
          "tool": {
            "name": "2x2 matrix",
            "slug": "matrix-2x2",
            "status": "active",
            "bestFor": null,
            "canonId": "019dd9e1-50ab-72d1-8afb-3ab0a38e32a8",
            "version": 1,
            "bodyDocId": null,
            "description": "BCG matrix, importance/urgency, any axes-and-quadrants frame.",
            "familyLabel": null,
            "categoryName": null,
            "categorySlug": null
          },
          "agent": null,
          "layer": "slide",
          "agents": null,
          "matchId": "c98c797a-85d6-40e6-b8a1-5ecb259fc542",
          "evidence": "Although not explicitly a 2x2 matrix, the comparison table could be interpreted as a form of matrix analysis.",
          "pageRefs": null,
          "priority": null,
          "whenToUse": null,
          "confidence": 0.5,
          "extraction": {
            "at": "2026-07-17 00:26:47.240961+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 32,
          "whyItWorks": null,
          "antipattern": null,
          "cardinality": "common",
          "narrativePurpose": null
        }
      ],
      "frameworks": [
        {
          "matchId": "68f27c1d-66d3-46b0-9ec9-c0cb0ed5584e",
          "evidence": "The slide uses a feature-by-feature comparison table to establish competitive superiority.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 11:46:14.084+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 32,
          "frameworkName": "comparison-frame"
        }
      ],
      "arcBeats": [
        {
          "to": 44,
          "arc": {
            "name": "Problem-Agitate-Solution",
            "slug": "problem-agitate-solution",
            "status": "active",
            "bestFor": "Sales pitches, urgency-driven, competitive displacement",
            "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
            "description": null,
            "familyLabel": null
          },
          "from": 31,
          "name": "Evidence",
          "beatId": "5c590fe3-bdd5-4bd1-85d4-420b5f2a4608",
          "matchId": "a1bcf76f-a4ea-452c-9399-8bc5a62efe28",
          "beatType": {
            "name": "Evidence",
            "slug": "evidence",
            "status": "active",
            "canonId": "019dd9b8-03f9-772a-b84a-4f07b415b77a",
            "version": 1,
            "description": "A dedicated proof beat exists in only ~4 arcs (Gambit, Sequoia, AIDA, Monroes). Other arcs embed evidence inline within development."
          },
          "evidence": "The document provides evidence to support the company's solution",
          "position": 4,
          "isPrimaryArc": true,
          "parentBeatType": null,
          "alignedBlockIds": null,
          "matchConfidence": 0.9
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 33,
      "type": "resolution",
      "title": "The slide uses a Y-shaped antibody diagram to annotate specific technical improvements.",
      "function": "present_solution",
      "rawType": "solution",
      "block": null,
      "metadata": {
        "slideType": "solution",
        "slideTypeCanon": {
          "name": "Solution",
          "slug": "solution",
          "status": "active",
          "canonId": "019de52d-0eb5-72ff-8b70-ba70a4199282",
          "version": 1,
          "description": null
        },
        "function": "present_solution",
        "functionCanon": {
          "name": "Present solution",
          "slug": "present_solution",
          "status": "active",
          "canonId": "019de52d-15b8-71da-bd23-2b767850cbce",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 66,
        "componentCount": 6,
        "textChars": 515,
        "nDataPoints": 3,
        "notes": "The slide uses a Y-shaped antibody diagram to annotate specific technical improvements.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:46:15.168+00",
          "seconds": 3.968,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de075-3cec-7700-94db-076a5ce30d84/33",
        "deck": "/decks/019de075-3cec-7700-94db-076a5ce30d84",
        "deckAnchor": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-33",
        "deckJson": "/decks/019de075-3cec-7700-94db-076a5ce30d84.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.85,
            "w": 0.315,
            "x": 0.173,
            "y": 0.275
          },
          "kind": "image",
          "text": "Antibody diagram",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Illustration",
              "slug": "illustration",
              "status": "active",
              "canonId": "019de52c-fe76-7772-a5ac-c0b7294d7615",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "illustration",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:15.168+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "c470bd69-4355-4e3d-b07c-8bca1f8e567f",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.25,
            "x": 0.53,
            "y": 0.6
          },
          "kind": "list",
          "text": "Significantly extended half-life: Q8-Q12W dosing based on validated half-life extension technology",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:15.168+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "04573993-b935-419a-a839-a3707edeebc5",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.2,
            "x": 0.53,
            "y": 0.25
          },
          "kind": "list",
          "text": "Novel IP for composition of matter into 2040s",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:15.168+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "0e19fca7-9aec-41ad-94ee-0ae38ab0a9b9",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.2,
            "w": 0.25,
            "x": 0.02,
            "y": 0.62
          },
          "kind": "list",
          "text": "High concentration SC: Ability to formulate at >150 mg/mL with low viscosity; Citrate-free formulation may improve patient comfort",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:15.168+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "4c68a556-fc02-42af-987d-e06b42b76d90",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.3,
            "w": 0.25,
            "x": 0.71,
            "y": 0.395
          },
          "kind": "table",
          "text": "SPY002 target profile: Efficacy >= PRA023; Subcutaneous 300 mg dose; Q8W or Q12W dose with citrate-free, patient-friendly formulation",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Table",
              "slug": "table",
              "status": "active",
              "canonId": "019de52c-f9c8-7148-8119-eaac9594cd28",
              "version": 1,
              "description": "Tabular data layout."
            },
            "tool": null,
            "subkind": {
              "name": "KPI table",
              "slug": "kpi",
              "status": "active",
              "canonId": "019de52d-0324-7799-a84e-d0885a8ad400",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "kpi",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:15.168+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "827f6d3d-c649-4731-9525-3608df4a6e9a",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.78,
            "x": 0.02,
            "y": 0.04
          },
          "kind": "title",
          "text": "SPY002 exploits biology that has been validated by PRA023 and is designed to be best-in-class",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:15.168+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "489786ef-f04e-40be-837b-efc89287c253",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [
        {
          "to": 44,
          "arc": {
            "name": "Problem-Agitate-Solution",
            "slug": "problem-agitate-solution",
            "status": "active",
            "bestFor": "Sales pitches, urgency-driven, competitive displacement",
            "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
            "description": null,
            "familyLabel": null
          },
          "from": 31,
          "name": "Evidence",
          "beatId": "5c590fe3-bdd5-4bd1-85d4-420b5f2a4608",
          "matchId": "a1bcf76f-a4ea-452c-9399-8bc5a62efe28",
          "beatType": {
            "name": "Evidence",
            "slug": "evidence",
            "status": "active",
            "canonId": "019dd9b8-03f9-772a-b84a-4f07b415b77a",
            "version": 1,
            "description": "A dedicated proof beat exists in only ~4 arcs (Gambit, Sequoia, AIDA, Monroes). Other arcs embed evidence inline within development."
          },
          "evidence": "The document provides evidence to support the company's solution",
          "position": 4,
          "isPrimaryArc": true,
          "parentBeatType": null,
          "alignedBlockIds": null,
          "matchConfidence": 0.9
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 34,
      "type": "setup",
      "title": "Includes visual representation of antibody binding mechanisms.",
      "function": "compare_peers",
      "rawType": "competitive_analysis",
      "block": null,
      "metadata": {
        "slideType": "competitive_analysis",
        "slideTypeCanon": {
          "name": "Competitive analysis",
          "slug": "competitive_analysis",
          "status": "active",
          "canonId": "019de52d-093e-776b-94c6-c1573f5f1a31",
          "version": 1,
          "description": null
        },
        "function": "compare_peers",
        "functionCanon": {
          "name": "Compare peers",
          "slug": "compare_peers",
          "status": "active",
          "canonId": "019de52d-1453-72ba-a367-9ba3d34c1630",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 62,
        "componentCount": 5,
        "textChars": 647,
        "nDataPoints": 2,
        "notes": "Includes visual representation of antibody binding mechanisms.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:46:13.844+00",
          "seconds": 2.592,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de075-3cec-7700-94db-076a5ce30d84/34",
        "deck": "/decks/019de075-3cec-7700-94db-076a5ce30d84",
        "deckAnchor": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-34",
        "deckJson": "/decks/019de075-3cec-7700-94db-076a5ce30d84.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.3,
            "w": 0.48,
            "x": 0.48,
            "y": 0.48
          },
          "kind": "callout",
          "text": "Spyre is advancing both monomeric/trimeric and trimeric-only TL1A mAbs to DC selection. Redundancy provides highest probability of creating a best-in-class therapeutic.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": null,
            "subkind": {
              "name": "Primary callout",
              "slug": "primary",
              "status": "active",
              "canonId": "019de52c-fbd1-70eb-a9ce-8997f8674c1d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "primary",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:13.844+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e44fc306-482c-46de-a39f-edefa93cb4f6",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.6,
            "w": 0.4,
            "x": 0.05,
            "y": 0.2
          },
          "kind": "chart",
          "text": "UC induction clinical remission rates Pbo-adjusted %",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Chart",
              "slug": "chart",
              "status": "active",
              "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8",
              "version": 1,
              "description": "Quantitative chart."
            },
            "tool": null,
            "subkind": {
              "name": "Vertical bar chart",
              "slug": "bar-vertical",
              "status": "active",
              "canonId": "019de52c-fe9d-70f2-b3b7-a9ae294f5917",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bar-vertical",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:13.844+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e09ce6bd-a605-4e9e-8eb4-3038d0022cc1",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.25,
            "w": 0.45,
            "x": 0.48,
            "y": 0.2
          },
          "kind": "list",
          "text": "Though PRA023 performed numerically better in a cross-trial comparison, it has yet to be determined whether monomeric/trimeric blockade is superior. Known biology suggests only trimeric blockade is necessary for effect.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:13.844+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "b8dae917-3cbe-4201-9c9d-eea7466e57f3",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.7,
            "x": 0.02,
            "y": 0.9
          },
          "kind": "source-note",
          "text": "Figure sources: Prometheus PRA023 P2 ARTEMIS-UC data release, December 7, 2022. Roivant RVT-3101 Release Deck, January 4, 2023.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:13.844+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "93658ec8-e90d-4884-889e-5fa14907a52a",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.7,
            "x": 0.02,
            "y": 0.04
          },
          "kind": "title",
          "text": "Spyre is evaluating both trimeric and monomeric/trimeric TL1A blockade for SPY002",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:13.844+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "0b054883-7944-43df-a3a4-56aa32ffcafc",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "dcd82ff2-1f5e-40da-bcea-0b28fd9216d7",
          "evidence": "Comparing clinical trial data between two competitors to justify a strategic product development decision.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 11:46:13.844+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 34,
          "frameworkName": "comparison_frame"
        }
      ],
      "arcBeats": [
        {
          "to": 44,
          "arc": {
            "name": "Problem-Agitate-Solution",
            "slug": "problem-agitate-solution",
            "status": "active",
            "bestFor": "Sales pitches, urgency-driven, competitive displacement",
            "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
            "description": null,
            "familyLabel": null
          },
          "from": 31,
          "name": "Evidence",
          "beatId": "5c590fe3-bdd5-4bd1-85d4-420b5f2a4608",
          "matchId": "a1bcf76f-a4ea-452c-9399-8bc5a62efe28",
          "beatType": {
            "name": "Evidence",
            "slug": "evidence",
            "status": "active",
            "canonId": "019dd9b8-03f9-772a-b84a-4f07b415b77a",
            "version": 1,
            "description": "A dedicated proof beat exists in only ~4 arcs (Gambit, Sequoia, AIDA, Monroes). Other arcs embed evidence inline within development."
          },
          "evidence": "The document provides evidence to support the company's solution",
          "position": 4,
          "isPrimaryArc": true,
          "parentBeatType": null,
          "alignedBlockIds": null,
          "matchConfidence": 0.9
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 35,
      "type": "resolution",
      "title": "The slide uses two charts: a dose-response curve (left) and a scatter plot (right) to demonstrate competitive advantage.",
      "function": "present_solution",
      "rawType": "solution",
      "block": null,
      "metadata": {
        "slideType": "solution",
        "slideTypeCanon": {
          "name": "Solution",
          "slug": "solution",
          "status": "active",
          "canonId": "019de52d-0eb5-72ff-8b70-ba70a4199282",
          "version": 1,
          "description": null
        },
        "function": "present_solution",
        "functionCanon": {
          "name": "Present solution",
          "slug": "present_solution",
          "status": "active",
          "canonId": "019de52d-15b8-71da-bd23-2b767850cbce",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 64,
        "componentCount": 5,
        "textChars": 622,
        "nDataPoints": 8,
        "notes": "The slide uses two charts: a dose-response curve (left) and a scatter plot (right) to demonstrate competitive advantage.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:46:14.407+00",
          "seconds": 3.138,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de075-3cec-7700-94db-076a5ce30d84/35",
        "deck": "/decks/019de075-3cec-7700-94db-076a5ce30d84",
        "deckAnchor": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-35",
        "deckJson": "/decks/019de075-3cec-7700-94db-076a5ce30d84.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.4,
            "w": 0.3,
            "x": 0.02,
            "y": 0.37
          },
          "kind": "chart",
          "text": "Dose-response curve showing % Inhibition of TF-1 Apoptosis vs Antibody Concentration",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Chart",
              "slug": "chart",
              "status": "active",
              "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8",
              "version": 1,
              "description": "Quantitative chart."
            },
            "tool": null,
            "subkind": {
              "name": "Line chart",
              "slug": "line",
              "status": "active",
              "canonId": "019de52c-ff62-778f-8f6c-a952ceae8677",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "line",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:14.407+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "ffd64bb7-8bbd-43f8-a4a3-d2b750d2ca49",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.4,
            "w": 0.3,
            "x": 0.35,
            "y": 0.37
          },
          "kind": "chart",
          "text": "Scatter plot of Relative DcR3/DR3 Blocking vs TF-1 Apoptosis Inhibition IC50",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Chart",
              "slug": "chart",
              "status": "active",
              "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8",
              "version": 1,
              "description": "Quantitative chart."
            },
            "tool": null,
            "subkind": {
              "name": "Scatter plot",
              "slug": "scatter",
              "status": "active",
              "canonId": "019de52d-007d-72ec-8689-c79fb78e21a2",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "scatter",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:14.407+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "27223b4f-e86e-4d12-abbe-ce8f71483307",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.6,
            "w": 0.28,
            "x": 0.7,
            "y": 0.2
          },
          "kind": "list",
          "text": "Spyre has multiple lead clones that have demonstrated superior potency as compared to PRA023. Diverse clones identified matching specificity profile with competitive antibodies. Development candidate to optimize against trimer and monomers, selectivity against decoy receptor.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:14.407+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "76e40aef-e954-4fbb-8ca1-de4014403822",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.9,
            "x": 0.05,
            "y": 0.85
          },
          "kind": "paragraph",
          "text": "Specialized reagents required to generate monomeric/trimeric TL1A mAbs, likely limiting fast-follower competition",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:14.407+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "d40e8abb-5bc6-4142-9594-8be44581349f",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.7,
            "x": 0.02,
            "y": 0.04
          },
          "kind": "title",
          "text": "De novo TL1A lead clones are highly potent and characteristically diverse",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:14.407+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "932297fb-fcc7-4ea4-b36b-cbf338ee9671",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [
        {
          "to": 44,
          "arc": {
            "name": "Problem-Agitate-Solution",
            "slug": "problem-agitate-solution",
            "status": "active",
            "bestFor": "Sales pitches, urgency-driven, competitive displacement",
            "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
            "description": null,
            "familyLabel": null
          },
          "from": 31,
          "name": "Evidence",
          "beatId": "5c590fe3-bdd5-4bd1-85d4-420b5f2a4608",
          "matchId": "a1bcf76f-a4ea-452c-9399-8bc5a62efe28",
          "beatType": {
            "name": "Evidence",
            "slug": "evidence",
            "status": "active",
            "canonId": "019dd9b8-03f9-772a-b84a-4f07b415b77a",
            "version": 1,
            "description": "A dedicated proof beat exists in only ~4 arcs (Gambit, Sequoia, AIDA, Monroes). Other arcs embed evidence inline within development."
          },
          "evidence": "The document provides evidence to support the company's solution",
          "position": 4,
          "isPrimaryArc": true,
          "parentBeatType": null,
          "alignedBlockIds": null,
          "matchConfidence": 0.9
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 36,
      "type": "resolution",
      "function": "present_solution",
      "rawType": "solution",
      "block": null,
      "metadata": {
        "slideType": "solution",
        "slideTypeCanon": {
          "name": "Solution",
          "slug": "solution",
          "status": "active",
          "canonId": "019de52d-0eb5-72ff-8b70-ba70a4199282",
          "version": 1,
          "description": null
        },
        "function": "present_solution",
        "functionCanon": {
          "name": "Present solution",
          "slug": "present_solution",
          "status": "active",
          "canonId": "019de52d-15b8-71da-bd23-2b767850cbce",
          "version": 1,
          "description": null
        },
        "density": "balanced",
        "densityScore": 46,
        "componentCount": 4,
        "textChars": 568,
        "nDataPoints": 0,
        "notes": null,
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:46:14.318+00",
          "seconds": 2.832,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de075-3cec-7700-94db-076a5ce30d84/36",
        "deck": "/decks/019de075-3cec-7700-94db-076a5ce30d84",
        "deckAnchor": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-36",
        "deckJson": "/decks/019de075-3cec-7700-94db-076a5ce30d84.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.15,
            "w": 0.5,
            "x": 0.4,
            "y": 0.75
          },
          "kind": "diagram",
          "text": "UPCOMING CATALYSTS: 2H2024 IND/CTN, 1H2025 Human PK/PD",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Diagram",
              "slug": "diagram",
              "status": "active",
              "canonId": "019de52c-f9f0-734a-81de-15382ff28c65",
              "version": 1,
              "description": "Schematic or relational diagram."
            },
            "tool": null,
            "subkind": {
              "name": "Timeline",
              "slug": "timeline",
              "status": "active",
              "canonId": "019de52d-03c5-73fc-84aa-4180cbf0f5cf",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "timeline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:14.318+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "62ab2f18-86d2-44c8-9ddc-ec906af9df5a",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.55,
            "w": 0.28,
            "x": 0.03,
            "y": 0.25
          },
          "kind": "image",
          "text": "Antibody illustration",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Illustration",
              "slug": "illustration",
              "status": "active",
              "canonId": "019de52c-fe76-7772-a5ac-c0b7294d7615",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "illustration",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:14.318+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "c3ff71ac-bef6-487e-a129-edcd3772a8c0",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.5,
            "w": 0.6,
            "x": 0.35,
            "y": 0.23
          },
          "kind": "list",
          "text": "Attractive target in a large market: Existing investigational products have demonstrated excellent clinical efficacy in UC and CD. Clinically validated pharmacology: SPY002 conserves the validated epitope to maximize TL1A blockade. Designed for differentiation: Q8W+ dosing and formulation improvements. Promising early data: SPY002 observed to bind to monomers and trimers with picomolar potency",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:14.318+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "dec52767-98d7-4141-b568-b6519ed8e4ab",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.75,
            "x": 0.03,
            "y": 0.04
          },
          "kind": "title",
          "text": "SPY002 is a potentially best-in-class anti-TL1A mAb with near-term de-risking studies anticipated",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:14.318+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "3d782de8-13b9-468f-b21a-c680958ccab2",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [
        {
          "to": 44,
          "arc": {
            "name": "Problem-Agitate-Solution",
            "slug": "problem-agitate-solution",
            "status": "active",
            "bestFor": "Sales pitches, urgency-driven, competitive displacement",
            "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
            "description": null,
            "familyLabel": null
          },
          "from": 31,
          "name": "Evidence",
          "beatId": "5c590fe3-bdd5-4bd1-85d4-420b5f2a4608",
          "matchId": "a1bcf76f-a4ea-452c-9399-8bc5a62efe28",
          "beatType": {
            "name": "Evidence",
            "slug": "evidence",
            "status": "active",
            "canonId": "019dd9b8-03f9-772a-b84a-4f07b415b77a",
            "version": 1,
            "description": "A dedicated proof beat exists in only ~4 arcs (Gambit, Sequoia, AIDA, Monroes). Other arcs embed evidence inline within development."
          },
          "evidence": "The document provides evidence to support the company's solution",
          "position": 4,
          "isPrimaryArc": true,
          "parentBeatType": null,
          "alignedBlockIds": null,
          "matchConfidence": 0.9
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 37,
      "type": "resolution",
      "title": "The visual uses a mountain-climbing metaphor to represent indication expansion.",
      "function": "present_solution",
      "rawType": "solution",
      "block": null,
      "metadata": {
        "slideType": "solution",
        "slideTypeCanon": {
          "name": "Solution",
          "slug": "solution",
          "status": "active",
          "canonId": "019de52d-0eb5-72ff-8b70-ba70a4199282",
          "version": 1,
          "description": null
        },
        "function": "present_solution",
        "functionCanon": {
          "name": "Present solution",
          "slug": "present_solution",
          "status": "active",
          "canonId": "019de52d-15b8-71da-bd23-2b767850cbce",
          "version": 1,
          "description": null
        },
        "density": "sparse",
        "densityScore": 24,
        "componentCount": 3,
        "textChars": 275,
        "nDataPoints": 0,
        "notes": "The visual uses a mountain-climbing metaphor to represent indication expansion.",
        "elementsJson": null,
        "confidence": 0.95,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:46:16.677+00",
          "seconds": 4.951,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de075-3cec-7700-94db-076a5ce30d84/37",
        "deck": "/decks/019de075-3cec-7700-94db-076a5ce30d84",
        "deckAnchor": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-37",
        "deckJson": "/decks/019de075-3cec-7700-94db-076a5ce30d84.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.7,
            "w": 0.88,
            "x": 0.11,
            "y": 0.2
          },
          "kind": "chart",
          "text": "Expansion roadmap: IBD, SSc-ILD, Expansion I&I indications",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Chart",
              "slug": "chart",
              "status": "active",
              "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8",
              "version": 1,
              "description": "Quantitative chart."
            },
            "tool": null,
            "subkind": {
              "name": "Area chart",
              "slug": "area",
              "status": "active",
              "canonId": "019de52c-ff89-71e0-911e-5cab78b90f53",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "area",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:16.677+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "aff4c944-b957-496a-afd6-4c177b303d93",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.25,
            "w": 0.28,
            "x": 0.04,
            "y": 0.25
          },
          "kind": "diagram",
          "text": "TL1A mechanism: Fibrosis (TL1A directly activates fibroblasts) and Inflammation (TL1A stimulates pro-inflammatory effect)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Diagram",
              "slug": "diagram",
              "status": "active",
              "canonId": "019de52c-f9f0-734a-81de-15382ff28c65",
              "version": 1,
              "description": "Schematic or relational diagram."
            },
            "tool": null,
            "subkind": {
              "name": "Process flow",
              "slug": "process",
              "status": "active",
              "canonId": "019de52d-039c-718f-ad3a-efe9c4b3c838",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "process",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:16.677+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "130adb08-036d-4849-95cf-77f9fbf4a192",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.85,
            "x": 0.02,
            "y": 0.04
          },
          "kind": "title",
          "text": "TL1A: Potential I&I indication expansion with dual anti-fibrotic and anti-inflammatory mechanism",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:16.677+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "ae916f62-9fe2-4a50-b6a0-1fd69f7accc2",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "87441833-b3d8-4459-8d98-0829660edd7f",
          "evidence": "Visual progression of indications over time/scale",
          "framework": null,
          "confidence": 0.8,
          "extraction": {
            "at": "2026-05-02 11:46:16.677+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 37,
          "frameworkName": "roadmap"
        }
      ],
      "arcBeats": [
        {
          "to": 44,
          "arc": {
            "name": "Problem-Agitate-Solution",
            "slug": "problem-agitate-solution",
            "status": "active",
            "bestFor": "Sales pitches, urgency-driven, competitive displacement",
            "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
            "description": null,
            "familyLabel": null
          },
          "from": 31,
          "name": "Evidence",
          "beatId": "5c590fe3-bdd5-4bd1-85d4-420b5f2a4608",
          "matchId": "a1bcf76f-a4ea-452c-9399-8bc5a62efe28",
          "beatType": {
            "name": "Evidence",
            "slug": "evidence",
            "status": "active",
            "canonId": "019dd9b8-03f9-772a-b84a-4f07b415b77a",
            "version": 1,
            "description": "A dedicated proof beat exists in only ~4 arcs (Gambit, Sequoia, AIDA, Monroes). Other arcs embed evidence inline within development."
          },
          "evidence": "The document provides evidence to support the company's solution",
          "position": 4,
          "isPrimaryArc": true,
          "parentBeatType": null,
          "alignedBlockIds": null,
          "matchConfidence": 0.9
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 38,
      "type": "resolution",
      "title": "The slide uses a matrix-like layout to map targets and programs against development stages.",
      "function": "plan_implementation",
      "rawType": "roadmap",
      "block": null,
      "metadata": {
        "slideType": "roadmap",
        "slideTypeCanon": {
          "name": "Roadmap",
          "slug": "roadmap",
          "status": "active",
          "canonId": "019de52d-0a55-72bc-9b7b-a47ef109839c",
          "version": 1,
          "description": null
        },
        "function": "plan_implementation",
        "functionCanon": {
          "name": "Plan implementation",
          "slug": "plan_implementation",
          "status": "active",
          "canonId": "019de52d-14a2-77ea-b210-d6a95eed4823",
          "version": 1,
          "description": null
        },
        "density": "sparse",
        "densityScore": 17,
        "componentCount": 3,
        "textChars": 159,
        "nDataPoints": 0,
        "notes": "The slide uses a matrix-like layout to map targets and programs against development stages.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:46:14.851+00",
          "seconds": 3.046,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de075-3cec-7700-94db-076a5ce30d84/38",
        "deck": "/decks/019de075-3cec-7700-94db-076a5ce30d84",
        "deckAnchor": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-38",
        "deckJson": "/decks/019de075-3cec-7700-94db-076a5ce30d84.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.7,
            "w": 0.9,
            "x": 0.05,
            "y": 0.2
          },
          "kind": "chart",
          "text": "Pipeline development status chart",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Chart",
              "slug": "chart",
              "status": "active",
              "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8",
              "version": 1,
              "description": "Quantitative chart."
            },
            "tool": null,
            "subkind": {
              "name": "Horizontal bar chart",
              "slug": "bar-horizontal",
              "status": "active",
              "canonId": "019de52c-fec4-7221-986b-1cb5f5e84b1f",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bar-horizontal",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:14.851+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "ab872993-b0bf-4fc3-81e6-0a4aaa05c8e9",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.12,
            "x": 0.79,
            "y": 0.17
          },
          "kind": "legend",
          "text": "Co-lead programs",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Legend",
              "slug": "legend",
              "status": "active",
              "canonId": "31361933-3d22-4c70-bbad-0801e9fffc0c",
              "version": 1,
              "description": "Color/symbol decoder placed adjacent to a chart or diagram."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:14.851+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "623d4c62-1e8d-4c0d-b5ec-e03a73ed602d",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.85,
            "x": 0.02,
            "y": 0.04
          },
          "kind": "title",
          "text": "Spyre is building a potentially best-in-class IBD pipeline with next-generation mAbs and rational combinations",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:14.851+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "77c7eaf3-a7e0-4c61-8261-775abd415af7",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "b710d2c3-7dae-4310-8fe2-feb5577120e3",
          "evidence": "Visual representation of drug development stages across multiple programs",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 11:46:14.851+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 38,
          "frameworkName": "pipeline-chart"
        }
      ],
      "arcBeats": [
        {
          "to": 44,
          "arc": {
            "name": "Problem-Agitate-Solution",
            "slug": "problem-agitate-solution",
            "status": "active",
            "bestFor": "Sales pitches, urgency-driven, competitive displacement",
            "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
            "description": null,
            "familyLabel": null
          },
          "from": 31,
          "name": "Evidence",
          "beatId": "5c590fe3-bdd5-4bd1-85d4-420b5f2a4608",
          "matchId": "a1bcf76f-a4ea-452c-9399-8bc5a62efe28",
          "beatType": {
            "name": "Evidence",
            "slug": "evidence",
            "status": "active",
            "canonId": "019dd9b8-03f9-772a-b84a-4f07b415b77a",
            "version": 1,
            "description": "A dedicated proof beat exists in only ~4 arcs (Gambit, Sequoia, AIDA, Monroes). Other arcs embed evidence inline within development."
          },
          "evidence": "The document provides evidence to support the company's solution",
          "position": 4,
          "isPrimaryArc": true,
          "parentBeatType": null,
          "alignedBlockIds": null,
          "matchConfidence": 0.9
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 39,
      "type": "resolution",
      "title": "The slide uses a biological process diagram to illustrate the mechanism of action for three drug candidates.",
      "function": "present_solution",
      "rawType": "solution",
      "block": null,
      "metadata": {
        "slideType": "solution",
        "slideTypeCanon": {
          "name": "Solution",
          "slug": "solution",
          "status": "active",
          "canonId": "019de52d-0eb5-72ff-8b70-ba70a4199282",
          "version": 1,
          "description": null
        },
        "function": "present_solution",
        "functionCanon": {
          "name": "Present solution",
          "slug": "present_solution",
          "status": "active",
          "canonId": "019de52d-15b8-71da-bd23-2b767850cbce",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 64,
        "componentCount": 6,
        "textChars": 639,
        "nDataPoints": 0,
        "notes": "The slide uses a biological process diagram to illustrate the mechanism of action for three drug candidates.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:46:15.11+00",
          "seconds": 3.095,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de075-3cec-7700-94db-076a5ce30d84/39",
        "deck": "/decks/019de075-3cec-7700-94db-076a5ce30d84",
        "deckAnchor": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-39",
        "deckJson": "/decks/019de075-3cec-7700-94db-076a5ce30d84.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.58,
            "w": 0.96,
            "x": 0.02,
            "y": 0.25
          },
          "kind": "diagram",
          "text": "Biological mechanism of action diagram showing three distinct pathways: T-cell trafficking (SPY001), Colonic Fibrosis/Inflammatory cascade (SPY002), and Th17 maturation/Inflammatory cascade (SPY003).",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Diagram",
              "slug": "diagram",
              "status": "active",
              "canonId": "019de52c-f9f0-734a-81de-15382ff28c65",
              "version": 1,
              "description": "Schematic or relational diagram."
            },
            "tool": null,
            "subkind": {
              "name": "Process flow",
              "slug": "process",
              "status": "active",
              "canonId": "019de52d-039c-718f-ad3a-efe9c4b3c838",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "process",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:15.11+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "751a5324-bbf1-4bd0-8000-dc012f35e780",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.3,
            "x": 0.68,
            "y": 0.185
          },
          "kind": "paragraph",
          "text": "Neutralization of IL-23 inhibits cascade of various proinflammatory cytokines",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:15.11+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "2be8f2ec-eb4c-4f71-b6bf-1145d26ff117",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.3,
            "x": 0.02,
            "y": 0.185
          },
          "kind": "paragraph",
          "text": "Blockade of a4b7 prevents circulating T cells from entering inflammatory gut tissues",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:15.11+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "b42b8605-6745-40f0-b295-318b877fc1b2",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.3,
            "x": 0.35,
            "y": 0.185
          },
          "kind": "paragraph",
          "text": "Neutralization of TL1A suppresses inflammation within the gut tissue and blocks immune cell activation",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:15.11+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "ec207286-ee7b-4245-931c-0090aae70b37",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.06,
            "w": 0.96,
            "x": 0.02,
            "y": 0.86
          },
          "kind": "title",
          "text": "Spyre is a pioneer in developing best-in-class mAbs against three top targets to enable superior combinations for IBD",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:15.11+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "f29bc95c-70d2-44b5-a59d-7492f6512f75",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.85,
            "x": 0.02,
            "y": 0.04
          },
          "kind": "title",
          "text": "Spyre portfolio addresses the diverse pathophysiology of IBD",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:15.11+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "0c6038b2-dbf4-480b-9bda-05076bce4984",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [
        {
          "tool": {
            "name": "Action Titles",
            "slug": "action-titles",
            "status": "active",
            "bestFor": "Any decision-grade deliverable — strategy recommendation, board update, investment memo, M&A review, post-mortem — where the reader is being asked to agree, decide, or act and will skim the title bar at speed.",
            "canonId": "019dd956-ac70-700b-a608-ba58e78f5dcc",
            "version": 1,
            "bodyDocId": "816dad3c-9983-41c1-a86e-978ebd582841",
            "description": "The McKinsey-bred discipline of writing every slide title as a complete declarative sentence with a verb and an insight, not a topic label. Each title is a sub-claim that ladders up to the deck's governing thought; read in sequence, the titles reconstruct the executive summary.",
            "familyLabel": null,
            "categoryName": "Slide",
            "categorySlug": "slide"
          },
          "agent": "Architect",
          "layer": "slide",
          "agents": [
            "Architect"
          ],
          "matchId": "c33715b2-6fb4-40ba-b9d6-7a572565f3f6",
          "evidence": "The slide contains action titles such as 'Spyre is a pioneer in developing best-in-class mAbs'.",
          "pageRefs": null,
          "priority": "Core",
          "whenToUse": "Any decision-grade deliverable — strategy recommendation, board update, investment memo, M&A review, post-mortem — where the reader is being asked to agree, decide, or act and will skim the title bar at speed.",
          "confidence": 0.7,
          "extraction": {
            "at": "2026-07-17 00:26:47.518947+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 39,
          "whyItWorks": "Solves two failure modes at once. (1) The buried claim: action titles place the conclusion on the page before any analysis is read, so a busy reader doesn't reverse-engineer it from the chart. (2) The spineless deck: because each title is a claim, slides have to ladder up to the governing thought; logical gaps become visible as topic-shaped titles in a sequence that no longer reads as a story.",
          "antipattern": "Topic labels disguised as titles — Volume by quarter, Key findings, Pricing strategy, Margins have been impacted. No verb, or a passive verb with no agent, or a fact (Revenue grew 12%) without the so-what. Also: titles that overreach the chart's evidence, multi-claim X-grew-but-Y-fell welded titles, and mechanical repetition of the same X-drove-Y template across the deck.",
          "cardinality": null,
          "narrativePurpose": "Forces the deck to carry its argument in the title bar so a senior reader can extract the recommendation without opening a single slide; converts a binder of topics into a navigable pyramid where every slide is a node defending the apex."
        }
      ],
      "frameworks": [],
      "arcBeats": [
        {
          "to": 44,
          "arc": {
            "name": "Problem-Agitate-Solution",
            "slug": "problem-agitate-solution",
            "status": "active",
            "bestFor": "Sales pitches, urgency-driven, competitive displacement",
            "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
            "description": null,
            "familyLabel": null
          },
          "from": 31,
          "name": "Evidence",
          "beatId": "5c590fe3-bdd5-4bd1-85d4-420b5f2a4608",
          "matchId": "a1bcf76f-a4ea-452c-9399-8bc5a62efe28",
          "beatType": {
            "name": "Evidence",
            "slug": "evidence",
            "status": "active",
            "canonId": "019dd9b8-03f9-772a-b84a-4f07b415b77a",
            "version": 1,
            "description": "A dedicated proof beat exists in only ~4 arcs (Gambit, Sequoia, AIDA, Monroes). Other arcs embed evidence inline within development."
          },
          "evidence": "The document provides evidence to support the company's solution",
          "position": 4,
          "isPrimaryArc": true,
          "parentBeatType": null,
          "alignedBlockIds": null,
          "matchConfidence": 0.9
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 40,
      "type": "setup",
      "title": "The chart uses a waterfall-style logic to show the additive effect of the combination therapy.",
      "function": "compare_peers",
      "rawType": "comparison_table",
      "block": null,
      "metadata": {
        "slideType": "comparison_table",
        "slideTypeCanon": {
          "name": "Comparison table",
          "slug": "comparison_table",
          "status": "active",
          "canonId": "019de52d-0a06-73f8-8813-fe022fab1de2",
          "version": 1,
          "description": null
        },
        "function": "compare_peers",
        "functionCanon": {
          "name": "Compare peers",
          "slug": "compare_peers",
          "status": "active",
          "canonId": "019de52d-1453-72ba-a367-9ba3d34c1630",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 64,
        "componentCount": 5,
        "textChars": 614,
        "nDataPoints": 12,
        "notes": "The chart uses a waterfall-style logic to show the additive effect of the combination therapy.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:46:15.11+00",
          "seconds": 2.899,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de075-3cec-7700-94db-076a5ce30d84/40",
        "deck": "/decks/019de075-3cec-7700-94db-076a5ce30d84",
        "deckAnchor": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-40",
        "deckJson": "/decks/019de075-3cec-7700-94db-076a5ce30d84.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.35,
            "w": 0.3,
            "x": 0.65,
            "y": 0.32
          },
          "kind": "callout",
          "text": "Despite non-optimal components, JNJ combination (JNJ-78934804) delivered superior UC efficacy compared to any single agent. Spyre aims to build on this success with combinations of best-in-class mAbs from superior MOAs.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": null,
            "subkind": {
              "name": "Primary callout",
              "slug": "primary",
              "status": "active",
              "canonId": "019de52c-fbd1-70eb-a9ce-8997f8674c1d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "primary",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:15.11+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "7d5c0ad7-a11f-468b-adc4-5a7992fa564a",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.4,
            "w": 0.5,
            "x": 0.12,
            "y": 0.25
          },
          "kind": "chart",
          "text": "Clinical remission rates (induction) for Golimumab, Guselkumab, and Combination",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Chart",
              "slug": "chart",
              "status": "active",
              "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8",
              "version": 1,
              "description": "Quantitative chart."
            },
            "tool": null,
            "subkind": {
              "name": "Stacked bar chart",
              "slug": "bar-stacked",
              "status": "active",
              "canonId": "019de52c-feec-74bf-9028-15b74f84f0a7",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bar-stacked",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:15.11+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "f54920e9-cb01-430a-a58c-ff70876aa09e",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.8,
            "x": 0.05,
            "y": 0.88
          },
          "kind": "source-note",
          "text": "NOTE: *In VEGA, only guselkumab (IL-23) was continued in maintenance for the combo arm in a treat-through design; Spyre plans to use combinations in maintenance.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:15.11+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "091d7d69-bc7e-46bd-b56f-8a3561aae17d",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.2,
            "w": 0.6,
            "x": 0.05,
            "y": 0.65
          },
          "kind": "table",
          "text": "N=, Maintenance remission, Safety data for the three arms",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Table",
              "slug": "table",
              "status": "active",
              "canonId": "019de52c-f9c8-7148-8119-eaac9594cd28",
              "version": 1,
              "description": "Tabular data layout."
            },
            "tool": null,
            "subkind": {
              "name": "Data table",
              "slug": "data",
              "status": "active",
              "canonId": "019de52d-02d5-75b8-8abf-88e92bf63569",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "data",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:15.11+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "44ade076-63a8-4078-b115-a6b5308d7dfa",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.8,
            "x": 0.05,
            "y": 0.05
          },
          "kind": "title",
          "text": "JNJ's VEGA study demonstrated power of combination therapy despite relative weakness of components",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:15.11+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "41112f85-72c0-4e1b-8580-e336de0dd348",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "d764f74c-ac6b-4998-a4bb-d2df44303517",
          "evidence": "Comparing single agents against a combination therapy to demonstrate additive value.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 11:46:15.11+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 40,
          "frameworkName": "comparison_frame"
        }
      ],
      "arcBeats": [
        {
          "to": 44,
          "arc": {
            "name": "Problem-Agitate-Solution",
            "slug": "problem-agitate-solution",
            "status": "active",
            "bestFor": "Sales pitches, urgency-driven, competitive displacement",
            "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
            "description": null,
            "familyLabel": null
          },
          "from": 31,
          "name": "Evidence",
          "beatId": "5c590fe3-bdd5-4bd1-85d4-420b5f2a4608",
          "matchId": "a1bcf76f-a4ea-452c-9399-8bc5a62efe28",
          "beatType": {
            "name": "Evidence",
            "slug": "evidence",
            "status": "active",
            "canonId": "019dd9b8-03f9-772a-b84a-4f07b415b77a",
            "version": 1,
            "description": "A dedicated proof beat exists in only ~4 arcs (Gambit, Sequoia, AIDA, Monroes). Other arcs embed evidence inline within development."
          },
          "evidence": "The document provides evidence to support the company's solution",
          "position": 4,
          "isPrimaryArc": true,
          "parentBeatType": null,
          "alignedBlockIds": null,
          "matchConfidence": 0.9
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 41,
      "type": "setup",
      "title": "The slide uses donut charts to represent remission rates and highlights the safety advantages of gut-selective backbones.",
      "function": "compare_peers",
      "rawType": "comparison_table",
      "block": null,
      "metadata": {
        "slideType": "comparison_table",
        "slideTypeCanon": {
          "name": "Comparison table",
          "slug": "comparison_table",
          "status": "active",
          "canonId": "019de52d-0a06-73f8-8813-fe022fab1de2",
          "version": 1,
          "description": null
        },
        "function": "compare_peers",
        "functionCanon": {
          "name": "Compare peers",
          "slug": "compare_peers",
          "status": "active",
          "canonId": "019de52d-1453-72ba-a367-9ba3d34c1630",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 72,
        "componentCount": 9,
        "textChars": 328,
        "nDataPoints": 6,
        "notes": "The slide uses donut charts to represent remission rates and highlights the safety advantages of gut-selective backbones.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:46:15.71+00",
          "seconds": 3.499,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de075-3cec-7700-94db-076a5ce30d84/41",
        "deck": "/decks/019de075-3cec-7700-94db-076a5ce30d84",
        "deckAnchor": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-41",
        "deckJson": "/decks/019de075-3cec-7700-94db-076a5ce30d84.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.2,
            "w": 0.1,
            "x": 0.45,
            "y": 0.45
          },
          "kind": "chart",
          "text": "TBD remission",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Chart",
              "slug": "chart",
              "status": "active",
              "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8",
              "version": 1,
              "description": "Quantitative chart."
            },
            "tool": null,
            "subkind": {
              "name": "Donut chart",
              "slug": "donut",
              "status": "active",
              "canonId": "019de52d-0006-752c-9528-0fef476b8004",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "donut",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:15.71+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "2042b837-14d1-43ec-b76b-9fb3c0dc69fa",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.2,
            "w": 0.1,
            "x": 0.25,
            "y": 0.45
          },
          "kind": "chart",
          "text": ">50% remission",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Chart",
              "slug": "chart",
              "status": "active",
              "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8",
              "version": 1,
              "description": "Quantitative chart."
            },
            "tool": null,
            "subkind": {
              "name": "Donut chart",
              "slug": "donut",
              "status": "active",
              "canonId": "019de52d-0006-752c-9528-0fef476b8004",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "donut",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:15.71+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "2a457ab8-5667-41e8-9a22-8966758a8f24",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.2,
            "w": 0.1,
            "x": 0.25,
            "y": 0.25
          },
          "kind": "chart",
          "text": "47% remission",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Chart",
              "slug": "chart",
              "status": "active",
              "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8",
              "version": 1,
              "description": "Quantitative chart."
            },
            "tool": null,
            "subkind": {
              "name": "Donut chart",
              "slug": "donut",
              "status": "active",
              "canonId": "019de52d-0006-752c-9528-0fef476b8004",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "donut",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:15.71+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "339f4e88-11e3-45ac-bc27-09cf28bb7523",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.2,
            "w": 0.1,
            "x": 0.25,
            "y": 0.65
          },
          "kind": "chart",
          "text": ">50% remission",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Chart",
              "slug": "chart",
              "status": "active",
              "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8",
              "version": 1,
              "description": "Quantitative chart."
            },
            "tool": null,
            "subkind": {
              "name": "Donut chart",
              "slug": "donut",
              "status": "active",
              "canonId": "019de52d-0006-752c-9528-0fef476b8004",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "donut",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:15.71+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "c151b216-b428-46b8-80b3-c2f3c42079c1",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.2,
            "w": 0.1,
            "x": 0.45,
            "y": 0.65
          },
          "kind": "chart",
          "text": ">50% remission",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Chart",
              "slug": "chart",
              "status": "active",
              "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8",
              "version": 1,
              "description": "Quantitative chart."
            },
            "tool": null,
            "subkind": {
              "name": "Donut chart",
              "slug": "donut",
              "status": "active",
              "canonId": "019de52d-0006-752c-9528-0fef476b8004",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "donut",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:15.71+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "d7a57b29-45fe-41e3-932f-8f6490f13140",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.2,
            "w": 0.1,
            "x": 0.45,
            "y": 0.25
          },
          "kind": "chart",
          "text": "48% remission",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Chart",
              "slug": "chart",
              "status": "active",
              "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8",
              "version": 1,
              "description": "Quantitative chart."
            },
            "tool": null,
            "subkind": {
              "name": "Donut chart",
              "slug": "donut",
              "status": "active",
              "canonId": "019de52d-0006-752c-9528-0fef476b8004",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "donut",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:15.71+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "fb08b6ac-b3bb-4105-96c4-793a04ac81fc",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.5,
            "x": 0.12,
            "y": 0.94
          },
          "kind": "disclaimer",
          "text": "The figures above are for illustrative purposes only, assuming combinations result in additive efficacy",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Disclaimer",
              "slug": "disclaimer",
              "status": "active",
              "canonId": "91173477-d91f-4024-bbaf-d4f93e3f82dc",
              "version": 1,
              "description": "Legal/cautionary text that occupies most of the body of its slide."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:15.71+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "119f992d-c98f-490e-8cb8-87beffd24556",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.7,
            "w": 0.9,
            "x": 0.05,
            "y": 0.2
          },
          "kind": "table",
          "text": "Program, UC Induction, UC Maintenance, Safety, Dosing",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Table",
              "slug": "table",
              "status": "active",
              "canonId": "019de52c-f9c8-7148-8119-eaac9594cd28",
              "version": 1,
              "description": "Tabular data layout."
            },
            "tool": null,
            "subkind": {
              "name": "Data table",
              "slug": "data",
              "status": "active",
              "canonId": "019de52d-02d5-75b8-8abf-88e92bf63569",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "data",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:15.71+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "c73b44ce-2387-4a52-8fef-103dc5f5c802",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.7,
            "x": 0.05,
            "y": 0.05
          },
          "kind": "title",
          "text": "Spyre could create optimal combinations in IBD to safely and conveniently maximize efficacy",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:15.71+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "8b23515c-4904-4895-8cbf-31ca4a85f136",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "c8aa86ea-5c51-4aeb-9d55-262947018935",
          "evidence": "Table comparing competitor JNJ-4804 against Spyre's internal programs.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 11:46:15.71+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 41,
          "frameworkName": "comparison_frame"
        }
      ],
      "arcBeats": [
        {
          "to": 44,
          "arc": {
            "name": "Problem-Agitate-Solution",
            "slug": "problem-agitate-solution",
            "status": "active",
            "bestFor": "Sales pitches, urgency-driven, competitive displacement",
            "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
            "description": null,
            "familyLabel": null
          },
          "from": 31,
          "name": "Evidence",
          "beatId": "5c590fe3-bdd5-4bd1-85d4-420b5f2a4608",
          "matchId": "a1bcf76f-a4ea-452c-9399-8bc5a62efe28",
          "beatType": {
            "name": "Evidence",
            "slug": "evidence",
            "status": "active",
            "canonId": "019dd9b8-03f9-772a-b84a-4f07b415b77a",
            "version": 1,
            "description": "A dedicated proof beat exists in only ~4 arcs (Gambit, Sequoia, AIDA, Monroes). Other arcs embed evidence inline within development."
          },
          "evidence": "The document provides evidence to support the company's solution",
          "position": 4,
          "isPrimaryArc": true,
          "parentBeatType": null,
          "alignedBlockIds": null,
          "matchConfidence": 0.9
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 42,
      "type": "resolution",
      "title": "The slide uses a timeline-based process diagram to illustrate the clinical trial strategy.",
      "function": "plan_implementation",
      "rawType": "roadmap",
      "block": null,
      "metadata": {
        "slideType": "roadmap",
        "slideTypeCanon": {
          "name": "Roadmap",
          "slug": "roadmap",
          "status": "active",
          "canonId": "019de52d-0a55-72bc-9b7b-a47ef109839c",
          "version": 1,
          "description": null
        },
        "function": "plan_implementation",
        "functionCanon": {
          "name": "Plan implementation",
          "slug": "plan_implementation",
          "status": "active",
          "canonId": "019de52d-14a2-77ea-b210-d6a95eed4823",
          "version": 1,
          "description": null
        },
        "density": "balanced",
        "densityScore": 30,
        "componentCount": 4,
        "textChars": 251,
        "nDataPoints": 0,
        "notes": "The slide uses a timeline-based process diagram to illustrate the clinical trial strategy.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:46:16.035+00",
          "seconds": 3.82,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de075-3cec-7700-94db-076a5ce30d84/42",
        "deck": "/decks/019de075-3cec-7700-94db-076a5ce30d84",
        "deckAnchor": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-42",
        "deckJson": "/decks/019de075-3cec-7700-94db-076a5ce30d84.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.7,
            "w": 0.96,
            "x": 0.02,
            "y": 0.18
          },
          "kind": "framework",
          "text": "Phase 1 to Phase 3 clinical trial progression",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Framework",
              "slug": "framework",
              "status": "active",
              "canonId": "019de52c-fa18-77c6-b10a-ccb8277ac0fa",
              "version": 1,
              "description": "Named conceptual framework instance."
            },
            "tool": null,
            "subkind": {
              "name": "Framework instance",
              "slug": "instance",
              "status": "active",
              "canonId": "019de52d-05a2-72af-be0b-7edc60708a03",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "instance",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:16.035+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "471019a6-16e2-461b-b917-511486cfcf30",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.06,
            "w": 0.58,
            "x": 0.4,
            "y": 0.8
          },
          "kind": "paragraph",
          "text": "Comparable development strategy to be pursued with SPY002 (TL1A) combinations",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:16.035+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "ce6c78e1-d760-44d4-b335-c34cbbe0762d",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.25,
            "x": 0.02,
            "y": 0.89
          },
          "kind": "source-note",
          "text": "Preliminary; pending regulatory feedback",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:16.035+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "39ada85e-c3dd-4c93-9a7d-1a9c34d92b94",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.75,
            "x": 0.02,
            "y": 0.04
          },
          "kind": "title",
          "text": "We plan to rapidly advance combination programs in parallel with monotherapies in Phase 2",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:16.035+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "509f66a4-a000-4702-a3dc-d14ab252449d",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "b338290d-bfc3-46b0-bf2e-335ffa29eead",
          "evidence": "The slide depicts a sequential progression of clinical trial phases over time.",
          "framework": null,
          "confidence": 1,
          "extraction": {
            "at": "2026-05-02 11:46:16.035+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 42,
          "frameworkName": "timeline"
        }
      ],
      "arcBeats": [
        {
          "to": 44,
          "arc": {
            "name": "Problem-Agitate-Solution",
            "slug": "problem-agitate-solution",
            "status": "active",
            "bestFor": "Sales pitches, urgency-driven, competitive displacement",
            "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
            "description": null,
            "familyLabel": null
          },
          "from": 31,
          "name": "Evidence",
          "beatId": "5c590fe3-bdd5-4bd1-85d4-420b5f2a4608",
          "matchId": "a1bcf76f-a4ea-452c-9399-8bc5a62efe28",
          "beatType": {
            "name": "Evidence",
            "slug": "evidence",
            "status": "active",
            "canonId": "019dd9b8-03f9-772a-b84a-4f07b415b77a",
            "version": 1,
            "description": "A dedicated proof beat exists in only ~4 arcs (Gambit, Sequoia, AIDA, Monroes). Other arcs embed evidence inline within development."
          },
          "evidence": "The document provides evidence to support the company's solution",
          "position": 4,
          "isPrimaryArc": true,
          "parentBeatType": null,
          "alignedBlockIds": null,
          "matchConfidence": 0.9
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 43,
      "type": "resolution",
      "title": "The slide uses a Y-shaped antibody illustration to represent the combination therapy approach.",
      "function": "present_solution",
      "rawType": "solution",
      "block": null,
      "metadata": {
        "slideType": "solution",
        "slideTypeCanon": {
          "name": "Solution",
          "slug": "solution",
          "status": "active",
          "canonId": "019de52d-0eb5-72ff-8b70-ba70a4199282",
          "version": 1,
          "description": null
        },
        "function": "present_solution",
        "functionCanon": {
          "name": "Present solution",
          "slug": "present_solution",
          "status": "active",
          "canonId": "019de52d-15b8-71da-bd23-2b767850cbce",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 54,
        "componentCount": 5,
        "textChars": 581,
        "nDataPoints": 0,
        "notes": "The slide uses a Y-shaped antibody illustration to represent the combination therapy approach.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:46:15.609+00",
          "seconds": 3.297,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de075-3cec-7700-94db-076a5ce30d84/43",
        "deck": "/decks/019de075-3cec-7700-94db-076a5ce30d84",
        "deckAnchor": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-43",
        "deckJson": "/decks/019de075-3cec-7700-94db-076a5ce30d84.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.15,
            "w": 0.55,
            "x": 0.4,
            "y": 0.7
          },
          "kind": "chart",
          "text": "UPCOMING CATALYSTS: 2025 Ph2 initiation with SPY001 backbone",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Chart",
              "slug": "chart",
              "status": "active",
              "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8",
              "version": 1,
              "description": "Quantitative chart."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": "timeline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:15.609+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e8b36273-4a63-481b-9047-86571caccf3e",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.55,
            "w": 0.28,
            "x": 0.02,
            "y": 0.245
          },
          "kind": "image",
          "text": "Antibody combination diagram",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Illustration",
              "slug": "illustration",
              "status": "active",
              "canonId": "019de52c-fe76-7772-a5ac-c0b7294d7615",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "illustration",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:15.609+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "cdac7a42-6f9b-4230-b1c1-f3e232bc1068",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.1,
            "x": 0.12,
            "y": 0.7
          },
          "kind": "list",
          "text": "SPY130, SPY120, SPY230",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:15.609+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "26252f98-08b3-445f-986b-b9ab2989df13",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.45,
            "w": 0.6,
            "x": 0.35,
            "y": 0.23
          },
          "kind": "list",
          "text": "Established combination precedent: JNJ VEGA study demonstrated unprecedented efficacy despite sub-optimal combination components. Ideal building blocks: Spyre's best-in-class engineered mAbs provide optionality for multiple rational combinations. Rapid proof of concept: Parallel progression of portfolio of mAbs will allow evaluation of combinations in Phase 2 studies.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:15.609+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "4f913a6f-badd-4ab0-867d-9aa96b2cf268",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.85,
            "x": 0.03,
            "y": 0.04
          },
          "kind": "title",
          "text": "Spyre is developing potentially best-in-class combinations to maximize efficacy for patients with IBD",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:15.609+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "0dbbe808-e07f-4d5c-8a41-3e6a4e3b08b8",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "21662e4d-2d2a-45f8-bb13-306a9e98dae2",
          "evidence": "JNJ VEGA study precedent",
          "framework": null,
          "confidence": 0.8,
          "extraction": {
            "at": "2026-05-02 11:46:15.609+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 43,
          "frameworkName": "authority-citation"
        }
      ],
      "arcBeats": [
        {
          "to": 44,
          "arc": {
            "name": "Problem-Agitate-Solution",
            "slug": "problem-agitate-solution",
            "status": "active",
            "bestFor": "Sales pitches, urgency-driven, competitive displacement",
            "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
            "description": null,
            "familyLabel": null
          },
          "from": 31,
          "name": "Evidence",
          "beatId": "5c590fe3-bdd5-4bd1-85d4-420b5f2a4608",
          "matchId": "a1bcf76f-a4ea-452c-9399-8bc5a62efe28",
          "beatType": {
            "name": "Evidence",
            "slug": "evidence",
            "status": "active",
            "canonId": "019dd9b8-03f9-772a-b84a-4f07b415b77a",
            "version": 1,
            "description": "A dedicated proof beat exists in only ~4 arcs (Gambit, Sequoia, AIDA, Monroes). Other arcs embed evidence inline within development."
          },
          "evidence": "The document provides evidence to support the company's solution",
          "position": 4,
          "isPrimaryArc": true,
          "parentBeatType": null,
          "alignedBlockIds": null,
          "matchConfidence": 0.9
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 44,
      "type": "resolution",
      "title": "The slide uses a Venn diagram to illustrate target overlap and a tree diagram to show potential combination therapy paths.",
      "function": "present_solution",
      "rawType": "solution",
      "block": null,
      "metadata": {
        "slideType": "solution",
        "slideTypeCanon": {
          "name": "Solution",
          "slug": "solution",
          "status": "active",
          "canonId": "019de52d-0eb5-72ff-8b70-ba70a4199282",
          "version": 1,
          "description": null
        },
        "function": "present_solution",
        "functionCanon": {
          "name": "Present solution",
          "slug": "present_solution",
          "status": "active",
          "canonId": "019de52d-15b8-71da-bd23-2b767850cbce",
          "version": 1,
          "description": null
        },
        "density": "balanced",
        "densityScore": 48,
        "componentCount": 5,
        "textChars": 416,
        "nDataPoints": 0,
        "notes": "The slide uses a Venn diagram to illustrate target overlap and a tree diagram to show potential combination therapy paths.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:46:15.829+00",
          "seconds": 3.366,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de075-3cec-7700-94db-076a5ce30d84/44",
        "deck": "/decks/019de075-3cec-7700-94db-076a5ce30d84",
        "deckAnchor": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-44",
        "deckJson": "/decks/019de075-3cec-7700-94db-076a5ce30d84.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.3,
            "w": 0.3,
            "x": 0.65,
            "y": 0.35
          },
          "kind": "diagram",
          "text": "Precision immunology tree diagram showing monotherapies and combinations",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Diagram",
              "slug": "diagram",
              "status": "active",
              "canonId": "019de52c-f9f0-734a-81de-15382ff28c65",
              "version": 1,
              "description": "Schematic or relational diagram."
            },
            "tool": null,
            "subkind": {
              "name": "Hub and spoke",
              "slug": "hub-spoke",
              "status": "active",
              "canonId": "019de52d-04db-73e6-81ca-a234f2f23fc1",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "hub-spoke",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:15.829+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "3ce63656-a50b-4090-9b90-61ce142406bd",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.2,
            "w": 0.2,
            "x": 0.05,
            "y": 0.4
          },
          "kind": "diagram",
          "text": "Circular process diagram showing IBD patient treatment cycling",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Diagram",
              "slug": "diagram",
              "status": "active",
              "canonId": "019de52c-f9f0-734a-81de-15382ff28c65",
              "version": 1,
              "description": "Schematic or relational diagram."
            },
            "tool": null,
            "subkind": {
              "name": "Process flow",
              "slug": "process",
              "status": "active",
              "canonId": "019de52d-039c-718f-ad3a-efe9c4b3c838",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "process",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:15.829+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "2ef53aff-f131-4cc7-b92a-f03b18eae9fc",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.25,
            "w": 0.25,
            "x": 0.35,
            "y": 0.35
          },
          "kind": "diagram",
          "text": "Venn diagram showing overlap of TL1A, IL-23, and alpha4beta7 targets",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Diagram",
              "slug": "diagram",
              "status": "active",
              "canonId": "019de52c-f9f0-734a-81de-15382ff28c65",
              "version": 1,
              "description": "Schematic or relational diagram."
            },
            "tool": null,
            "subkind": {
              "name": "Venn diagram",
              "slug": "venn",
              "status": "active",
              "canonId": "019de52d-0463-710d-b529-cce18d828d2f",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "venn",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:15.829+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "b503d0fc-9072-4ed0-afbf-19e11e9d7eaa",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.65,
            "x": 0.29,
            "y": 0.18
          },
          "kind": "title",
          "text": "We believe the future of IBD includes combination therapies and precision approaches to break the therapeutic ceiling",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:15.829+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "0be3d09a-56ec-4b87-8f9e-88c5a00dbb05",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.85,
            "x": 0.02,
            "y": 0.04
          },
          "kind": "title",
          "text": "We aim to develop companion diagnostics to augment our therapeutic combinations and monotherapies",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:15.829+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "92773657-d053-423d-a889-e590acce7e66",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [
        {
          "tool": {
            "name": "Audience Definition",
            "slug": "audience-definition",
            "status": "active",
            "bestFor": null,
            "canonId": "019dd956-7f2a-775d-aeee-ff099bcb7756",
            "version": 1,
            "bodyDocId": null,
            "description": "Six key questions: Who are they? What do they know? What do they believe? What do they care about? What do they fear? What decisions can they make?",
            "familyLabel": null,
            "categoryName": "Block",
            "categorySlug": "block"
          },
          "agent": "Storyteller",
          "layer": "slide",
          "agents": [
            "Storyteller"
          ],
          "matchId": "84476625-8ef6-4b4d-88dd-eb7791b6e217",
          "evidence": "The slide seems to be targeted towards investors or stakeholders in the pharmaceutical industry, indicating a specific audience definition.",
          "pageRefs": null,
          "priority": "Core",
          "whenToUse": null,
          "confidence": 0.7,
          "extraction": {
            "at": "2026-07-17 03:38:14.138225+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 44,
          "whyItWorks": null,
          "antipattern": null,
          "cardinality": null,
          "narrativePurpose": null
        },
        {
          "tool": {
            "name": "Big Idea Formula",
            "slug": "big-idea-formula",
            "status": "active",
            "bestFor": "Any narrative-driven persuasive deck whose job is to move the audience: keynotes, fundraising pitches, capital-allocation board asks, all-hands behaviour-change talks, conference talks meant to shift mental models. Use it before structuring; pair with Pyramid when the deck must also withstand line-by-line scrutiny.",
            "canonId": "019dd956-7dd1-74d7-9866-ffdef19ecfbf",
            "version": 1,
            "bodyDocId": "c30d7484-69e0-4e21-82cf-20fa0966869e",
            "description": "Nancy Duarte's articulation of how to frame a presentation's central message: the speaker's unique point of view plus what's at stake for the audience, expressed as one complete declarative sentence. The narrative-driven counterpart to Minto's analytical governing thought.",
            "familyLabel": null,
            "categoryName": "Block",
            "categorySlug": "block"
          },
          "agent": "Storyteller",
          "layer": "slide",
          "agents": [
            "Storyteller"
          ],
          "matchId": "16bfd72d-eff5-45ce-b226-f419fe10c2c6",
          "evidence": "The slide presents a clear and concise big idea: 'the future of IBD includes combination therapies and precision approaches to break the therapeutic ceiling'.",
          "pageRefs": null,
          "priority": "Core",
          "whenToUse": "Any narrative-driven persuasive deck whose job is to move the audience: keynotes, fundraising pitches, capital-allocation board asks, all-hands behaviour-change talks, conference talks meant to shift mental models. Use it before structuring; pair with Pyramid when the deck must also withstand line-by-line scrutiny.",
          "confidence": 0.7,
          "extraction": {
            "at": "2026-07-17 03:38:14.176576+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 44,
          "whyItWorks": "Solves the topic-not-thesis trap and the stake-less recommendation trap simultaneously. A single declarative sentence with a verb forces the speaker's stance into the room; routing the consequence through the word 'you' translates internal urgency into the audience's currency. The result is short enough to be repeated after the meeting — and that repetition is the persuasion mechanism.",
          "antipattern": "A topic dressed as a thesis ('Sustainability Roadmap 2026'), a stake attached to the speaker rather than the audience, two ideas spliced with 'and', abstract verbs (leverage / unlock / empower) that survive deletion, or writing the Big Idea after the deck is already built so the slides don't actually defend it.",
          "cardinality": null,
          "narrativePurpose": "Forces the deck to commit to a single declarative thesis before slide one — a sentence that names the speaker's stance and routes a consequence through the audience's currency. Acts as the filter every slide, anecdote, and chart must ladder up to."
        },
        {
          "tool": {
            "name": "SCQA Framework",
            "slug": "scqa-framework",
            "status": "active",
            "bestFor": null,
            "canonId": "019dd956-7bcb-763f-bdf6-1dfedf3bd36c",
            "version": 1,
            "bodyDocId": "019df22a-a0b0-719e-937e-2ac31e53d32c",
            "description": "Situation, Complication, Question, Answer - structured problem framing",
            "familyLabel": null,
            "categoryName": "Block",
            "categorySlug": "block"
          },
          "agent": "Architect",
          "layer": "slide",
          "agents": [
            "Architect"
          ],
          "matchId": "c9f21eef-0aa7-4992-a83f-fe583d362db6",
          "evidence": "The slide follows a general SCQA ( Situation, Complication, Question, Answer) framework.",
          "pageRefs": null,
          "priority": "Core",
          "whenToUse": null,
          "confidence": 0.5,
          "extraction": {
            "at": "2026-07-17 03:38:14.216092+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 44,
          "whyItWorks": null,
          "antipattern": null,
          "cardinality": null,
          "narrativePurpose": null
        }
      ],
      "frameworks": [
        {
          "matchId": "cf470829-c85e-4007-8bed-682dfc81df39",
          "evidence": "Venn diagram used to show target overlap",
          "framework": null,
          "confidence": 1,
          "extraction": {
            "at": "2026-05-02 11:46:15.829+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 44,
          "frameworkName": "venn"
        }
      ],
      "arcBeats": [
        {
          "to": 44,
          "arc": {
            "name": "Problem-Agitate-Solution",
            "slug": "problem-agitate-solution",
            "status": "active",
            "bestFor": "Sales pitches, urgency-driven, competitive displacement",
            "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
            "description": null,
            "familyLabel": null
          },
          "from": 31,
          "name": "Evidence",
          "beatId": "5c590fe3-bdd5-4bd1-85d4-420b5f2a4608",
          "matchId": "a1bcf76f-a4ea-452c-9399-8bc5a62efe28",
          "beatType": {
            "name": "Evidence",
            "slug": "evidence",
            "status": "active",
            "canonId": "019dd9b8-03f9-772a-b84a-4f07b415b77a",
            "version": 1,
            "description": "A dedicated proof beat exists in only ~4 arcs (Gambit, Sequoia, AIDA, Monroes). Other arcs embed evidence inline within development."
          },
          "evidence": "The document provides evidence to support the company's solution",
          "position": 4,
          "isPrimaryArc": true,
          "parentBeatType": null,
          "alignedBlockIds": null,
          "matchConfidence": 0.9
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 45,
      "type": "evidence",
      "title": "The slide uses a comparative framework to validate the efficacy of CDx-guided patient selection.",
      "function": "show_traction",
      "rawType": "traction",
      "block": null,
      "metadata": {
        "slideType": "traction",
        "slideTypeCanon": {
          "name": "Traction",
          "slug": "traction",
          "status": "active",
          "canonId": "019de52d-0edd-72ab-820f-3ebc71a9c542",
          "version": 1,
          "description": null
        },
        "function": "show_traction",
        "functionCanon": {
          "name": "Show traction",
          "slug": "show_traction",
          "status": "active",
          "canonId": "019de52d-16a8-756a-9b38-a7d35420561d",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 51,
        "componentCount": 5,
        "textChars": 338,
        "nDataPoints": 4,
        "notes": "The slide uses a comparative framework to validate the efficacy of CDx-guided patient selection.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:46:15.472+00",
          "seconds": 2.865,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de075-3cec-7700-94db-076a5ce30d84/45",
        "deck": "/decks/019de075-3cec-7700-94db-076a5ce30d84",
        "deckAnchor": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-45",
        "deckJson": "/decks/019de075-3cec-7700-94db-076a5ce30d84.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.08,
            "w": 0.9,
            "x": 0.05,
            "y": 0.8
          },
          "kind": "callout",
          "text": "Spyre aims to develop genetic companion diagnostics across a portfolio of best-in-class therapeutics",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": null,
            "subkind": {
              "name": "Primary callout",
              "slug": "primary",
              "status": "active",
              "canonId": "019de52c-fbd1-70eb-a9ce-8997f8674c1d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "primary",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:15.472+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "5f84e5a5-f302-4f57-814b-fa85b852ffcf",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.6,
            "w": 0.4,
            "x": 0.1,
            "y": 0.2
          },
          "kind": "chart",
          "text": "Prometheus Biosciences PRA023 TL1A UC clinical remission at 12 weeks",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Chart",
              "slug": "chart",
              "status": "active",
              "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8",
              "version": 1,
              "description": "Quantitative chart."
            },
            "tool": null,
            "subkind": {
              "name": "Grouped bar chart",
              "slug": "bar-grouped",
              "status": "active",
              "canonId": "019de52c-ff3b-751e-a8ff-f21ff11097b1",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bar-grouped",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:15.472+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "161c057b-d0c7-4b88-81b9-2bfb8a3ce48f",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.6,
            "w": 0.4,
            "x": 0.55,
            "y": 0.2
          },
          "kind": "chart",
          "text": "Roivant RVT-3101 TL1A UC clinical remission at 12 weeks",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Chart",
              "slug": "chart",
              "status": "active",
              "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8",
              "version": 1,
              "description": "Quantitative chart."
            },
            "tool": null,
            "subkind": {
              "name": "Grouped bar chart",
              "slug": "bar-grouped",
              "status": "active",
              "canonId": "019de52c-ff3b-751e-a8ff-f21ff11097b1",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bar-grouped",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:15.472+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "3b9f202d-a8ac-4afa-a36e-08dbafcfdc4c",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.15,
            "x": 0.02,
            "y": 0.9
          },
          "kind": "source-note",
          "text": "Source: Company materials",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:15.472+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "8dc73569-c7bf-405e-b304-9dbe89c2d9cb",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.8,
            "x": 0.02,
            "y": 0.04
          },
          "kind": "title",
          "text": "Prometheus and Roivant demonstrated POC that a genetic CDx can identify responders to TL1A",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:15.472+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "d5275593-7fca-4f44-8288-f66ed2f84d3f",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [
        {
          "tool": {
            "name": "Chart Selection Guide",
            "slug": "chart-selection-guide",
            "status": "active",
            "bestFor": null,
            "canonId": "019dd956-b1a0-700b-ba17-0e16c4d5bcae",
            "version": 1,
            "bodyDocId": null,
            "description": "Choosing the right chart type for your data and message",
            "familyLabel": null,
            "categoryName": "Slide",
            "categorySlug": "slide"
          },
          "agent": "Designer",
          "layer": "slide",
          "agents": [
            "Designer"
          ],
          "matchId": "d68d4fbe-faa9-4e8b-ae5e-1c71ff4c1188",
          "evidence": "The slide uses bar charts to display clinical remission data.",
          "pageRefs": null,
          "priority": null,
          "whenToUse": null,
          "confidence": 0.5,
          "extraction": {
            "at": "2026-07-17 03:38:14.332576+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 45,
          "whyItWorks": null,
          "antipattern": null,
          "cardinality": null,
          "narrativePurpose": null
        },
        {
          "tool": {
            "name": "Evidence Matrix",
            "slug": "evidence-matrix",
            "status": "active",
            "bestFor": null,
            "canonId": "019dd956-7ecc-74c2-b46c-0b9c1f4c73d7",
            "version": 1,
            "bodyDocId": null,
            "description": "Planning visual assets: Claim → Evidence Needed → Data Source → Visual Type",
            "familyLabel": null,
            "categoryName": "Block",
            "categorySlug": "block"
          },
          "agent": "Designer",
          "layer": "slide",
          "agents": [
            "Designer"
          ],
          "matchId": "6a669d76-d616-4a23-adee-9f8eb29e3b12",
          "evidence": "The slide presents clinical data in a table format to support the proof of concept (POC) for a genetic CDx.",
          "pageRefs": null,
          "priority": null,
          "whenToUse": null,
          "confidence": 0.7,
          "extraction": {
            "at": "2026-07-17 03:38:14.293454+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 45,
          "whyItWorks": null,
          "antipattern": null,
          "cardinality": null,
          "narrativePurpose": null
        }
      ],
      "frameworks": [
        {
          "matchId": "9ae806ff-4a3b-4a8f-accc-50ed9d6f90a8",
          "evidence": "Side-by-side comparison of two clinical trial outcomes to validate a business thesis.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 11:46:15.472+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 45,
          "frameworkName": "comparison_frame"
        }
      ],
      "arcBeats": [
        {
          "to": 56,
          "arc": {
            "name": "Problem-Agitate-Solution",
            "slug": "problem-agitate-solution",
            "status": "active",
            "bestFor": "Sales pitches, urgency-driven, competitive displacement",
            "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
            "description": null,
            "familyLabel": null
          },
          "from": 45,
          "name": "Action",
          "beatId": "712c62dc-223b-4b2c-ba9f-cd5c102db383",
          "matchId": "a1bcf76f-a4ea-452c-9399-8bc5a62efe28",
          "beatType": {
            "name": "Action",
            "slug": "monroes-sequence-action",
            "status": "active",
            "canonId": "019dd9b8-181e-760d-befc-010c2424fa89",
            "version": 1,
            "description": null
          },
          "evidence": "The document calls for action, outlining the company's plans and milestones",
          "position": 5,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Resolution",
            "slug": "resolution",
            "status": "active",
            "canonId": "019dd9b8-045d-703b-8dd7-e92aba3ba91b",
            "version": 1,
            "description": "How the deck ends. Required in 19/20 arcs. The exception (Sparkline) ends with new bliss which is functionally a resolution."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.9
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 46,
      "type": "setup",
      "function": "transition",
      "rawType": "section_divider",
      "block": null,
      "metadata": {
        "slideType": "section_divider",
        "slideTypeCanon": {
          "name": "Section divider",
          "slug": "section_divider",
          "status": "active",
          "canonId": "019de52d-066a-7402-9554-6ae504999041",
          "version": 1,
          "description": null
        },
        "function": "transition",
        "functionCanon": {
          "name": "Transition",
          "slug": "transition",
          "status": "active",
          "canonId": "019de52d-1365-7149-92aa-66df859e75fd",
          "version": 1,
          "description": null
        },
        "density": "sparse",
        "densityScore": 4,
        "componentCount": 2,
        "textChars": 32,
        "nDataPoints": 0,
        "notes": null,
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:46:15.085+00",
          "seconds": 2.315,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de075-3cec-7700-94db-076a5ce30d84/46",
        "deck": "/decks/019de075-3cec-7700-94db-076a5ce30d84",
        "deckAnchor": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-46",
        "deckJson": "/decks/019de075-3cec-7700-94db-076a5ce30d84.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.3,
            "w": 0.27,
            "x": 0.08,
            "y": 0.11
          },
          "kind": "image",
          "text": "Spyre Therapeutics logo",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Logo",
              "slug": "logo",
              "status": "active",
              "canonId": "019de52c-fdaf-743d-94c4-d7c6a0e55302",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "logo",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:15.085+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "ad7641f6-a4fe-4170-85be-ded3196a7e41",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.06,
            "w": 0.18,
            "x": 0.41,
            "y": 0.53
          },
          "kind": "title",
          "text": "Corporate",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:15.085+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "6d35313c-4ac7-45b9-b4ee-133154d04fb7",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [
        {
          "to": 56,
          "arc": {
            "name": "Problem-Agitate-Solution",
            "slug": "problem-agitate-solution",
            "status": "active",
            "bestFor": "Sales pitches, urgency-driven, competitive displacement",
            "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
            "description": null,
            "familyLabel": null
          },
          "from": 45,
          "name": "Action",
          "beatId": "712c62dc-223b-4b2c-ba9f-cd5c102db383",
          "matchId": "a1bcf76f-a4ea-452c-9399-8bc5a62efe28",
          "beatType": {
            "name": "Action",
            "slug": "monroes-sequence-action",
            "status": "active",
            "canonId": "019dd9b8-181e-760d-befc-010c2424fa89",
            "version": 1,
            "description": null
          },
          "evidence": "The document calls for action, outlining the company's plans and milestones",
          "position": 5,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Resolution",
            "slug": "resolution",
            "status": "active",
            "canonId": "019dd9b8-045d-703b-8dd7-e92aba3ba91b",
            "version": 1,
            "description": "How the deck ends. Required in 19/20 arcs. The exception (Sparkline) ends with new bliss which is functionally a resolution."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.9
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 47,
      "type": "setup",
      "title": "The slide uses a grid layout for headshots and a logo cloud at the bottom.",
      "function": "other",
      "rawType": "team_bio",
      "block": null,
      "metadata": {
        "slideType": "team_bio",
        "slideTypeCanon": {
          "name": "Team bio",
          "slug": "team_bio",
          "status": "active",
          "canonId": "019de52d-0a7d-7394-ae5b-037478e71f1e",
          "version": 1,
          "description": null
        },
        "function": "other",
        "functionCanon": {
          "name": "Other (fallback)",
          "slug": "other",
          "status": "active",
          "canonId": "019de52d-15e1-75bc-99dc-07732380e2ce",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 51,
        "componentCount": 5,
        "textChars": 471,
        "nDataPoints": 0,
        "notes": "The slide uses a grid layout for headshots and a logo cloud at the bottom.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:46:16.198+00",
          "seconds": 3.332,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de075-3cec-7700-94db-076a5ce30d84/47",
        "deck": "/decks/019de075-3cec-7700-94db-076a5ce30d84",
        "deckAnchor": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-47",
        "deckJson": "/decks/019de075-3cec-7700-94db-076a5ce30d84.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.45,
            "w": 0.96,
            "x": 0.02,
            "y": 0.3
          },
          "kind": "image",
          "text": "Cameron Turtle, Jonathan Alspaugh, Cortney Caudill, Josh Friedman, Janet Gunzner-Toste, Andy Spencer, Justin LaFountaine, Russell J. Cox, Hunter C. Smith, Ivana Magovčević-Liebisch, Alison Lawton, Peter Harwin, Tomas Kiselak, Michael Henderson",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Headshot",
              "slug": "headshot",
              "status": "active",
              "canonId": "019de52c-fd5f-765c-9282-38b54f61bbbf",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headshot",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:16.198+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "03cb7f29-6865-4c34-a431-befc930d2ef6",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.84,
            "x": 0.08,
            "y": 0.78
          },
          "kind": "image",
          "text": "Apogee, BridgeBio, Eidos, Aeglea, Merck, Abbvie, Eisai, Sanofi Genzyme, Pandion, Fairmount, RA Capital, Dragonfly, Abcuro, Seagen, Adimab, TG Therapeutics, FairJourney Biologics",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Logo grid",
              "slug": "logo-grid",
              "status": "active",
              "canonId": "019de52c-fdd7-7409-93e5-81280a8ca215",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "logo-grid",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:16.198+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "ae97c666-5817-43b9-a245-8a136120b848",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.33,
            "x": 0.025,
            "y": 0.03
          },
          "kind": "title",
          "text": "Leadership and BOD",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:16.198+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "75a6c5ea-ca76-4c86-ac40-cb758b290038",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.04,
            "w": 0.18,
            "x": 0.635,
            "y": 0.215
          },
          "kind": "title",
          "text": "Board of Directors",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:16.198+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "94dd3b00-a6cb-490e-bea8-9d9a7ab8e83a",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.04,
            "w": 0.18,
            "x": 0.145,
            "y": 0.215
          },
          "kind": "title",
          "text": "Management team",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:16.198+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "bb3e9858-9864-41c8-8d26-5b7887e064c3",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [
        {
          "to": 56,
          "arc": {
            "name": "Problem-Agitate-Solution",
            "slug": "problem-agitate-solution",
            "status": "active",
            "bestFor": "Sales pitches, urgency-driven, competitive displacement",
            "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
            "description": null,
            "familyLabel": null
          },
          "from": 45,
          "name": "Action",
          "beatId": "712c62dc-223b-4b2c-ba9f-cd5c102db383",
          "matchId": "a1bcf76f-a4ea-452c-9399-8bc5a62efe28",
          "beatType": {
            "name": "Action",
            "slug": "monroes-sequence-action",
            "status": "active",
            "canonId": "019dd9b8-181e-760d-befc-010c2424fa89",
            "version": 1,
            "description": null
          },
          "evidence": "The document calls for action, outlining the company's plans and milestones",
          "position": 5,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Resolution",
            "slug": "resolution",
            "status": "active",
            "canonId": "019dd9b8-045d-703b-8dd7-e92aba3ba91b",
            "version": 1,
            "description": "How the deck ends. Required in 19/20 arcs. The exception (Sparkline) ends with new bliss which is functionally a resolution."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.9
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 48,
      "type": "resolution",
      "title": "The slide uses a table-based timeline structure to map specific drug candidates (SPY001-004) to expected regulatory and clinical milestones.",
      "function": "plan_implementation",
      "rawType": "roadmap",
      "block": null,
      "metadata": {
        "slideType": "roadmap",
        "slideTypeCanon": {
          "name": "Roadmap",
          "slug": "roadmap",
          "status": "active",
          "canonId": "019de52d-0a55-72bc-9b7b-a47ef109839c",
          "version": 1,
          "description": null
        },
        "function": "plan_implementation",
        "functionCanon": {
          "name": "Plan implementation",
          "slug": "plan_implementation",
          "status": "active",
          "canonId": "019de52d-14a2-77ea-b210-d6a95eed4823",
          "version": 1,
          "description": null
        },
        "density": "balanced",
        "densityScore": 34,
        "componentCount": 4,
        "textChars": 234,
        "nDataPoints": 1,
        "notes": "The slide uses a table-based timeline structure to map specific drug candidates (SPY001-004) to expected regulatory and clinical milestones.",
        "elementsJson": null,
        "confidence": 0.95,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:46:19.325+00",
          "seconds": 6.441,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de075-3cec-7700-94db-076a5ce30d84/48",
        "deck": "/decks/019de075-3cec-7700-94db-076a5ce30d84",
        "deckAnchor": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-48",
        "deckJson": "/decks/019de075-3cec-7700-94db-076a5ce30d84.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.08,
            "w": 0.92,
            "x": 0.04,
            "y": 0.83
          },
          "kind": "callout",
          "text": "$200M expected to fund broad pipeline into 2026 through multiple key value creation events",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": null,
            "subkind": {
              "name": "Primary callout",
              "slug": "primary",
              "status": "active",
              "canonId": "019de52c-fbd1-70eb-a9ce-8997f8674c1d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "primary",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:19.325+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "7eb3eced-1175-44de-93b8-38db71ffed83",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.65,
            "w": 0.92,
            "x": 0.04,
            "y": 0.17
          },
          "kind": "framework",
          "text": "Timeline of milestones",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Framework",
              "slug": "framework",
              "status": "active",
              "canonId": "019de52c-fa18-77c6-b10a-ccb8277ac0fa",
              "version": 1,
              "description": "Named conceptual framework instance."
            },
            "tool": null,
            "subkind": {
              "name": "Framework instance",
              "slug": "instance",
              "status": "active",
              "canonId": "019de52d-05a2-72af-be0b-7edc60708a03",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "instance",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:19.325+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "3dfe5f4d-2c07-44d4-9bff-5f7543ef4469",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.65,
            "w": 0.92,
            "x": 0.04,
            "y": 0.17
          },
          "kind": "table",
          "text": "Pipeline development table mapping SPY001-004 and combinations to 2024 and 2025 milestones.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Table",
              "slug": "table",
              "status": "active",
              "canonId": "019de52c-f9c8-7148-8119-eaac9594cd28",
              "version": 1,
              "description": "Tabular data layout."
            },
            "tool": null,
            "subkind": {
              "name": "Data table",
              "slug": "data",
              "status": "active",
              "canonId": "019de52d-02d5-75b8-8abf-88e92bf63569",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "data",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:19.325+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "d4037a1a-8842-45e3-8319-99be4d508f66",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.45,
            "x": 0.02,
            "y": 0.03
          },
          "kind": "title",
          "text": "Cash and anticipated milestones",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:19.325+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "0a299bc9-b08c-4964-95a4-1a94196108f2",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "fc4041ba-3fea-44d0-a062-44a83a1a24c9",
          "evidence": "The slide uses a horizontal timeline structure to track project milestones over time.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 11:46:19.325+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 48,
          "frameworkName": "gantt-chart"
        }
      ],
      "arcBeats": [
        {
          "to": 56,
          "arc": {
            "name": "Problem-Agitate-Solution",
            "slug": "problem-agitate-solution",
            "status": "active",
            "bestFor": "Sales pitches, urgency-driven, competitive displacement",
            "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
            "description": null,
            "familyLabel": null
          },
          "from": 45,
          "name": "Action",
          "beatId": "712c62dc-223b-4b2c-ba9f-cd5c102db383",
          "matchId": "a1bcf76f-a4ea-452c-9399-8bc5a62efe28",
          "beatType": {
            "name": "Action",
            "slug": "monroes-sequence-action",
            "status": "active",
            "canonId": "019dd9b8-181e-760d-befc-010c2424fa89",
            "version": 1,
            "description": null
          },
          "evidence": "The document calls for action, outlining the company's plans and milestones",
          "position": 5,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Resolution",
            "slug": "resolution",
            "status": "active",
            "canonId": "019dd9b8-045d-703b-8dd7-e92aba3ba91b",
            "version": 1,
            "description": "How the deck ends. Required in 19/20 arcs. The exception (Sparkline) ends with new bliss which is functionally a resolution."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.9
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 49,
      "type": "setup",
      "title": "The chart uses a custom range bar (min/max) with markers for IPO and Today's market cap.",
      "function": "compare_peers",
      "rawType": "peer_benchmark",
      "block": null,
      "metadata": {
        "slideType": "peer_benchmark",
        "slideTypeCanon": {
          "name": "Peer benchmark",
          "slug": "peer_benchmark",
          "status": "active",
          "canonId": "019de52d-08f0-7158-a78d-d7b5331fefaf",
          "version": 1,
          "description": null
        },
        "function": "compare_peers",
        "functionCanon": {
          "name": "Compare peers",
          "slug": "compare_peers",
          "status": "active",
          "canonId": "019de52d-1453-72ba-a367-9ba3d34c1630",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 55,
        "componentCount": 5,
        "textChars": 380,
        "nDataPoints": 20,
        "notes": "The chart uses a custom range bar (min/max) with markers for IPO and Today's market cap.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:46:16.543+00",
          "seconds": 3.355,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de075-3cec-7700-94db-076a5ce30d84/49",
        "deck": "/decks/019de075-3cec-7700-94db-076a5ce30d84",
        "deckAnchor": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-49",
        "deckJson": "/decks/019de075-3cec-7700-94db-076a5ce30d84.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.06,
            "w": 0.7,
            "x": 0.28,
            "y": 0.87
          },
          "kind": "callout",
          "text": "Initial financing rounds expected to generate valuable milestones.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": null,
            "subkind": {
              "name": "Primary callout",
              "slug": "primary",
              "status": "active",
              "canonId": "019de52c-fbd1-70eb-a9ce-8997f8674c1d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "primary",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:16.543+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "5d4af9bb-9e74-4342-9bd9-2299961f513c",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.35,
            "w": 0.22,
            "x": 0.24,
            "y": 0.28
          },
          "kind": "chart",
          "text": "Market cap range bars showing min, IPO, Today, and max values.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Chart",
              "slug": "chart",
              "status": "active",
              "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8",
              "version": 1,
              "description": "Quantitative chart."
            },
            "tool": null,
            "subkind": {
              "name": "Horizontal bar chart",
              "slug": "bar-horizontal",
              "status": "active",
              "canonId": "019de52c-fec4-7221-986b-1cb5f5e84b1f",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bar-horizontal",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:16.543+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "04b02226-7919-4b2b-8c60-943d1883007d",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.25,
            "x": 0.02,
            "y": 0.87
          },
          "kind": "source-note",
          "text": "NOTE: “Today” market cap as of April 17, 2023 SOURCE: FactSet. Company S-1s.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:16.543+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "95f0ed62-c34a-41ab-a304-894a7ba58dc9",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.65,
            "w": 0.96,
            "x": 0.02,
            "y": 0.188
          },
          "kind": "table",
          "text": "Peer company data including IPO raise, market cap range, clinical stage, and program status.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Table",
              "slug": "table",
              "status": "active",
              "canonId": "019de52c-f9c8-7148-8119-eaac9594cd28",
              "version": 1,
              "description": "Tabular data layout."
            },
            "tool": null,
            "subkind": {
              "name": "Data table",
              "slug": "data",
              "status": "active",
              "canonId": "019de52d-02d5-75b8-8abf-88e92bf63569",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "data",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:16.543+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "a1e975f1-2e10-45b5-80d9-fdebb7c597d8",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.85,
            "x": 0.02,
            "y": 0.04
          },
          "kind": "title",
          "text": "I&I companies with compelling science have maintained value even in market downturns",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:16.543+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "02faad48-d3f1-421a-9517-8f45c3bfbf0a",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [
        {
          "tool": {
            "name": "Table data",
            "slug": "table-data",
            "status": "active",
            "bestFor": null,
            "canonId": "019dd9e1-4fab-7168-a82f-b847350a006d",
            "version": 1,
            "bodyDocId": null,
            "description": "Tabular layouts of structured data.",
            "familyLabel": null,
            "categoryName": null,
            "categorySlug": null
          },
          "agent": null,
          "layer": "slide",
          "agents": null,
          "matchId": "ce71bf24-99fa-440e-b9c6-b3c2697eb0aa",
          "evidence": "The slide presents a table with peer company data.",
          "pageRefs": null,
          "priority": null,
          "whenToUse": null,
          "confidence": 0.7,
          "extraction": {
            "at": "2026-07-17 03:38:14.480807+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 49,
          "whyItWorks": null,
          "antipattern": null,
          "cardinality": "common",
          "narrativePurpose": null
        }
      ],
      "frameworks": [
        {
          "matchId": "0ac3f694-4d2c-4ba5-afb6-50ac7d8ae793",
          "evidence": "Comparing peer company performance metrics against internal projections.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 11:46:16.543+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 49,
          "frameworkName": "comparison_frame"
        }
      ],
      "arcBeats": [
        {
          "to": 56,
          "arc": {
            "name": "Problem-Agitate-Solution",
            "slug": "problem-agitate-solution",
            "status": "active",
            "bestFor": "Sales pitches, urgency-driven, competitive displacement",
            "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
            "description": null,
            "familyLabel": null
          },
          "from": 45,
          "name": "Action",
          "beatId": "712c62dc-223b-4b2c-ba9f-cd5c102db383",
          "matchId": "a1bcf76f-a4ea-452c-9399-8bc5a62efe28",
          "beatType": {
            "name": "Action",
            "slug": "monroes-sequence-action",
            "status": "active",
            "canonId": "019dd9b8-181e-760d-befc-010c2424fa89",
            "version": 1,
            "description": null
          },
          "evidence": "The document calls for action, outlining the company's plans and milestones",
          "position": 5,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Resolution",
            "slug": "resolution",
            "status": "active",
            "canonId": "019dd9b8-045d-703b-8dd7-e92aba3ba91b",
            "version": 1,
            "description": "How the deck ends. Required in 19/20 arcs. The exception (Sparkline) ends with new bliss which is functionally a resolution."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.9
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 50,
      "type": "evidence",
      "title": "The slide uses a timeline-based comparison to suggest that Spyre's assets are on a similar trajectory to high-value acquired assets.",
      "function": "cite_precedent",
      "rawType": "peer_benchmark",
      "block": null,
      "metadata": {
        "slideType": "peer_benchmark",
        "slideTypeCanon": {
          "name": "Peer benchmark",
          "slug": "peer_benchmark",
          "status": "active",
          "canonId": "019de52d-08f0-7158-a78d-d7b5331fefaf",
          "version": 1,
          "description": null
        },
        "function": "cite_precedent",
        "functionCanon": {
          "name": "Cite precedent",
          "slug": "cite_precedent",
          "status": "active",
          "canonId": "019de52d-142b-714b-86d4-58aad7b568ec",
          "version": 1,
          "description": null
        },
        "density": "balanced",
        "densityScore": 41,
        "componentCount": 4,
        "textChars": 282,
        "nDataPoints": 10,
        "notes": "The slide uses a timeline-based comparison to suggest that Spyre's assets are on a similar trajectory to high-value acquired assets.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:46:16.552+00",
          "seconds": 2.973,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de075-3cec-7700-94db-076a5ce30d84/50",
        "deck": "/decks/019de075-3cec-7700-94db-076a5ce30d84",
        "deckAnchor": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-50",
        "deckJson": "/decks/019de075-3cec-7700-94db-076a5ce30d84.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.05,
            "w": 0.62,
            "x": 0.02,
            "y": 0.85
          },
          "kind": "callout",
          "text": "Comparable acquisitions illustrate optionality that exists for potential exits.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": null,
            "subkind": {
              "name": "Primary callout",
              "slug": "primary",
              "status": "active",
              "canonId": "019de52c-fbd1-70eb-a9ce-8997f8674c1d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "primary",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:16.552+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "a7cb19f0-3864-461f-aaa5-e26101147947",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.15,
            "x": 0.02,
            "y": 0.91
          },
          "kind": "source-note",
          "text": "SOURCE: Press releases.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:16.552+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "79594a66-a718-4e0e-816a-c98dcfd30036",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.65,
            "w": 0.96,
            "x": 0.02,
            "y": 0.18
          },
          "kind": "table",
          "text": "Acquirer, Target, Deal economics, Status, Spyre timeline",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Table",
              "slug": "table",
              "status": "active",
              "canonId": "019de52c-f9c8-7148-8119-eaac9594cd28",
              "version": 1,
              "description": "Tabular data layout."
            },
            "tool": null,
            "subkind": {
              "name": "Data table",
              "slug": "data",
              "status": "active",
              "canonId": "019de52d-02d5-75b8-8abf-88e92bf63569",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "data",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:16.552+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "517f986a-f4f7-4f26-9d0e-2e2cdc3da2e5",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.85,
            "x": 0.02,
            "y": 0.04
          },
          "kind": "title",
          "text": "Acquisitions illustrate value of validated targets in I&I, which have supported multiple transactions >$1B per Spyre program",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:16.552+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "d038736d-4ac3-4fe4-b99a-c084321ecb76",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [
        {
          "tool": {
            "name": "Slide recipe: the peer-gap chart",
            "slug": "peer-gap-chart-recipe",
            "status": "active",
            "bestFor": null,
            "canonId": "019df269-2b04-75bc-ad85-e0179264bdd7",
            "version": 1,
            "bodyDocId": "019df269-2ae1-771d-9cd1-193a2e25f21c",
            "description": "The single most-copied slide in activism. This is the exact layout, used",
            "familyLabel": "slide-recipe",
            "categoryName": "Slide",
            "categorySlug": "slide"
          },
          "agent": "designer",
          "layer": "slide",
          "agents": [
            "designer"
          ],
          "matchId": "35dabfbe-d288-4f34-bc27-8b112c237339",
          "evidence": "Comparable acquisitions illustrate optionality that exists for potential exits.",
          "pageRefs": null,
          "priority": null,
          "whenToUse": null,
          "confidence": 0.7,
          "extraction": {
            "at": "2026-07-17 03:58:10.349255+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 50,
          "whyItWorks": null,
          "antipattern": null,
          "cardinality": null,
          "narrativePurpose": null
        }
      ],
      "frameworks": [
        {
          "matchId": "6407fe20-dd36-4c09-ac39-44a3f091b1db",
          "evidence": "Compares historical M&A data against internal pipeline milestones to establish valuation potential.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 11:46:16.552+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 50,
          "frameworkName": "comparison_frame"
        }
      ],
      "arcBeats": [
        {
          "to": 56,
          "arc": {
            "name": "Problem-Agitate-Solution",
            "slug": "problem-agitate-solution",
            "status": "active",
            "bestFor": "Sales pitches, urgency-driven, competitive displacement",
            "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
            "description": null,
            "familyLabel": null
          },
          "from": 45,
          "name": "Action",
          "beatId": "712c62dc-223b-4b2c-ba9f-cd5c102db383",
          "matchId": "a1bcf76f-a4ea-452c-9399-8bc5a62efe28",
          "beatType": {
            "name": "Action",
            "slug": "monroes-sequence-action",
            "status": "active",
            "canonId": "019dd9b8-181e-760d-befc-010c2424fa89",
            "version": 1,
            "description": null
          },
          "evidence": "The document calls for action, outlining the company's plans and milestones",
          "position": 5,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Resolution",
            "slug": "resolution",
            "status": "active",
            "canonId": "019dd9b8-045d-703b-8dd7-e92aba3ba91b",
            "version": 1,
            "description": "How the deck ends. Required in 19/20 arcs. The exception (Sparkline) ends with new bliss which is functionally a resolution."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.9
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 51,
      "type": "setup",
      "function": "state_next_steps",
      "rawType": "closing_ask",
      "block": null,
      "metadata": {
        "slideType": "closing_ask",
        "slideTypeCanon": {
          "name": "Closing ask",
          "slug": "closing_ask",
          "status": "active",
          "canonId": "019de52d-0aa4-750f-8aa1-8d622dd99f5c",
          "version": 1,
          "description": null
        },
        "function": "state_next_steps",
        "functionCanon": {
          "name": "State next steps",
          "slug": "state_next_steps",
          "status": "active",
          "canonId": "019de52d-14ca-70ac-b534-971f458cdf29",
          "version": 1,
          "description": null
        },
        "density": "sparse",
        "densityScore": 1,
        "componentCount": 1,
        "textChars": 9,
        "nDataPoints": 0,
        "notes": null,
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:46:14.86+00",
          "seconds": 1.228,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de075-3cec-7700-94db-076a5ce30d84/51",
        "deck": "/decks/019de075-3cec-7700-94db-076a5ce30d84",
        "deckAnchor": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-51",
        "deckJson": "/decks/019de075-3cec-7700-94db-076a5ce30d84.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.06,
            "w": 0.215,
            "x": 0.125,
            "y": 0.535
          },
          "kind": "title",
          "text": "Thank you",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:14.86+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "7515a9c2-3f15-4290-851a-ba41617ca696",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [
        {
          "to": 56,
          "arc": {
            "name": "Problem-Agitate-Solution",
            "slug": "problem-agitate-solution",
            "status": "active",
            "bestFor": "Sales pitches, urgency-driven, competitive displacement",
            "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
            "description": null,
            "familyLabel": null
          },
          "from": 45,
          "name": "Action",
          "beatId": "712c62dc-223b-4b2c-ba9f-cd5c102db383",
          "matchId": "a1bcf76f-a4ea-452c-9399-8bc5a62efe28",
          "beatType": {
            "name": "Action",
            "slug": "monroes-sequence-action",
            "status": "active",
            "canonId": "019dd9b8-181e-760d-befc-010c2424fa89",
            "version": 1,
            "description": null
          },
          "evidence": "The document calls for action, outlining the company's plans and milestones",
          "position": 5,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Resolution",
            "slug": "resolution",
            "status": "active",
            "canonId": "019dd9b8-045d-703b-8dd7-e92aba3ba91b",
            "version": 1,
            "description": "How the deck ends. Required in 19/20 arcs. The exception (Sparkline) ends with new bliss which is functionally a resolution."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.9
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 52,
      "type": "setup",
      "title": "The slide serves as a credibility transfer by showcasing the partner's team and achievements.",
      "function": "cite_precedent",
      "rawType": "team_bio",
      "block": null,
      "metadata": {
        "slideType": "team_bio",
        "slideTypeCanon": {
          "name": "Team bio",
          "slug": "team_bio",
          "status": "active",
          "canonId": "019de52d-0a7d-7394-ae5b-037478e71f1e",
          "version": 1,
          "description": null
        },
        "function": "cite_precedent",
        "functionCanon": {
          "name": "Cite precedent",
          "slug": "cite_precedent",
          "status": "active",
          "canonId": "019de52d-142b-714b-86d4-58aad7b568ec",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 83,
        "componentCount": 8,
        "textChars": 739,
        "nDataPoints": 4,
        "notes": "The slide serves as a credibility transfer by showcasing the partner's team and achievements.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:46:17.196+00",
          "seconds": 3.402,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de075-3cec-7700-94db-076a5ce30d84/52",
        "deck": "/decks/019de075-3cec-7700-94db-076a5ce30d84",
        "deckAnchor": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-52",
        "deckJson": "/decks/019de075-3cec-7700-94db-076a5ce30d84.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.13,
            "w": 0.08,
            "x": 0.74,
            "y": 0.348
          },
          "kind": "image",
          "text": "Hussam Shaheen, SVP Biotherapeutics",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Headshot",
              "slug": "headshot",
              "status": "active",
              "canonId": "019de52c-fd5f-765c-9282-38b54f61bbbf",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headshot",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:17.196+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "38ec050f-827e-4a2e-9810-62960a845e4f",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.13,
            "w": 0.08,
            "x": 0.87,
            "y": 0.348
          },
          "kind": "image",
          "text": "Jason Oh, VP Biology",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Headshot",
              "slug": "headshot",
              "status": "active",
              "canonId": "019de52c-fd5f-765c-9282-38b54f61bbbf",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headshot",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:17.196+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "4fd5bce6-72a1-4a30-a184-c81119dd1d42",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.13,
            "w": 0.08,
            "x": 0.61,
            "y": 0.568
          },
          "kind": "image",
          "text": "Shawn Russell, VP CMC",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Headshot",
              "slug": "headshot",
              "status": "active",
              "canonId": "019de52c-fd5f-765c-9282-38b54f61bbbf",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headshot",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:17.196+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "9ccf418f-3ed9-4dd3-beed-c7c6ba6efa13",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.13,
            "w": 0.08,
            "x": 0.61,
            "y": 0.348
          },
          "kind": "image",
          "text": "Evan Thompson, COO",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Headshot",
              "slug": "headshot",
              "status": "active",
              "canonId": "019de52c-fd5f-765c-9282-38b54f61bbbf",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headshot",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:17.196+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "b8a98f5e-0029-44a0-b48d-978a12683fbe",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.13,
            "w": 0.08,
            "x": 0.87,
            "y": 0.568
          },
          "kind": "image",
          "text": "Neta Batscha, VP Operations & Strategy",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Headshot",
              "slug": "headshot",
              "status": "active",
              "canonId": "019de52c-fd5f-765c-9282-38b54f61bbbf",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headshot",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:17.196+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "c3929f33-7409-4c3d-89a3-716bf6940926",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.13,
            "w": 0.08,
            "x": 0.74,
            "y": 0.568
          },
          "kind": "image",
          "text": "Cyrus Stacey, VP Quality",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Headshot",
              "slug": "headshot",
              "status": "active",
              "canonId": "019de52c-fd5f-765c-9282-38b54f61bbbf",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headshot",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:17.196+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "d46ed4f3-0c49-41a1-b45b-71b827fd0508",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.65,
            "w": 0.55,
            "x": 0.02,
            "y": 0.195
          },
          "kind": "list",
          "text": "Paragon Therapeutics was founded in 2021 by Fairmount. 21 Professionals with deep expertise in antibody engineering and drug development from across the industry. Capabilities augmented by facilities and scientists at FairJourney Biologics and contract research organizations across the globe. 12 Programs currently in development with lead program on track to enter clinical trials in 3Q23, less than 2 years from ideation. Launched first spinout, Apogee Therapeutics, in 2022, which went public in July 2023 in a $345M IPO.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:17.196+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "6ab503be-7093-4b5d-92bd-cbbb99beb509",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.75,
            "x": 0.02,
            "y": 0.04
          },
          "kind": "title",
          "text": "Spyre antibodies were developed by our partners at Paragon",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:17.196+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "d04603dd-14e9-41e4-b88f-bf7a07f3db78",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "e4f78b45-81bd-4c83-a26d-385126fc314b",
          "evidence": "Leveraging partner reputation to validate internal development",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 11:46:17.196+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 52,
          "frameworkName": "credibility-transfer"
        }
      ],
      "arcBeats": [
        {
          "to": 56,
          "arc": {
            "name": "Problem-Agitate-Solution",
            "slug": "problem-agitate-solution",
            "status": "active",
            "bestFor": "Sales pitches, urgency-driven, competitive displacement",
            "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
            "description": null,
            "familyLabel": null
          },
          "from": 45,
          "name": "Action",
          "beatId": "712c62dc-223b-4b2c-ba9f-cd5c102db383",
          "matchId": "a1bcf76f-a4ea-452c-9399-8bc5a62efe28",
          "beatType": {
            "name": "Action",
            "slug": "monroes-sequence-action",
            "status": "active",
            "canonId": "019dd9b8-181e-760d-befc-010c2424fa89",
            "version": 1,
            "description": null
          },
          "evidence": "The document calls for action, outlining the company's plans and milestones",
          "position": 5,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Resolution",
            "slug": "resolution",
            "status": "active",
            "canonId": "019dd9b8-045d-703b-8dd7-e92aba3ba91b",
            "version": 1,
            "description": "How the deck ends. Required in 19/20 arcs. The exception (Sparkline) ends with new bliss which is functionally a resolution."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.9
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 53,
      "type": "resolution",
      "function": "present_solution",
      "rawType": "solution",
      "block": null,
      "metadata": {
        "slideType": "solution",
        "slideTypeCanon": {
          "name": "Solution",
          "slug": "solution",
          "status": "active",
          "canonId": "019de52d-0eb5-72ff-8b70-ba70a4199282",
          "version": 1,
          "description": null
        },
        "function": "present_solution",
        "functionCanon": {
          "name": "Present solution",
          "slug": "present_solution",
          "status": "active",
          "canonId": "019de52d-15b8-71da-bd23-2b767850cbce",
          "version": 1,
          "description": null
        },
        "density": "balanced",
        "densityScore": 37,
        "componentCount": 4,
        "textChars": 359,
        "nDataPoints": 0,
        "notes": null,
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:46:16.269+00",
          "seconds": 2.385,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de075-3cec-7700-94db-076a5ce30d84/53",
        "deck": "/decks/019de075-3cec-7700-94db-076a5ce30d84",
        "deckAnchor": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-53",
        "deckJson": "/decks/019de075-3cec-7700-94db-076a5ce30d84.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.15,
            "w": 0.8,
            "x": 0.1,
            "y": 0.69
          },
          "kind": "callout",
          "text": "Established workflows and CRO relationships enable fast and reliable antibody discovery to generate novel drug candidates with best-in-class properties",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": null,
            "subkind": {
              "name": "Primary callout",
              "slug": "primary",
              "status": "active",
              "canonId": "019de52c-fbd1-70eb-a9ce-8997f8674c1d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "primary",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:16.269+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "505bd453-237a-4495-bd74-c2fbbf178f3c",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.35,
            "w": 0.85,
            "x": 0.08,
            "y": 0.32
          },
          "kind": "image",
          "text": null,
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Icon grid",
              "slug": "icon-grid",
              "status": "active",
              "canonId": "019de52c-fdfe-749d-9990-1db465a3eed4",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "icon-grid",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:16.269+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "abeb3026-adf9-48f5-bdba-7004f5b2eb7e",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.95,
            "x": 0.03,
            "y": 0.24
          },
          "kind": "paragraph",
          "text": "Antibody engineering expertise in a variety of techniques to fulfill the needs of a wide range of programs",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:16.269+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "27cc4ba3-fb64-4beb-9232-56846ae9ee46",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.85,
            "x": 0.02,
            "y": 0.04
          },
          "kind": "title",
          "text": "Diverse expertise in antibody discovery and engineering enables potentially best-in-class therapeutics",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:16.269+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "4314882d-b2ee-4d9f-b020-43c01c962e1f",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [
        {
          "to": 56,
          "arc": {
            "name": "Problem-Agitate-Solution",
            "slug": "problem-agitate-solution",
            "status": "active",
            "bestFor": "Sales pitches, urgency-driven, competitive displacement",
            "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
            "description": null,
            "familyLabel": null
          },
          "from": 45,
          "name": "Action",
          "beatId": "712c62dc-223b-4b2c-ba9f-cd5c102db383",
          "matchId": "a1bcf76f-a4ea-452c-9399-8bc5a62efe28",
          "beatType": {
            "name": "Action",
            "slug": "monroes-sequence-action",
            "status": "active",
            "canonId": "019dd9b8-181e-760d-befc-010c2424fa89",
            "version": 1,
            "description": null
          },
          "evidence": "The document calls for action, outlining the company's plans and milestones",
          "position": 5,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Resolution",
            "slug": "resolution",
            "status": "active",
            "canonId": "019dd9b8-045d-703b-8dd7-e92aba3ba91b",
            "version": 1,
            "description": "How the deck ends. Required in 19/20 arcs. The exception (Sparkline) ends with new bliss which is functionally a resolution."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.9
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 54,
      "type": "resolution",
      "title": "The slide uses a pentagon diagram to represent the five pillars of their antibody engineering platform.",
      "function": "present_solution",
      "rawType": "solution",
      "block": null,
      "metadata": {
        "slideType": "solution",
        "slideTypeCanon": {
          "name": "Solution",
          "slug": "solution",
          "status": "active",
          "canonId": "019de52d-0eb5-72ff-8b70-ba70a4199282",
          "version": 1,
          "description": null
        },
        "function": "present_solution",
        "functionCanon": {
          "name": "Present solution",
          "slug": "present_solution",
          "status": "active",
          "canonId": "019de52d-15b8-71da-bd23-2b767850cbce",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 53,
        "componentCount": 7,
        "textChars": 257,
        "nDataPoints": 0,
        "notes": "The slide uses a pentagon diagram to represent the five pillars of their antibody engineering platform.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:46:16.962+00",
          "seconds": 2.719,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de075-3cec-7700-94db-076a5ce30d84/54",
        "deck": "/decks/019de075-3cec-7700-94db-076a5ce30d84",
        "deckAnchor": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-54",
        "deckJson": "/decks/019de075-3cec-7700-94db-076a5ce30d84.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.12,
            "w": 0.15,
            "x": 0.54,
            "y": 0.15
          },
          "kind": "chart",
          "text": "Potency curve",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Chart",
              "slug": "chart",
              "status": "active",
              "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8",
              "version": 1,
              "description": "Quantitative chart."
            },
            "tool": null,
            "subkind": {
              "name": "Line chart",
              "slug": "line",
              "status": "active",
              "canonId": "019de52c-ff62-778f-8f6c-a952ceae8677",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "line",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:16.962+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "9232375a-e9b1-4e1e-a083-ced88c10d636",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.6,
            "w": 0.5,
            "x": 0.25,
            "y": 0.25
          },
          "kind": "diagram",
          "text": "Pentagonal framework of antibody properties",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Diagram",
              "slug": "diagram",
              "status": "active",
              "canonId": "019de52c-f9f0-734a-81de-15382ff28c65",
              "version": 1,
              "description": "Schematic or relational diagram."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": "other",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:16.962+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "c5df4b36-cd16-438b-b87c-81bbfcf2f6e8",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.1,
            "x": 0.85,
            "y": 0.35
          },
          "kind": "image",
          "text": "Safety icons",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Illustration",
              "slug": "illustration",
              "status": "active",
              "canonId": "019de52c-fe76-7772-a5ac-c0b7294d7615",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "illustration",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:16.962+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "177f5416-8a83-4396-89c3-f8abfb518901",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.25,
            "x": 0.03,
            "y": 0.5
          },
          "kind": "image",
          "text": "Pharmacokinetics syringe transition",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Illustration",
              "slug": "illustration",
              "status": "active",
              "canonId": "019de52c-fe76-7772-a5ac-c0b7294d7615",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "illustration",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:16.962+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "925a3791-6e47-47ea-ba83-3d5fc1b2dd00",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.2,
            "w": 0.3,
            "x": 0.65,
            "y": 0.65
          },
          "kind": "image",
          "text": "Manufacturability process flow",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Illustration",
              "slug": "illustration",
              "status": "active",
              "canonId": "019de52c-fe76-7772-a5ac-c0b7294d7615",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "illustration",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:16.962+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "af12c6ea-810a-4918-bfa2-03e558f29f59",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.2,
            "x": 0.15,
            "y": 0.85
          },
          "kind": "image",
          "text": "Formulatability syringe transition",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Illustration",
              "slug": "illustration",
              "status": "active",
              "canonId": "019de52c-fe76-7772-a5ac-c0b7294d7615",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "illustration",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:16.962+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "b97b21ea-3469-4900-aed6-ab90abc98af3",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.8,
            "x": 0.02,
            "y": 0.03
          },
          "kind": "title",
          "text": "Paragon aims to engineer best-in-class antibodies by optimizing across five key properties",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:16.962+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "c5cefa1b-7a72-451b-bd11-40aba588d97d",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [
        {
          "tool": {
            "name": "2x2 matrix",
            "slug": "matrix-2x2",
            "status": "active",
            "bestFor": null,
            "canonId": "019dd9e1-50ab-72d1-8afb-3ab0a38e32a8",
            "version": 1,
            "bodyDocId": null,
            "description": "BCG matrix, importance/urgency, any axes-and-quadrants frame.",
            "familyLabel": null,
            "categoryName": null,
            "categorySlug": null
          },
          "agent": null,
          "layer": "slide",
          "agents": null,
          "matchId": "e26f0613-b299-40a5-bfc3-5cdce52d9a98",
          "evidence": "The slide presents a pentagonal framework of antibody properties.",
          "pageRefs": null,
          "priority": null,
          "whenToUse": null,
          "confidence": 0.5,
          "extraction": {
            "at": "2026-07-17 03:38:14.592918+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 54,
          "whyItWorks": null,
          "antipattern": null,
          "cardinality": "common",
          "narrativePurpose": null
        }
      ],
      "frameworks": [
        {
          "matchId": "b062bcb0-3e9a-4e7e-ae11-f8ad490240ab",
          "evidence": "Visual representation of 5 key optimization pillars",
          "framework": null,
          "confidence": 0.8,
          "extraction": {
            "at": "2026-05-02 11:46:16.962+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 54,
          "frameworkName": "Pentagon Framework"
        }
      ],
      "arcBeats": [
        {
          "to": 56,
          "arc": {
            "name": "Problem-Agitate-Solution",
            "slug": "problem-agitate-solution",
            "status": "active",
            "bestFor": "Sales pitches, urgency-driven, competitive displacement",
            "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
            "description": null,
            "familyLabel": null
          },
          "from": 45,
          "name": "Action",
          "beatId": "712c62dc-223b-4b2c-ba9f-cd5c102db383",
          "matchId": "a1bcf76f-a4ea-452c-9399-8bc5a62efe28",
          "beatType": {
            "name": "Action",
            "slug": "monroes-sequence-action",
            "status": "active",
            "canonId": "019dd9b8-181e-760d-befc-010c2424fa89",
            "version": 1,
            "description": null
          },
          "evidence": "The document calls for action, outlining the company's plans and milestones",
          "position": 5,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Resolution",
            "slug": "resolution",
            "status": "active",
            "canonId": "019dd9b8-045d-703b-8dd7-e92aba3ba91b",
            "version": 1,
            "description": "How the deck ends. Required in 19/20 arcs. The exception (Sparkline) ends with new bliss which is functionally a resolution."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.9
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 55,
      "type": "resolution",
      "title": "The diagram illustrates the mechanism of FcRn-mediated antibody recycling, contrasting physiological affinity with high affinity.",
      "function": "present_solution",
      "rawType": "solution",
      "block": null,
      "metadata": {
        "slideType": "solution",
        "slideTypeCanon": {
          "name": "Solution",
          "slug": "solution",
          "status": "active",
          "canonId": "019de52d-0eb5-72ff-8b70-ba70a4199282",
          "version": 1,
          "description": null
        },
        "function": "present_solution",
        "functionCanon": {
          "name": "Present solution",
          "slug": "present_solution",
          "status": "active",
          "canonId": "019de52d-15b8-71da-bd23-2b767850cbce",
          "version": 1,
          "description": null
        },
        "density": "balanced",
        "densityScore": 38,
        "componentCount": 4,
        "textChars": 377,
        "nDataPoints": 0,
        "notes": "The diagram illustrates the mechanism of FcRn-mediated antibody recycling, contrasting physiological affinity with high affinity.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:46:17.318+00",
          "seconds": 2.99,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de075-3cec-7700-94db-076a5ce30d84/55",
        "deck": "/decks/019de075-3cec-7700-94db-076a5ce30d84",
        "deckAnchor": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-55",
        "deckJson": "/decks/019de075-3cec-7700-94db-076a5ce30d84.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.65,
            "w": 0.63,
            "x": 0.03,
            "y": 0.2
          },
          "kind": "diagram",
          "text": "Comparison of 1st gen mAb vs Spyre mAb recycling mechanism",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Diagram",
              "slug": "diagram",
              "status": "active",
              "canonId": "019de52c-f9f0-734a-81de-15382ff28c65",
              "version": 1,
              "description": "Schematic or relational diagram."
            },
            "tool": null,
            "subkind": {
              "name": "Process flow",
              "slug": "process",
              "status": "active",
              "canonId": "019de52d-039c-718f-ad3a-efe9c4b3c838",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "process",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:17.318+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "24164133-bb46-4c45-96be-0b882d22a0f4",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.35,
            "w": 0.28,
            "x": 0.68,
            "y": 0.35
          },
          "kind": "list",
          "text": "Spyre mAbs designed to be recycled back into circulation more readily; Drug exists at much higher levels for longer duration of effect; Fewer injections decrease patient burden and can improve compliance and penetration",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:17.318+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "1f87421f-fead-4c8b-be6c-b115aa379726",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.2,
            "x": 0.03,
            "y": 0.93
          },
          "kind": "source-note",
          "text": "SOURCE: Adapted from Ko S et al BioDrugs 2021",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:17.318+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "c41f860e-98c6-4048-b942-103c582c181f",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.85,
            "x": 0.02,
            "y": 0.03
          },
          "kind": "title",
          "text": "Spyre mAbs employ proven half-life extension technology",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:17.318+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "1ec648b9-622c-4e36-88a5-cc2be7d13e3c",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "89591c26-5439-4c90-9705-1378ea67a949",
          "evidence": "Visual flow of antibody recycling mechanism",
          "framework": null,
          "confidence": 0.8,
          "extraction": {
            "at": "2026-05-02 11:46:17.318+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 55,
          "frameworkName": "process"
        }
      ],
      "arcBeats": [
        {
          "to": 56,
          "arc": {
            "name": "Problem-Agitate-Solution",
            "slug": "problem-agitate-solution",
            "status": "active",
            "bestFor": "Sales pitches, urgency-driven, competitive displacement",
            "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
            "description": null,
            "familyLabel": null
          },
          "from": 45,
          "name": "Action",
          "beatId": "712c62dc-223b-4b2c-ba9f-cd5c102db383",
          "matchId": "a1bcf76f-a4ea-452c-9399-8bc5a62efe28",
          "beatType": {
            "name": "Action",
            "slug": "monroes-sequence-action",
            "status": "active",
            "canonId": "019dd9b8-181e-760d-befc-010c2424fa89",
            "version": 1,
            "description": null
          },
          "evidence": "The document calls for action, outlining the company's plans and milestones",
          "position": 5,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Resolution",
            "slug": "resolution",
            "status": "active",
            "canonId": "019dd9b8-045d-703b-8dd7-e92aba3ba91b",
            "version": 1,
            "description": "How the deck ends. Required in 19/20 arcs. The exception (Sparkline) ends with new bliss which is functionally a resolution."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.9
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 56,
      "type": "resolution",
      "title": "Includes two distinct chart types: a scatter plot for half-life correlation and bar charts for ADA rates.",
      "function": "present_solution",
      "rawType": "solution",
      "block": null,
      "metadata": {
        "slideType": "solution",
        "slideTypeCanon": {
          "name": "Solution",
          "slug": "solution",
          "status": "active",
          "canonId": "019de52d-0eb5-72ff-8b70-ba70a4199282",
          "version": 1,
          "description": null
        },
        "function": "present_solution",
        "functionCanon": {
          "name": "Present solution",
          "slug": "present_solution",
          "status": "active",
          "canonId": "019de52d-15b8-71da-bd23-2b767850cbce",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 50,
        "componentCount": 5,
        "textChars": 313,
        "nDataPoints": 6,
        "notes": "Includes two distinct chart types: a scatter plot for half-life correlation and bar charts for ADA rates.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:46:17.293+00",
          "seconds": 2.882,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de075-3cec-7700-94db-076a5ce30d84/56",
        "deck": "/decks/019de075-3cec-7700-94db-076a5ce30d84",
        "deckAnchor": "/decks/019de075-3cec-7700-94db-076a5ce30d84#slide-56",
        "deckJson": "/decks/019de075-3cec-7700-94db-076a5ce30d84.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.08,
            "w": 0.35,
            "x": 0.08,
            "y": 0.82
          },
          "kind": "callout",
          "text": "Extent of half-life extension dependent on target (soluble vs. membrane bound)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": null,
            "subkind": {
              "name": "Primary callout",
              "slug": "primary",
              "status": "active",
              "canonId": "019de52c-fbd1-70eb-a9ce-8997f8674c1d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "primary",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:17.293+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "c273a417-235b-4418-8d2e-8c9d07364d6c",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.6,
            "w": 0.4,
            "x": 0.55,
            "y": 0.25
          },
          "kind": "chart",
          "text": "ADA rates bar charts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Chart",
              "slug": "chart",
              "status": "active",
              "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8",
              "version": 1,
              "description": "Quantitative chart."
            },
            "tool": null,
            "subkind": {
              "name": "Vertical bar chart",
              "slug": "bar-vertical",
              "status": "active",
              "canonId": "019de52c-fe9d-70f2-b3b7-a9ae294f5917",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bar-vertical",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:17.293+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "90c96dbf-faf1-4bda-954e-50b10760bcd5",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.6,
            "w": 0.4,
            "x": 0.05,
            "y": 0.25
          },
          "kind": "chart",
          "text": "Human Half-Life vs Cyno Half-Life scatter plot",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Chart",
              "slug": "chart",
              "status": "active",
              "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8",
              "version": 1,
              "description": "Quantitative chart."
            },
            "tool": null,
            "subkind": {
              "name": "Scatter plot",
              "slug": "scatter",
              "status": "active",
              "canonId": "019de52d-007d-72ec-8689-c79fb78e21a2",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "scatter",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:17.293+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "d1117a66-2edb-4955-9d83-43c01c036aad",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.4,
            "x": 0.05,
            "y": 0.92
          },
          "kind": "source-note",
          "text": "Source: 1) Rocca, A, et al. Int J of Mol Sci, 2021; 2) Domachowske NEJM 2022",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:17.293+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "883dd5fd-7f33-4a08-8312-83609f9f7541",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.6,
            "x": 0.05,
            "y": 0.05
          },
          "kind": "title",
          "text": "YTE technology shown to significantly prolong half-life and without increasing immunogenicity",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:46:17.293+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e6b550ad-073e-480b-b997-ed2253739e6e",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [
        {
          "tool": {
            "name": "Waterfall chart",
            "slug": "waterfall-chart",
            "status": "active",
            "bestFor": null,
            "canonId": "e2799da3-725f-44a9-a093-570f1f388e64",
            "version": 1,
            "bodyDocId": null,
            "description": null,
            "familyLabel": null,
            "categoryName": null,
            "categorySlug": null
          },
          "agent": null,
          "layer": "slide",
          "agents": null,
          "matchId": "a4767ef7-79e0-4965-a4e9-ce1f6563efcb",
          "evidence": "chart/waterfall: not present, but chart/scatter and chart/bar-vertical are present",
          "pageRefs": null,
          "priority": null,
          "whenToUse": null,
          "confidence": 0.8,
          "extraction": {
            "at": "2026-07-17 03:38:15.304113+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 56,
          "whyItWorks": null,
          "antipattern": null,
          "cardinality": null,
          "narrativePurpose": null
        }
      ],
      "frameworks": [],
      "arcBeats": [
        {
          "to": 56,
          "arc": {
            "name": "Problem-Agitate-Solution",
            "slug": "problem-agitate-solution",
            "status": "active",
            "bestFor": "Sales pitches, urgency-driven, competitive displacement",
            "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
            "description": null,
            "familyLabel": null
          },
          "from": 45,
          "name": "Action",
          "beatId": "712c62dc-223b-4b2c-ba9f-cd5c102db383",
          "matchId": "a1bcf76f-a4ea-452c-9399-8bc5a62efe28",
          "beatType": {
            "name": "Action",
            "slug": "monroes-sequence-action",
            "status": "active",
            "canonId": "019dd9b8-181e-760d-befc-010c2424fa89",
            "version": 1,
            "description": null
          },
          "evidence": "The document calls for action, outlining the company's plans and milestones",
          "position": 5,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Resolution",
            "slug": "resolution",
            "status": "active",
            "canonId": "019dd9b8-045d-703b-8dd7-e92aba3ba91b",
            "version": 1,
            "description": "How the deck ends. Required in 19/20 arcs. The exception (Sparkline) ends with new bliss which is functionally a resolution."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.9
        }
      ],
      "loops": [],
      "locked": true
    }
  ],
  "arcBeats": [
    {
      "from": 1,
      "to": 4,
      "label": "Setup",
      "description": "The document sets up the company and its mission"
    },
    {
      "from": 5,
      "to": 8,
      "label": "Problem (Identify pain)",
      "description": "The document identifies the problem and the need for new approaches"
    },
    {
      "from": 9,
      "to": 12,
      "label": "Agitate (Make it worse)",
      "description": "The document agitates the problem, highlighting the limitations of current treatments"
    },
    {
      "from": 13,
      "to": 30,
      "label": "Solution (Provide relief)",
      "description": "The document presents the company's solution, including its pipeline and strategy"
    },
    {
      "from": 31,
      "to": 44,
      "label": "Evidence",
      "description": "The document provides evidence to support the company's solution"
    },
    {
      "from": 45,
      "to": 56,
      "label": "Action",
      "description": "The document calls for action, outlining the company's plans and milestones"
    }
  ],
  "loops": [
    {
      "from": 5,
      "to": 12,
      "label": "Golden Circle",
      "description": "Why is this important?"
    },
    {
      "from": 9,
      "to": 12,
      "label": "Cost Of Inaction",
      "description": "What are the consequences of not acting?"
    },
    {
      "from": 13,
      "to": 30,
      "label": "Quick Win Big Bet",
      "description": "What is the company's solution?"
    }
  ]
}